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 Noroviruses are common pathogens associated with gastroenteritis in 
humans. As single-stranded positive-sense RNA viruses, noroviruses achieve their 
genome replication through the synthesis of negative strand RNA intermediates that 
template the generation of new positive strand RNA genomes. The murine norovirus 
(MNV) RNA-dependent RNA polymerase (NS7) protein which is a key player in 
catalysing this process, has been characterised in this study.  
 Tandem affinity purification of MNV NS7 was performed in order to identify 
host cell factors which interact with the NS7 protein. Proteomic analysis 
demonstrated that guanosine monophosphate reductase and N(2)-
dimethylguanosine tRNA methyltransferase could potentially interact with the MNV 
NS7. Furthermore, affinity selection of small peptides which specifically bind to the 
NS7 was carried out by using the phage display technique in an effort to generate 
peptide inhibitors. Peptide phage with two different conserved motifs and several 
peptide phage pools with binding activity to the NS7 were successfully identified. 
However, further cross-binding analysis using ELISA demonstrated that these 
peptide phage possibly bound non-specifically to the MNV NS7.  
 An optimised RNA based reverse genetics system and reporter-tagged 
replicon system for MNV were also successfully developed and used to quantify the 
effects of specific mutations in the MNV genome on viral replication in tissue culture. 
Using these newly developed systems, the functional role of a small stem loop 
structure located upstream of the start site of the subgenomic RNA was 
characterised. This was identified as the potential viral RNA polymerase promoter 
responsible for subgenomic RNA synthesis. Furthermore, identification and 
characterisation of this stem loop using mutations suggested the potential 
involvement of long range RNA-RNA interactions (on negative strand RNA) in 
regulating the norovirus subgenomic RNA synthesis.  
 Overall, this study has unveiled the importance of protein-protein interactions 
and RNA-protein interactions in regulating norovirus replication. These interactions 
could provide interesting targets for antiviral therapeutic intervention in the future. 
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SDS   sodium dodecyl sulfate 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SG RNA  subgenomic RNA 
SP   sepharose 
STAT-1  signal transducer and activation of transcription 1 
T   thymine 
TAP   tandem affinity purification 
TBS   tris buffered saline 
TBST   tris buffered saline containing Tween 20 
TBSV   tomato bushy stunt virus 
TCID50  tissue culture infectious dose 50 
TetR   tetracycline repressor 
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TEV   tobacco etch virus 
TURBs  termination upstream ribosome binding site motif 
U   uracil 
UnTFN  untransfected 
UTR   untranslated region 
v/v    volume per volume 
VAP   vesicle associated membrane protein 
VLP   viral-like particle 
VPg   viral protein linked genome 
WT   wild type 
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 Acute gastroenteritis (GE), also known as gastric flu and stomach flu, is an 
inflammation of the gastrointestinal tract resulting in acute diarrhoea, cramps, 
abdominal pain, nausea and vomiting. The most common causal agents of this 
disease are viruses such as the rotaviruses, astroviruses, enteric adenoviruses and 
human caliciviruses, but others include torovirus, coronavirus and picobirnaviruses 
(Wilhelmi et al., 2003). In addition, GE can also be caused by non-viral agents like 
bacteria (Salmonella, Shigella and Campylobacter) and parasites (Giardia). Most 
cases of epidemic viral GE in the developed world are due to human calicivirus 
infections (Lopman et al., 2003).  
1.1  Caliciviruses 
1.1.1 Classification and taxonomy 
 There are five established genera within the family of Caliciviridae as detailed 
in Figure 1.1 (Kitchen et al., 2011). In addition, three additional unclassified 
caliciviruses have been proposed and may represent three new genera according to 
the Ninth Report of the International Committee on Taxonomy of Viruses (ICTV) in 
2011. Of the recognised genera, the Norovirus and Sapovirus genera contain the 
viruses that are predominantly responsible for acute gastroenteritis infections in 
humans. The Norovirus genus is further classified into 5 genogroups based on the 
amino acid sequences of the major capsid protein (Ando et al., 2000; Green et al., 
2000; Katayama et al., 2002; Zheng et al., 2006). Noroviruses within genogroups I, II 
and IV infect humans, as well as porcine (group II), canine and feline species (group 
IV) (Scipioni et al., 2008). Meanwhile genogroups III and V comprise the bovine and 
murine noroviruses respectively (Bailey, 2009; Estes et al., 2006). The Sapovirus 
genus (also known as “Sapporo-like viruses”) includes Manchester virus and porcine 
enteric calicivirus (PEC). The Vesivirus genus can be sub-divided into 2 main groups, 
the Feline calicivirus (FCV) which mainly infects cats and the ‘ocean virus’ group, 
which includes San Miguel sea lion virus found in marine and terrestrial mammals 
(Neill et al., 1995). The Rabbit haemorrhagic disease virus (RHDV) and the 
European brown hare syndrome virus (EBHSV) belong to the Lagovirus genus and 
cause a rapidly progressive, and frequently fatal, haemorrhagic disease in rabbits 
(Thiel and Konig, 1999). The fifth genus is recognised as Nebovirus which includes 
bovine calicivirus Newbury-1 which has been identified as one of the causes of 
diarrhoea and intestinal disease in calves (Oliver et al., 2006). In addition to these 
five established genera there are also three unclassified calciviruses (proposed to the 
ICTV) that could potentially represent new calicivirus genera. Of these three potential 
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genera, the first proposed recovirus genus contains the Tulane virus that infects 
rhesus macaques (Farkas et al., 2008). The second proposed valovirus genus is 
represented by the St. Valerien-like virus which infects swine and was first isolated in 
Quebec, Canada between 2005 and 2007 (L'Homme et al., 2009). The third 
proposed genus is the chicken calicivirus. 
 
1.1.2 Disease and epidemiology 
 Caliciviruses are now established as the causative agents for a number of 
human and veterinary diseases. Human caliciviruses (HuCv) can be found in both 
the Norovirus and Sapovirus genera of the Caliciviridae family. These viruses are 
often associated with outbreaks of gastroenteritis in hospitals, cruise ships, schools, 
nursing homes and military camps where close person to person contact cannot be 
 
         
Figure 1.1 Phylogenetic relationships among caliciviruses. Maximum-likelihood tree of 
the Caliciviridae family. Analysis is based on the amino acid sequence of the capsid 
region of caliciviruses. The scale bar indicates the distance ratio (amino acid substitution). 
TV represents the Tulane virus from the proposed recovirus genus. The figure is adapted 
from (Kitchen et al., 2011).  
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avoided (Bailey, 2009). Infection is typically followed by a 24 to 48 hour incubation 
period before emergence of the clinical disease, symptoms of which include acute 
diarrhoea and projectile vomiting, usually accompanied by several signs / symptoms 
such as abdominal cramps, myalgia, malaise, headache, nausea and low grade fever 
(Dolin et al., 1971; Hardy, 1999). HuCv infection is usually self-limiting and the 
symptoms typically last between 12 and 60 hours (Hardy, 1999). However, viral 
shedding can be prolonged for up to several weeks after the symptoms are resolved, 
especially in persons with impaired immunity where persistent infection can occur 
(Atmar et al., 2008; Gallimore et al., 2006). More importantly, illness among the 
elderly and immunocompromised patients can be fatal due to the associated severe 
dehydration. Recent findings also demonstrated that norovirus infections are 
associated with significant clinical diseases like an outbreak of neonatal enterocolitis, 
the occurrence of convulsive disorders in infants and exacerbation of inflammatory 
bowel disease in children (Chen et al., 2009; Khan et al., 2009; Turcios-Ruiz et al., 
2008) 
 The main transmission route for HuCv is via the faecal-oral route, through 
contaminated food, water or surfaces (Bailey, 2009; Boxman et al., 2009). 
Consumption of contaminated fresh produce food such as salads, fruits and 
sandwiches, that require no prior heating, has also been cited as a possible frequent 
source of food-borne infections (Widdowson et al., 2005b). Furthermore, a high 
concentration of norovirus also has been found within the gastrointestinal tissue of 
contaminated bivalves such as oysters and mussels that are filter feeders. Therefore, 
these contaminated bivalves are also considered as another important foodborne 
source of norovirus infection (Tian et al., 2007). Airborne transmission has also been 
demonstrated involving the aerosolised vomit from an infected person (Marks et al., 
2000; Widdowson et al., 2005a). These findings are supported by the low infectious 
dose required for norovirus infection; less than 10 viral particles are sufficient to 
establish infection with Norwalk virus (Teunis et al., 2008).  
 Noroviruses are the most common cause of gastroenteritis infections due to 
their stability, low infectious dose, large host reservoir (humans), short term 
immunity, multiple transmission routes and the large genetic diversity between 
strains (Estes et al., 2006). First described as Norwalk virus, which was responsible 
for a gastroenteritis outbreak at a school in Norwalk, Ohio US, in 1968 (Kapikian, 
2000), human noroviruses (HuNv) are today recognised as the leading cause of viral 
gastroenteritis infections in the human population. The United States Centre for 
Disease Control and Prevention (CDC) has estimated that noroviruses are 
responsible for at least 23 million cases of food borne illness each year in the United 
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States with approximately 50 thousand hospitalisations and 300 deaths (Estes et al., 
2006; Mead et al., 1999). In a recent review which involved a period of study from 
1996 to 2007, it was estimated that nearly 110,000 hospitalisation per epidemic years 
occurred with a cost of approximately 500 million US dollars (Lopman et al., 2011). 
Surveillance data from the Food Borne Viruses in Europe Network indicates that 
more than 85% of viral gastroenteritis outbreaks that occurred between 1995 and 
2000 could be attributed to these viruses (Estes et al., 2006; Lopman et al., 2003). 
The cost to the United Kingdom National Health Service (NHS) in England and 
Wales as a direct result of the outbreaks occurring in hospitals was estimated to be 
approximately 115 million pounds in 2002-2003 (Lopman et al., 2004). However, due 
to the acute nature of the infection, it is difficult to identify all the norovirus infection 
cases and therefore the real cost could be considerably higher. Furthermore, the 
global impact of GE caused by HuCv is hard to estimate since most of the annual 3.5 
to 5 million deaths caused by GE are in the developing world which in parts, has 
inadequate healthcare, surveillance and diagnostic systems in place to record and 
characterise infections (Bailey, 2009).  
 As mentioned, caliciviruses also infect animals, however the clinical 
symptoms and diseases are different from one animal to another. Murine 
noroviruses, (MNV) are highly common enteric pathogens in laboratory mice colonies 
with up to 64.3% of the population being found positive for MNV in some instances 
(Henderson, 2008; Muller et al., 2007). In the livestock sector, bovine caliciviruses 
from the Nebovirus genus (Newbury 1 virus) and the Norovirus genogroup III (Jena 
virus & Newbury 2 virus) are common enteric pathogens in cattle (Liu et al., 1999; 
Oliver et al., 2006; Scipioni et al., 2008; Woode and Bridger, 1978). The porcine 
noroviruses are also found as a common enteric pathogen in swine species (Farkas 
et al., 2005). FCV infection of cats causes an acute oral and upper respiratory 
system disease which is also known as ‘cat flu’ since the clinical symptoms are 
similar to those caused by influenza virus in humans (TerWee et al., 1997). 
Interestingly, a higher prevalence of FCV was reported for cats that live in large 
colonies compared to domestic cats (Radford et al., 2007). Animal caliciviruses that 
infect lagomorphs (rabbits and hares) include RHDV and EBSHV respectively. These 
viruses cause a fatal haemorrhagic disease in both animals and RHDV in fact has 
been used to control rabbit populations in some countries like Australia and New 
Zealand (Forrester et al., 2003). Unlike for noroviruses, there are commercially 
available vaccines available for FCV and RHDV. Licensed vaccines for FCV consist 
of live attenuated and inactivated viruses grown in cell culture. These vaccines are 
generally safe and effective at reducing or preventing classical oral /respiratory 
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disease in cats. However, they do not provide full protection (Radford et al., 2007). 
As for RHDV, effective vaccines that give full protection against the disease are 
recombinant vaccines generated through expression of the VP60 capsid protein of 
RHDV (Castanon et al., 1999; Fernandez et al., 2011; Henning et al., 2005). 
1.1.3 Morphology and genome organisation 
 The first calicivirus virion to be observed by immune-electron microscopy was 
Norwalk virus in 1972 by Albert Kapikian (Figure 1.2a). Calicivirus particles are 
icosahedral, with a diameter ranging from 27 to 39 nm and a buoyant density of 1.36 
± 0.04 g/cm3 (Estes et al., 2006; Kapikian, 2000; Karst et al., 2003; Venkataram 
Prasad et al., 2000). Calicivirus capsids are composed of 180 copies of a major 
protein VP1 (formed into 90 dimers) (Figure 1.2b) and one or two copies of the minor 
capsid protein VP2 (Hutson et al., 2004; Konig et al., 1998; Prasad et al., 1999; 
Sosnovtsev and Green, 2000). Studies using Norwalk virus-like particles (VLPs) 
revealed that the major protein VP1 is structurally divided into two domains referred 
to as the ‘shell’ (S) and ‘protruding’ (P) domain, with the P domain being further 
divided into P1 and P2 subdomains (Figure 1.2b) (Prasad et al., 1999). The inner S 
domain sub units interact with neighbouring S domains to form a continuous ‘internal 
shell’ structure to the capsid while the P domain emanates from the S domain 
surface forming cup-like structures (Figure 1.2b). Furthermore, the outer P2 
subdomain has been recognised as the most variable region of the calicivirus capsid 
and the region that determines the species-specific binding of these viruses to their 
respective cell receptors (Chen et al., 2004; Tan et al., 2004).   
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 The calicivirus capsid encloses the viral genome, a positive-sense single 
stranded RNA molecule of about 7.4 to 8.3 kb in size. The genome has a virus 
encoded protein covalently linked to the 5’ end (VPg) and a poly A tail at the 3’ end 
(Schaffer et al., 1980). This genomic RNA (G RNA) is thought to usually encode two 
or three open reading frames (ORFs) flanked by two short untranslated regions 
(UTRs) (Carter et al., 1992; Sosnovtsev et al., 2006). The structure of the genome is 
conserved in all caliciviruses, however they differ in the length of each ORF. Within 
the Norovirus and Vesivirus genera there are typically three distinct open reading 
frames (ORFs) with a small degree of overlap at the 5’ and 3’ junctions between 
ORF1 and ORF2. The capsid encoding regions of the genome are in frame (ORF1) 
for the Sapovirus, Lagovirus and Nebovirus which results in only 2 distinct ORFs for 
these viruses (Figure 1.3) (Clarke and Lambden, 2000; Oliver et al., 2006). 
Interestingly, within the Norovirus genus, MNV contains a fourth alternative open 
reading frame (ORF4) which overlaps ORF2 in a +1 frameshift and the encoded 
protein appears to function as an innate immune antagonist (McFadden et al., 2011). 
There is also an additional, and comparable, ORF4 overlapping reading frame at the 
same position in some viruses within the Sapovirus genus, specifically Manchester 
virus, Sapporovirus and Parkville virus (Clarke and Lambden, 2000).  
(a)     (b) 
        
 
Figure 1.2 Physical morphology of Norwalk virus. (a) Electron microscopic image of 
Norwalk virus, white bar represents 50 nm (adapted from www.epa.gov) (b) Cryo-
electron microscopic reconstruction and x-ray crystallography of the Norwalk viral like 
particles (VLPs), (top; virus surface, bottom; cross-section, left; dimer structure of capsid, 
right; monomeric capsid with domains) (Hutson et al., 2004). 
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1.1.4 The study of caliciviruses 
 Progress on molecular studies of HuCv has been impeded compared to other 
mammalian positive-sense RNA viruses. This is predominantly due to an inability to 
propagate HuCv efficiently in tissue culture systems. Therefore, the ultimate objective 
of developing and discovering reliable and effective vaccines or antiviral drugs for 
these important pathogens has also been delayed. Despite numerous efforts in a 
number of cell types (human gastrointestinal epithelial cells as well as other human 
and animal tissues) with various manipulations, a routine cell culture system for 
HuCv has yet to be determined (Duizer et al., 2004). However, a recent discovery 
demonstrated that human hepatoma Huh-7 cells transfected with Norwalk virus RNA 
                  
 
Figure 1.3 Schematic representation of the genome organisation of caliciviruses. A 
nonstructural polyprotein is encoded by the first open reading frame (ORF1; black box) of 
the genome. The major capsid protein (shaded area) is in frame for the sapoviruses, 
lagoviruses and neboviruses while it is in the +1 frame for noroviruses and −1 frame for 
the vesiviruses. A minor capsid protein is encoded at the 3′ end of the genome for all four 
genera (clear box). A fourth alternative ORF (ORF4; red box) is only thought to exist in 
MNV and not in other noroviruses, and only some sapovirus members possess an 
alternative open reading frame at the equivalent position. The figure is adapted from 
Atmar and Estes, 2001. 
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isolated from human stool samples were able to undergo a single cycle of replication. 
This results in viral protein expression and synthesis of new virus particles, indicating 
that the viral RNA is infectious (Guix et al., 2007). Although transfection of purified 
viral VPg-linked RNA enabled a single cycle of replication, the synthesised viruses 
were unable to infect other cells, resulting in no further amplification. This observation 
supports the hypothesis that receptor binding and/or genome uncoating are the major 
barriers in obtaining the successful cultivation of HuCv in tissue culture (Guix et al., 
2007). Recently, it has been reported that infection of a 3D-organoid tissue culture 
model of human small intestine epithelium (INT-407) with HuNv from stool samples 
resulted in infectious virus progeny (Straub et al., 2007). However, the reliability of 
this system has yet to be validated by an independent laboratory and it is unlikely to 
be widely used because it is very costly, technically demanding and requires 
specialist equipment (Vashist et al., 2009). Even though there is no readily available 
system for the cultivation of HuCv in cell culture, alternative approaches to study 
HuCv are also available. The development of a stable viral replicon system that is 
maintained in human Huh-7 cells or the hamster BHK-21 cell line has facilitated 
some studies (Chang et al., 2006). Through the application of this system, various 
potential antiviral molecules such as ribavirin and IFN-γ (Chang and George, 2007), 
as well as peptide conjugated phosphorodiamidate morpholino oligomers (PPMOs) 
targeting the norovirus genome (Bok et al., 2008) have been identified. Furthermore, 
the use of recombinant viral like particles (VLPs) has also enabled extensive studies 
on norovirus binding to cells (Jiang et al., 1992; Taube et al., 2005). 
 Despite a delay in the molecular understanding of HuCv life cycle, there have 
been several advances achieved using animal caliciviruses as surrogates. Animal 
caliciviruses are frequently used as surrogate systems for HuCv since many of them 
grow efficiently in tissue culture cell lines. The availability of virus propagation in 
tissue culture and reverse genetics system for FCV has made it a common model 
system for the study of HuCv (Sosnovtsev and Green, 1995). Even though it does 
not accurately represent HuCv disease, (FCV causes respiratory and systemic 
disease while HuCv causes gastroenteritis), several advances have been made by 
using the FCV system. For instance, studies using FCV led to the identification of 
functional interactions between a host cell factor and the viral RNA genome where 
the polypyrimidine tract binding protein is required for FCV replication (Karakasiliotis 
et al., 2006).  Comparable interactions have also been observed for HuNv using in 
vitro assays (Sandoval-Jaime and Gutierrez-Escolano, 2009). However, the 
functional role of these interactions in the HuNv life cycle has yet to be elucidated. 
Another attractive model system for studying HuCv, specifically the human 
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Sapovirus, is through the employment of animal sapoviruses as models, namely 
porcine enteric calicivirus (PEC). A reverse genetics system based on the 
transfection of bile acid treated porcine kidney cell line (LLC-PK) with capped RNA 
transcripts derived from a cDNA clone of the Cowden strain of PEC has been 
established (Chang et al., 2005). Recently, pathogenesis studies using newborn 
calves infected with Jena virus (Norovirus genotype III) have also been carried out to 
try and understand the pathological aspects of norovirus infection (Otto et al., 2011). 
Furthermore, the recovery of another newly identified calicivirus from the stool 
samples of rhesus macaques, namely Tulane virus (in the proposed Recovirus 
genus), has also led to the development of a reverse genetics system and 
interestingly this primate virus grows well in monkey kidney cells (Farkas et al., 2008; 
Wei et al., 2008). It is hoped that with the availability of both these systems, more 
studies regarding the replication mechanism and other aspects of the calicivirus life 
cycle can be determined. However, for in vivo studies, both of the models require the 
involvement of specialist equipment and high cost to maintain the large animals. Due 
to this, other animal caliciviruses, primarily MNV, are often preferentially used for 
molecular studies since they can be propagated in tissue culture (Karst et al., 2003; 
Wobus et al., 2004; Wobus et al., 2006). In addition, there are well established 
reverse genetics systems available for MNV (Chaudhry et al., 2007; Ward et al., 
2007; Yunus et al., 2010). 
1.1.5 The virus life cycle  
1.1.5.1 Attachment and entry 
 Like all viruses, the life cycle of caliciviruses begins with the attachment of the 
viral particles to their specific receptor on the membrane of the host cell (Figure 1.4). 
Susceptibility to norovirus infections in humans, specifically Norwalk virus, is 
associated with ABO histo-blood group antigens (HBGA) and individual secretor 
status (Huang et al., 2003). HBGA are carbohydrates found on the gut’s epithelial 
cells (Dolin, 2007; Estes et al., 2006; Hutson et al., 2004). These carbohydrate 
molecules are involved in the attachment of noroviruses but are unlikely to be the 
main proteinaceous receptor and co-receptors may also be involved (Dolin, 2007). 
Interestingly, the secretor status of individuals also determines the susceptibility to 
norovirus infections (Hutson et al., 2005). Individuals who are non-secretors of H type 
1 were found to be resistant to norovirus infections due to a mutation in the α-(1,2)-
fucosyltransferase (FUT2) gene,  involved in the production of H-type 1 antigen in 
saliva and mucosa  (Thorven et al., 2005). Studies on FCV have found that its entry 
occurs via clathrin-mediated endocytosis followed by acidification of the endosome 
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which uncoats the capsid thus allowing the release of the viral genome into the host 
cell cytoplasm (Stuart and Brown, 2006). Further detailed studies on FCV also 
demonstrated that the immunoglobulin-like superfamily member junctional adhesion 
molecule 1 (JAM-1) and α-(2,6)-sialic acid act as a functional receptor at the cell 
surface (Makino et al., 2006; Stuart and Brown, 2007). Studies using murine 
macrophages which support the propagation of MNV have found that terminal sialic 
acid moieties present on gangliosides can act as a receptor for MNV (Taube et al., 
2009). MNV entry into permissive cells has also been shown to be pH independent 
(Perry et al., 2009). 
 
1.1.5.2 Translation of viral proteins 
 After entry of the positive sense viral genome into the host cell cytoplasm, it 
can immediately act as mRNA for protein synthesis. The calicivirus VPg (viral protein 
genome link) protein is a 13-15 kDa non-structural protein covalently linked to the 5’ 
end of the viral genomic (G RNA) and subgenomic RNA (SG RNA) and acts as a cap 
substitute. The VPg protein recruits host cells translation initiation factors in initiating 
      
Figure 1.4 Schematic representation of the positive strand RNA virus life cycle. 
Starting with viral entry, the released viral RNA acts as messenger RNA resulting in 
immediate translation of viral non structural and structural proteins. The non structural 
proteins facilitate the formation of membrane-bound replication complexes and initiate the 
synthesis of viral positive strand RNA via a negative sense intermediate. The resulting 
positive strand RNA genomes are then encapsidated to form a mature virion and released 
from the infected cells. This figure is taken from Arturo Diaz, 2009. 
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the translation process to produce viral proteins (Daughenbaugh et al., 2003; 
Goodfellow et al., 2005). This mechanism is a unique strategy employed by 
caliciviruses to ensure the preferential translation of their RNA over host cell mRNA 
which possess a classical 5’ cap structure. All caliciviruses use this translational 
strategy since their 5’UTR is relatively short (only 5 nucleotides in MNV) compared to 
the closely related picornavirus genome which contains a much longer 5’UTR. Even 
though the picornavirus genome also possesses a VPg at the 5’end, this smaller 
protein (~22 amino acids) does not have any sequence homology with the calicivirus 
VPg and is not involved in picornavirus translation. Indeed, picornavirus translation is 
driven by the presence of an internal ribosomal entry site (IRES) structure within its 
5’UTR (Liu et al., 2009b). Translation of the first open reading frame of noroviruses 
typically yields a large polyprotein, representing the non-structural proteins. This 
large polyprotein is subjected to further processing by the virus encoded 3C-like 
(3CL) protease at five specific protease cleavage sites yielding six mature forms of 
the non-structural proteins (Blakeney et al., 2003; Liu et al., 1996). Sosnovtsev et al. 
have demonstrated that the proteolytic processing of MNV non-structural proteins in 
an in vitro system closely correlates to the products observed in infected RAW264.7 
cells (Sosnovtsev et al., 2006). Uncleaved precursor proteins like NS6/NS7 (Pro-Pol) 
and NS1/NS2 can also be detected (Sosnovtsev et al., 2006). Furthermore, in 
infected cells, the FCV protease and polymerase functions as a fusion protein called 
p76 while for MNV these proteins must be separated in order to be functionally active 
(Sosnovtsev et al., 2006; Sosnovtsev et al., 2002). 
 The NS1/2 protein is the first non-structural protein in noroviruses (Figure 1.5) 
and is predicted to have a similar function to the picornavirus 2B protein, which is 
involved in membrane rearrangement and results in a modification of membrane 
permeability (Fernandez-Vega et al., 2004). The enterovirus 2B protein which is a 
member of the Picornaviridae family is localised to the endoplasmic reticulum (ER) 
and the Golgi complex, reduces ER and Golgi complex calcium ion levels, and 
further inhibits protein trafficking through the Golgi complex (de Jong et al., 2008). 
Studies using Norwalk virus revealed that expression of the NS1/2 protein, also 
referred to as the N-Term protein, leads to Golgi disassembly (Ettayebi and Hardy, 
2003; Fernandez-Vega et al., 2004), indicating a potential role for this protein in 
replication complex formation. 
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 The norovirus NS3 protein is a nucleotide triphosphatase (NTPase) (Figure 
1.5). A study using a human norovirus (Southampton virus) showed that NS3 has 
NTPase activity that functions to hydrolyse nucleotide triphosphate (Pfister and 
Wimmer, 2001). In MNV infected cells, the NS3 has been shown to associate with 
the viral replication complex (Hyde et al., 2009). In addition, the equivalent protein in 
FCV called p39, was found to co-localise with viral replication complexes suggesting 
a possible role in replication (Bailey et al., 2010a; Sosnovtsev et al., 2002).  
 Little is known about the NS4 protein. However, it is thought that NS4 may 
play a role in tissue culture adaptation of MNV since repeated passage of MNV-1 in 
RAW264.7 cells give rise to attenuated viruses in part caused by sequence changes 
in NS4 (Bailey et al., 2008). Furthermore, NS4 is also thought to recruit VPg to 
membranous replication complexes during replication (Hyde et al., 2009). Targeted 
mutations in poliovirus 3A, the NS4 equivalent, resulted in viruses defective in RNA 
synthesis (Berstein and Baltimore, 1988) indicating that by analogy, the norovirus 
NS4 may also contribute to viral RNA synthesis.  
  The NS5 encodes the viral VPg protein that plays a multifunctional role in the 
viral life cycle. The main role of VPg has been identified to be in translation initiation. 
This 13-15 kDa protein is covalently linked to the 5’ end of the G RNA and SG RNA 
of caliciviruses (Herbert et al., 1997). VPg has been shown to be essential for viral 
RNA infectivity as treatment of viral RNA with proteinase K rendered the viral RNA 
non-infectious (Burroughs and Brown, 1978). In vitro translation and infectivity of 
RNA are also abolished upon the removal of FCV and MNV VPg from viral RNA 
(Chaudhry et al., 2006; Herbert et al., 1997). However, in vitro transcribed capped 
FCV and MNV RNA generated from a cDNA clone were infectious when transfected 
 
Figure 1.5 Diagrammatic representation of the norovirus genome. The length of the 
genomic RNA (G RNA) is approximately 7.3 to 7.7 kb with the subgenomic RNA (SG 
RNA) about 2.4 kb. The genome normally contains three ORFs with an additional ORF4 in 
MNV. ORF1 is translated into a large polyprotein which is post-translationally cleaved into 
non-structural proteins (NS1-NS7) at the positions indicated. These NS proteins have 
alternative nomenclature dependant on the virus (indicated in the diagram). ORF2 and 
ORF3 (and ORF4 of MNV) are thought to be translated from the SG RNA template and 
produce structural proteins; the major capsid (VP1) and minor capsid (VP2) protein. 
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into cells (Sosnovtsev and Green, 1995; Yunus et al., 2010). These observations 
indicate that the VPg plays a role as a cap substitute during the typical mRNA 
translation process. Using in vitro assays, MNV, FCV and Lordsdale virus VPg have 
been shown to bind the cap-binding eIF4F component, eIF4E (Chaudhry et al., 2006; 
Daughenbaugh et al., 2006; Goodfellow et al., 2005). Glutathione S-transferase 
(GST) pulldowns using Norwalk virus VPg demonstrated that other eIF4F 
components such as the eIF4A helicase and the scaffold protein eIF4G also 
associate with the translation complex (Daughenbaugh et al., 2003). Although both 
the FCV and MNV VPg proteins bind to eIF4E, only this interaction in FCV is 
essential as inhibition of eIF4E activity was found to severely affect FCV VPg linked 
RNA (Goodfellow et al., 2005). The same inhibition in MNV did not affect in vitro 
translation of MNV VPg linked RNA (Chaudhry et al., 2006). Differences were also 
observed in the requirement for eIF4A in vitro, where an increased requirement of 
MNV translation for eIF4A had been demonstrated (Chaudhry et al., 2006). Encoded 
by NS5 in the ORF 1 of the viral G RNA, the calicivirus VPg protein has also been 
shown to interact with the viral polymerase and capsid protein indicating a 
multifunctional role for this protein in the calicivirus life cycle (Kaiser et al., 2006). 
 The NS6 encodes the viral 3C-like protease and is thought to play a role in 
inhibition of cellular protein synthesis in infected cells. In vitro studies using 
recombinant norovirus 3CLpro demonstrated that it cleaved polyA binding protein 
(PABP) (Kuyumcu-Martinez et al., 2004) and the eukaryotic initiation factor eIF4G 
(Willcocks et al., 2004), both of which are required in mRNA translation of host cells.  
In FCV, the protease is present only in its active state when fused to the polymerase. 
In other caliciviruses, 3C-like protease is released from the ORF1 polyprotein by 
autocatalytic cleavage, subsequently cleaving the other proteins in ORF1 with high 
specificity (Sosnovtsev et al., 2002).  
 The NS7 protein, located at the C-terminus the norovirus ORF 1, encodes the 
RNA-dependent RNA polymerase (RdRp), which is a key enzyme in viral replication. 
This protein will be discussed in more detail in a later section (Section 1.3).  
  The ORF2 and ORF3 of noroviruses encode the structural proteins VP1 and 
VP2. Both of these proteins are expressed from the viral VPg-linked SG RNA that is 
3’ co-terminal with the G RNA (Figure 1.5). However, in lagoviruses, sapoviruses and 
neboviruses, the capsid protein may also be produced from the G RNA as the capsid 
genes for these viruses are in frame with ORF1 giving rise to a polyprotein that 
contains both the non-structural proteins and the major capsid protein (Figure 1.3) 
(Atmar and Estes, 2001; Oliver et al., 2006). ORF2 of norovirus encodes the 58.9 
kDa major capsid protein (VP1) and ORF3 encodes the 22.1 kDa minor capsid 
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protein (VP2) (Clarke and Lambden, 2000). As discussed above, the expression of 
VP1 protein with or without co-expression of VP2 allows dimer formation that can be 
further assembled to produce VLPs in the absence of the RNA genome (Bertolotti-
Ciarlet et al., 2002; Green et al., 1997; Jiang et al., 1992). Since the human 
caliciviruses cannot be propagated in tissue culture, VLPs have been used to study a 
variety of virus-host interactions as they are morphologically and antigenically 
indistinguishable from real virus particles (Estes et al., 2006). In FCV, the capsid 
protein contains a leader peptide (leader capsid or LC) at its N terminus that is 
cleaved by p76 to give rise to the mature capsid protein VP1. The VP2 protein has 
been shown to stabilise and protect VLPs from proteolytic degradation when this 
protein is co-expressed with VP1 in the baculovirus system (Bertolotti-Ciarlet et al., 
2003a). The very basic character of VP2 suggests an interaction with nucleic acid 
and it may contribute to the encapsidation of the viral RNA. However, this hypothesis 
has yet to be examined and confirmed. Furthermore, at least for FCV, the VP2 
protein is essential for the production of infectious particles and for virus replication 
(Sosnovtsev et al., 2005). In addition to the ORF2 and ORF3, there is another 
alternative ORF, namely ORF4, which was found in MNV overlapping with the VP1 
coding region and encoding the virulence factor 1 protein (VF1) (McFadden et al., 
2011). This VF1 protein has been demonstrated to play a role in infection and 
virulence in vivo. Infection of STAT1-/- mice with a mutant virus lacking the ability to 
express ORF4 resulted in a delayed onset of clinical signs compared with WT virus 
infected mice. Using a reverse genetics system, VF1 has been shown to function as 
a classical viral accessory protein that is not required for replication in tissue culture 
(McFadden et al., 2011).  
1.1.5.3 Genome replication, packaging and virus release 
 Once the translation of the viral non-structural proteins has begun, their 
presence in infected cells induces the formation of cytoplasmic membrane-bound 
replication complexes, enabling the viral genome replication process to take place 
(Green et al., 2002) (Figure 1.4). These replication complexes, which contain the viral 
RdRp, viral RNA (single and double stranded intermediates) and other viral enzymes 
and host cell factors, act as a surface or platform for the viral replication. The 
rearrangement of intracellular membranes (particularly the endoplasmic reticulum 
and Golgi apparatus) of MNV-1 infected RAW264.7 cells has been observed 
whereby membrane vesicles start to appear at twelve hours post infection (Wobus et 
al., 2004). As a positive stranded RNA virus, the viral genome RNA can directly act 
as a template for synthesis of negative sense RNA. The negative strand RNA then 
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acts as a template to produce large amounts of positive strand G RNA as well as SG 
RNA. The viral RdRp, which is thought to interact with other viral and cellular factors, 
binds at specific promoter sequences at the 3’end of both the positive and negative 
strand RNAs to drive viral RNA synthesis. It is important to note however, the 
mechanism of norovirus genome replication has not been studied in any great detail 
to date. 
 When all the viral proteins become available and the replication has occurred, 
the viral RNA progeny is then packaged into viral particles. As mentioned earlier, the 
VP2 protein may contribute to this event. The mechanism of calicivirus encapsidation 
has yet to be studied in great detail. Evidence suggests that the SG RNA could be 
encapsidated separately in the case of RHDV as well as in FCV (Meyers et al., 
1991a; Neill, 2002). However, little is known about the mechanisms of viral release, 
but since many calicivirus infections induce apoptosis, it can be speculated that 
apoptosis-induced membrane collapse releases the virus particles (Alonso et al., 
1998; Bok et al., 2009; Sosnovtsev et al., 2003). 
1.2  MNV 
 The first MNV strain (MNV-1) was identified and characterised in 
immunocompromised mice lacking the recombination activation gene 2 (RAG2) and 
signal transducer and activation of transcription 1 (STAT-1) in 2003 (Karst et al., 
2003). In STAT-1 knockout mice (STAT-1-/-), or those lacking type I and II interferon 
receptors, challenge with MNV-1 led to a fatal systemic disease (Karst et al., 2003; 
Mumphrey et al., 2007; Wobus et al., 2006). In RAG2 knockout mice (RAG2-/-) 
however, MNV-1 infection is not lethal but causes a persistent infection with 
continuous virus shedding (Karst et al., 2003). These observations indicate that the 
innate immune system is required for infection control and that the adaptive immune 
system is essential for viral clearance (Wobus et al., 2006). Similar to human 
norovirus, MNV is an enteric virus that shares the capacity to spread via the faecal-
oral route (Wobus et al., 2006). However, the symptoms of disease in MNV are 
different from those of human gastroenteritis caused by HuCv. The infected 
immunocompromised mice show a meningitis, encephalitis, pneumonia, hepatitis and 
vasculitis of the cerebral vessels, which frequently leads to death (Karst et al., 2003). 
Interestingly, it was found that mice lacking either type I or type II interferon receptors 
did not succumb to fatal disease (Karst et al., 2003). Only those lacking both types of 
receptors succumbed to fatal disease demonstrating the importance of IFN in 
clearing MNV-1 infection. This observation provides an example of how type I and 
type II interferon receptors can substitute for each other if necessary (Karst et al., 
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2003). In inbred immunocompetent mice, MNV-1 causes a subclinical infection where 
disease is perturbed by a functioning STAT-1 pathway, which is critical for the 
interferon (IFN) response (Mumphrey et al., 2007). Although the infection is 
subclinical, the virus replicates in the intestine and spleen where the infection can be 
associated with histopathological changes (Mumphrey et al., 2007).  
 In 2006, three new strains of MNV (named as MNV-2, MNV-3 and MNV-4) 
were isolated and they share about 86% to 91% nucleotide identity (Hsu et al., 2006). 
Interestingly, although all these strains are similar very genetically, the phenotypes 
observed during infection varied greatly (Hsu et al., 2007). MNV-2, MNV-3 and MNV-
4 cause persistent infections and prolonged faecal shedding in immuncompetent 
mice, while MNV-1 causes a short subclinical infection which is typically shed in the 
faeces of mice for less than 1 week after experimental inoculation (Hsu et al., 2007). 
Similar to human norovirus, MNV is also a widespread pathogen. When tested up to 
67.5% of mice in research colonies contain MNV reactive antibodies (Muller et al., 
2007). This observation may have an impact in other mice model research studies 
especially those involving intestinal pathogens. Recently, disease progression in the 
mouse model of inflammatory bowel disease caused by bacteria infection has been 
shown to be affected by MNV infection (Lencioni et al., 2008). 
 In tissue culture, MNV replicates efficiently in macrophages and dendritic cells 
(Wobus et al., 2004) and is therefore used as the most authentic model for norovirus 
replication since, as stated previously, human noroviruses cannot currently be 
propagated in conventional tissue culture systems (Duizer et al., 2004). Routine 
propagation of MNV in RAW264.7 cells (an immortalised mouse macrophage cell 
line, which was established from a lymphocytic lymphoma induced by Abelson 
murine leukaemia) is now common in research laboratories that study this virus. 
Further to this, there are two available reverse genetics systems that were 
established based on the first isolated strain of MNV, MNV-1 (CW1)(Karst et al., 
2003; Wobus et al., 2004). The system presented by Ward et al., is based on a 
polymerase II driven system to recover MNV and a number of variations to this 
approach have been described (Ward et al., 2007). These variations will be further 
discussed in Chapter 5. An alternative system described by Chaudhry et al., employs 
a recombinant fowlpox virus (FPV) expressing T7 RNA polymerase to drive the 
expression of a MNV cDNA clones under the control of a T7 promoter (Chaudhry et 
al., 2007). As this latter system is associated with higher virus yields, it is currently 
being preferentially used in MNV studies.  
 The availability of a cost-effective small animal host enables MNV to be used 
an excellent model system to study norovirus biology and pathogenesis in vivo. From 
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a molecular basis, MNV also provides the best suitable model for human norovirus 
since these two viruses are genetically very closely related. However, some aspects 
of MNV may not apply to human noroviruses especially in terms of disease 
manifestation. Mice cannot vomit due to the lack of an emetic reflex and they also do 
not routinely develop diarrhoea after MNV infection. Furthermore, prolonged faecal 
shedding and viral persistence is commonly associated with MNV infection, even in 
immunocompetent mice. In humans however, persistent norovirus infections are 
usually associated only with immunocompromised individuals (Estes et al., 2006). 
Despite this, MNV provides the only readily available model with which to study 
norovirus translation, replication and aspects of pathogenesis. 
1.3  RNA-dependent RNA polymerase (RdRp)  
 The viral RNA-dependent RNA polymerase (RdRp), also known as the RNA 
replicase, is an enzyme that catalyses the synthesis of RNA from RNA templates. 
This particular virus enzyme is therefore distinct from the typical eukaryotic DNA-
dependent RNA polymerase that catalyses transcription of mRNA from a DNA 
template. All RNA viruses carry an RdRp gene in their RNA genome since this viral 
replication enzyme is pivotal for genome replication in infected cells. In addition, the 
virions of negative strand and double-stranded genome viruses must contain the 
RdRp as a ribonucleoprotein component since the incoming RNA genome cannot be 
translated or copied directly by the cellular machinery. The first viral RdRp was 
discovered in the early 1960’s from poliovirus (PV). The poliovirus RNA polymerase 
(PV3D) is one of the best-studied viral RdRp and is often used as a reference for 
other newly identified RdRps. Studies including structural, RNA binding, nucleoside 
triphosphate (NTP) binding, polymerization of nucleotides, RNA strand displacement, 
and interactions with other viral proteins have been thoroughly investigated for PV3D 
(Gohara et al., 2000; Hansen et al., 1997; Richards and Ehrenfeld, 1990; Wimmer et 
al., 1993). The discovery of poliovirus RdRp started with one particular experiment 
where the lysates from poliovirus-infected cells were incubated with ribonucleoside 
triphosphate (one of which was radiolabelled) in the presence of actinomycin D and 
the incorporation of nucleoside monophosphate into RNA was achieved (Baltimore, 
1964; Baltimore et al., 1964). The lack of sensitivity of poliovirus RNA synthesis to 
actinomycin D, which typically inhibits the cellular DNA directed RNA synthesis by 
forming a complex with DNA suggested that the replication enzyme was indeed virus 
specific and could copy RNA from an RNA template. This enzyme was therefore 
presumed to be an RdRp and several years later, attempts to purify the enzyme were 
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successfully carried out and it was confirmed to copy viral RNA (Flanegan and Van 
Dyke, 1979; Plotch et al., 1989). 
 Generally, all polymerases have very different amino acid sequences. 
However, there are four common motifs or domains (A to D) (Figure 1.6) that have 
been identified in polymerases. The vast majority of positive strand RNA virus RdRps 
contain a conserved motif C (Figure 1.6) which is a Gly-Asp-Asp (GDD) amino acid 
sequence. Further studies indicate that this typical conserved motif is part of the 
active site for the RdRp. Alteration of this motif often produces inactive viral RdRp. 
Furthermore, the presence of this motif in certain uncharacterised viral proteins can 
be used as possible evidence that such a protein is most likely a viral RdRp.  
 In terms of three-dimensional structure, RdRp possess a typical closed right 
handed shape which consists of a palm, fingers and thumb with the active site of the 
enzyme encircled in the palm (Ferrer-Orta et al., 2006b) (Figure 1.8). The closed 
conformation of the RdRp, which is formed by interactions between the finger and 
thumb domains, creates a ribonucleoside triphosphate (rNTP) entry tunnel at the 
back of the enzyme and a template binding site at the front (Ferrer-Orta et al., 2004). 
Amino acid residues within motif F, which is conserved and unique to the RdRps, are 
responsible for the formation of the rNTP entry tunnel (Hansen et al., 1997). 
Structural studies of viral RdRps from positive strand RNA viruses indicate that the 
general features of RdRp architecture are highly conserved throughout a diverse 
range of viruses. This structural conservation suggests that the enzymatic 
mechanism of nucleotidyl transfer is also highly conserved. Generally the structure of 
the palm domain for RdRps is similar to other polymerases that contain the four 
conserved motifs (motif A to D) (Figure 1.6). Each of the motifs has a specific 
 
 
Figure 1.6 Conserved domains obtained from alignment of amino acid sequences 
among the four categories of polymerases. The RdRp (RNA-RNA) is represented by the 
poliovirus 3Dpol. The numbers at the top represent the amino acid sequence of the 
poliovirus 3Dpol. Amino acid sequence motifs in each category of polymerase are shown 
as solid black boxes while the alignment of conserved motifs between different type of 
polymerases are represent by solid lines. Note that motif F is only found in RdRps. The 
figure is adapted from Hansen et al., 1997. 
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function. For instance, motif A and B are involved in nucleotide recognition and 
binding, motif A and C facilitate phosphoryl transfer and motif D mediates the 
structure of the palm domain. Motif E which is unique to RNA directed RNA and DNA 
polymerases only is required for the binding of nucleotide primer (Hansen et al., 
1997). 
 Most of our understanding on the properties of viral RdRps comes from in 
vitro studies using purified proteins. This includes the initiation of RNA synthesis that 
is driven by RdRps. The mechanism of RNA synthesis initiation is divergent between 
RdRps from different viruses. However, common mechanisms have been determined 
to be the de novo and the primer-dependent initiation (Figure 1.7a). The presence of 
an RdRp, an RNA template, the initiating NTP (NTPi) and a second NTP is required 
in order to achieve the de novo initiation. The initiating NTPi, sometimes known as 
the one-nucleotide primer provides the 3’-hydroxyl (OH) group for the addition of the 
next nucleotide and elongation usually follows immediately (Kao et al., 2001). The de 
novo initiation normally occurs at the 3’end of the viral RNA. However, internal 
initiation may also occur as in the case of SG RNA synthesis. For RdRps that employ 
a primer for primer-dependent initiation (Figure 1.7b), the primer can be a protein-
linked oligonucleotide (i.e; VPg-pU-pU, as in the case of picornavirus) or 
oligonucleotides with a 5’end capped structure that is cleaved from the cellular 
mRNA in a process called ‘cap-snatching’ (as used by many segmented negative 
strand RNA viruses such as influenza virus) (Kao et al., 2001). Some viral RdRps 
also exhibit the terminal transferase activity that confers an ability to incorporate 
NTPs at the 3’ end of the viral RNA template. RdRps with this property can initiate 
RNA replication by ‘copy-back’ or ‘template-primed’ synthesis mechanism (Figure 
1.7c). Incorporation of NTPs at the 3’ end of RNA template forms a loop structure 
able to fall back onto the RNA template and eventually serve as a primer for the 
RdRp to carry on with elongation. Terminal transferase activity for hepatitis C virus 
(Ranjith-Kumar et al., 2001), poliovirus (Arnold and Cameron, 1999; Arnold et al., 
1999) and more significantly for HuNv RdRp (Rohayem et al., 2006a) has been 
reported in vitro whereby the detection of double length RNA as a predominant 
product compared to the template RNA used in the reaction is often observed. 
However, this ‘copy-back’ synthesis by RdRp could theoretically be an artefact of in 
vitro reactions (Kao et al., 2001). 
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 Compared to DNA-dependent DNA polymerases, RdRps do not possess any 
proofreading capabilities in the form of exonuclease activities that can correct the 
misincorporation of nucleotides during RNA synthesis. Therefore, the error 
frequencies in RNA replication can be as high as one misincorporation per 103 to 105 
nucleotides being polymerised. The error frequencies in DNA replication are about 
103 fold lower than those of RNA replication. Whilst many of these errors cause lethal 
amino acid changes, some of them may appear in the genomes of infectious virions. 
Therefore, RNA virus populations often exist as a quasispecies (or mixture) of many 
different genome sequences. This characteristic of RdRps contributes to the 
antigenic drift phenomenon seen among the caliciviruses (Estes et al., 2006; 
(a)     
                               
 
(b)  
                           
 
(c) 
                                      
 
Figure 1.7 Mechanism for RNA synthesis initiation by positive strand RNA virus 
RdRps. (a) De novo initiation at the 3’ terminal end of RNA template  (top panel) or 
internally on virus genome (bottom panel). The initiating NTPi is represented by the 
triphosphate form (pppPu) while the template nucleotide is shown as “Py”. The green star 
symbol on all the diagrams represents the nucleotide to be added by the RdRp on the 
growing chain (during elongation). (b) Protein-prime initiation (top panel) whereby the 
uridylylated VPg is employed as a primer to initiate RNA synthesis at 3’ poly-A RNA 
template. The orange shaded circle represents the VPg protein. Capped oligonucleotide-
primed initiation (bottom panel) as demonstrated in influenza virus whereby a 5’capped 
structure from cellular mRNA is being cleaved and used as a primer for RNA synthesis 
initiation. The capped (m7G) structure is shown as a black shaded crescent. (c) Copy-back 
or template-primed synthesis mechanism is achieved via terminal transferase activity of 
RdRp where incorporation of NTP’s at the 3’ end of the RNA template forms a loop 
structure that fall back onto the RNA template and subsequently act as a primer for 
elongation.   
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Sosnovtsev et al., 2006; Wobus et al., 2006). Studies on structural replicative 
complexes of picornavirus 3Dpol as well as Norwalk virus RdRp with NTP substrates 
or analogues such as ribavirin and 5-florouracil (5FU) have shown that the inhibition 
of replication and the fidelity of copying by RdRps is determined by how the template, 
primer and NTP interact at the active site during RNA replication, a process which 
involves conformational changes to the enzyme (Ferrer-Orta et al., 2004, 2007; 
Zamyatkin et al., 2008; Zamyatkin et al., 2009).  
 The RdRp gene of caliciviruses is located at the C-terminal of the non-
structural polyprotein. With an approximate size of 57.5 kDa (in MNV), this virally 
encoded non-structural (NS7 in MNV) protein plays a key role in norovirus G RNA 
and SG RNA replication. Generally, the replication of G RNA is achieved through a 
negative sense RNA intermediate which serves as a template for the production of 
nascent positive sense viral G RNA. This general mechanism also applies to the 
caliciviruses where the presence of negative sense G RNA as well as SG RNA has 
been shown by Northern blot analysis during the infection of FCV in tissue culture 
(Green et al., 2002). Currently, four main mechanisms for the initiation of RNA 
synthesis by recombinant calicivirus RdRps have been demonstrated in vitro. They 
are: a de novo initiation and primer-independent initiation (Fukushi et al., 2004; 
Rohayem et al., 2006a; Rohayem et al., 2006b), back-priming base initiation (Kao et 
al., 2001; Lopez Vazquez et al., 2001; Rohayem et al., 2006a; Rohayem et al., 
2006b; Wei et al., 2001) and a protein-primed initiation via VPg nucleotidylylation 
(Han et al., 2010; Kaiser et al., 2006; Machin et al., 2001; Rohayem et al., 2006b). 
The biochemical features of bacterially expressed recombinant RdRp noroviruses 
(HuNV and MNV) have been well characterised and in vitro enzymatic activity has 
been described (Belliot et al., 2005; Han et al., 2010; Hogbom et al., 2009; Lee et al., 
2011; Rohayem et al., 2006a; Rohayem et al., 2006b). RdRp activity for other 
caliciviruses has also been demonstrated using bacterial expression systems, 
specifically for RHDV (Lopez Vazquez et al., 2001) and FCV (Wei et al., 2001). In 
FCV, the active form of the RdRp and the only form found during infection is the full-
length p76 (3CD) which consists of the protease and polymerase precursor (Wei et 
al., 2001), while in noroviruses and RHDV, the RdRp (in its active form) is separated 
from the protease.  
 Generally, the overall calicivirus RdRps display a catalytic and structural motif 
which are typical of other positive strand RNA viruses RdRp, namely the fingers, 
palm and thumb domain (Figure 1.8). The crystal structure of HuNv RdRps (PDB 
code; 2B43 and 1SH0) (Hogbom et al., 2009; Ng et al., 2004) and MNV-1 RdRp (Lee 
et al., 2011) (Figure 1.8) revealed a general similarity to the structure of RdRp from 
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RHDV, another calicivirus (Ng et al., 2002). However, the C terminus of HuNv RdRp 
(1SH0) lies directly in the active site cleft while the C terminus of the RHDV and the 
poliovirus RdRp lie more towards the front of the active site cleft, based on the 
computer prediction (Ng et al., 2004). Interaction between the metal ions and 
aspartate residues (GDD) in the active site of calicivirus RdRps has been shown to 
be essential for viral RNA synthesis (Ng et al., 2002; Zamyatkin et al., 2009). 
Introduced mutations which altered these residues led to the loss of in vitro activity in 
the case of RHDV and MNV-1 RdRp (Lee et al., 2011; Vazquez et al., 2000).  
 
1.4  SG RNA transcription and translation 
 The genome organisation and strategies for gene expression of positive 
strand RNA viruses are diverse. In addition to the occurrence of specific proteolytic 
cleavage sites which mediate the translational processing of the large polyprotein 
(a)                (b) 
           
   (c) 
                                            
Figure 1.8 Crystal structures of norovirus RdRp with typical right hand palm 
fingers and thumb domains. (a) Crystal structure of the MNV-1 RdRp (Lee et al., 2011). 
The fingers, palm and thumb domains are represented by the blue, green and red coour 
ribbons respectively. (b) Crystal structure of the HuNv (1SH0) RdRp (Ng et al., 2004). 
The fingers, palm and thumb domains are represented by the magenta, green and blue 
ribbons respectively. (c) Crystal structure of HuNv (2B43) RdRp (Hogbom et al., 2009). 
The fingers, palm and thumb domains are represented by the blue/cyan, green and red 
ribbons respectively. 
 
 Amir Yunus PhD Thesis 2012 
42 
and give rise to several mature proteins encoded by one large ORF, many viruses 
often express their downstream ORFs through the transcription and translation of a 
SG RNA. Generally, SG RNAs of positive strand RNA viruses are identical to the 3’ 
ends of their parental G RNA. However, they vary in length where the 5’ ends of 
these SG RNAs are in proximity with the start codon of respective ORF. In most 
cases, these viral SG RNAs carry the ORFs that code for proteins required in the 
intermediate and late stages of infection, such as the structural proteins. Animal 
positive stranded RNA viruses that produce SG RNA include the Coronaviridae and 
Arteriviridae family of Nidovirales order, Togaviridae, Nodaviridae, Astrovoridae and 
Caliciviridae families. However, the vast majority of plant viruses have been 
demonstrated to produce SG RNAs. These viruses are from the Luteoviridae, 
Bromoviridae, Tombusviridae and Closteroviridae families and the Tobravirus, 
Carlavirus, Tymovirus, Potexvirus, Hordeivirus, Tobamovirus, Sobemovirus and 
Furovirus genera (Miller and Koev, 2000). The mechanism of SG RNA synthesis has 
been studied in more detail in plant viruses than in animal viruses. Therefore, most of 
our understanding of the mechanisms of how SG RNA synthesis is achieved comes 
from established models for plant viruses.  
1.4.1 Mechanisms for SG RNA transcription 
 There are currently two well-characterised and one additional mechanism for 
positive strand RNA virus SG RNA synthesis. The first described mechanism and the 
most widely recognised model is internal initiation, which has been clearly 
demonstrated in studies involving brome mosaic virus (BMV) (Bromoviridae family). 
In this instance the viral RdRp initiates (+) strand SG RNA4 transcription internally at 
a specific promoter region on the full-length (-) strand template of G RNA3 (Adkins et 
al., 1997; French and Ahlquist, 1988; Miller et al., 1985) (Figure 1.9). Brome mosaic 
virus is a member of the alphavirus-like supergroup which infects plants such as 
bromegrass causing brown streaks and chlorotic lesions (Kao and Sivakumaran, 
2000). The BMV genome is composed of three positive sense, capped RNAs. RNA1 
(monicistronic) encodes protein 1a with capping and putative RNA helicase activities. 
RNA2 (monocistronic) encodes protein 2a, a putative RNA-dependent RNA 
polymerase. RNA3 (dicistronic) encodes for two proteins: 3a, which is required for 
cell-to-cell movement, and the capsid protein. The capsid is translated from a 
subgenomic RNA, RNA4 (Figure 1.9) (Kao and Sivakumaran, 2000). The 
transcription of SG RNA4 is driven by the interaction of the replicase with the 
promoter sequence which functions on the minus-strand RNA3 and is situated 
directly upstream of the SG RNA4 initiation site. Initial studies showed that at least 
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four key nucleotides in the core promoter are recognized by the viral replicase prior 
to the initiation of SG RNA4 synthesis highlighting the importance of primary RNA 
sequences in the SG RNA promoter (Adkins and Kao, 1998). Subsequent studies 
however, showed that a short RNA hairpin in the core promoter serves as the 
replicase binding site and that some of the key nucleotides help to form a stable 
hairpin structure in this core promoter region (Haasnoot et al., 2000; Haasnoot et al., 
2002). Eventually, Sivakumaran et al., 2004 concluded that the key nucleotides in the 
core promoter as reported previously act by directing replicase recognition whilst the 
formation of a stem-loop is only required at a step after the binding of replicase to this 
promoter region (Sivakumaran et al., 2004).  
 
 Animal viruses such as Sindbis virus (alphavirus) and Rubella virus (rubivirus) 
from the Togaviridae family have also been extensively studied as models for internal 
initiation of SG RNA synthesis (Levis et al., 1990; Tzeng and Frey, 2002). Sindbis 
virus (the prototype virus of Togaviridae family) is an arthropod-borne virus that is 
maintained in nature by transmission between vertebrate (bird) hosts and 
invertebrate (mosquito) vectors. Humans are infected with Sindbis virus when they 
                           
Figure 1.9 Schematic representations of brome mosaic virus RNAs and the initiation 
sites for viral RNA synthesis. All three RNAs (RNA1, RNA2 and RNA3) are capped 
with a 7-methyl-guanylate at the 5′ end and possess a tRNA-like structure at the 3ʹ end. 
The initiation site of minus-strand RNA synthesis from the penultimate cytidylate are 
indicated with an arrow. The protein coding sequences are indicated in boxes. The grey 
region in 2a contains the central RdRp-like sequences. Minus-strand RNA3 with promoter 
elements is used to promote synthesis of genomic RNA3 and subgenomic RNA4. This 
figure is taken from Kao and Sivakumaran, 2000. 
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get bitten by an infected mosquito. Sindbis virus causes sindbis fever in humans and 
the symptoms include arthralgia, rash and malaise. The Sindbis virus genome 
consists of an 11.7 kb positive strand RNA which is capped at its 5’end and is 
polyadenylated at the 3’end (Figure 1.10) (Spurgers and Glass, 2011). The four 
alphavirus non-structural proteins (nsP1234; which involve in catalysis the genome 
replication) are translated from the 5′ ORF, and are synthesized as a polyprotein, 
which are subsequently processed into individual proteins. The 3’ ORF codes for the 
three structural proteins; capsid (C) and envelope proteins (E123) are translated from 
the SG RNA. Synthesis of SG RNA is mediated via an internal promoter on the (−) 
strand viral RNA. The minimal sequence on the (−) strand RNA which has SG 
promoter activity in vivo corresponds to a region from −19 to +5 on the viral genome, 
using the initiation nucleotide of the SG RNA (nucleotide 7598 of the viral genome) 
as +1 (Levis et al., 1990). Further studies have shown that a longer nucleotide 
sequence from -98 to +14 is required to obtain a more efficient SG RNA transcription 
(Wielgosz et al., 2001). On the other hand, the in vitro synthesis of SG RNA using a 
cell-free system proved that the internal initiation mechanism is employed, where the 
critical component which is a minus-strand promoter-template corresponding to the 
region of the Sindbis virus genome from nucleotide 7441 to nucleotide 7772 (−157 to 
+175 relative to the SG RNA transcription initiation site at nucleotide 7598) (Li et al., 
2005). Therefore, it could be concluded that sometimes, the minimal promoter 
requirements in vitro are generally insufficient in vivo. Additional sequences are 
required in vivo to allow the replicase complex to come into proximity with the core 
promoter. Such requirements may not be critical in highly purified in vitro systems 
(Miller and Koev, 2000). 
 
 The second mechanism for SG RNA synthesis is termed as a premature 
termination and occurs during the (-) strand template synthesis from the full-length 
 
Figure 1.10 Schematic representation of the alphavirus virus genome organization. 
The genomic RNA (G RNA) has a methyl guanine cap structure (m7G) at the 5’end and a 
polyadenylated tail (An) at the 3’end. The non-structural proteins are translated from non-
structural protein ORF from the G RNA while the structural proteins are translated from 
SG 26S RNA that is transcribed from a replication intermediate negative strand RNA and 
the 26S subgenomic RNA promoter. The figure is adapted from Spurgers and Glass, 2011. 
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(+) strand G RNA. This premature termination gives rise to a subgenomic-length (-) 
strand RNA that then serves as a template for subsequent end-to-end (+) strand SG 
RNA synthesis. The generation of this smaller subgenomic-length (-) strand 
complementary RNA is due to the early disengagement of the RdRp when it reaches 
a RNA secondary structure in the (+) strand viral genome template (known as a 
termination signal). These RNA structures are normally comprised of either local 
secondary structures or long distance RNA interactions that form a highly ordered 
structure. The plant virus tomato bushy stunt virus (TBSV), a prototype member of 
the Tombusviridae family provides the best-studied and complex example for 
premature termination mechanism during SG RNA synthesis. This virus was first 
isolated from tomato plants in 1935 where it causes stunting of growth, leaf mottling, 
and deformed or absent fruit. The size of the (+) strand TBSV genome is 4.8 kb in 
length and it contains five functional ORFs (Figure 1.11) (Wang et al., 2008). The 5’-
terminal ORF encodes p33 and a read through product p92. These two proteins are 
the only viral proteins required for viral RNA synthesis, and both are translated 
directly from the viral G RNA (Oster et al., 1998). The translation of the other three 
proteins (p41, p22 and p19) is supported by the production of two SG RNAs. The 
coat protein, p41 is translated from the SG RNA1 while the p22 (cell to cell 
movement) and the p19 (suppression of host defense mechanism) proteins are 
translated from SG RNA2 via overlapping ORFs (White and Nagy, 2004). The 
employment of a premature termination mechanism for TBSV SG RNAs synthesis is 
mediated by the formation of two different sets of long-distance RNA–RNA 
interactions, both present in the positive strand genomic RNA. The first one involves 
an RNA sequence located immediately 5’ to the site of transcriptional initiation of SG 
RNA1 called receptor sequence (RS1) and partner segments positioned ~1000 
nucleotides upstream called activator sequence (AS1) which mediate the 
transcription of SG RNA1 (Lin and White, 2004). The second interaction which 
mediates the synthesis of SG RNA2 involves the distal element (DE) which is located 
~1100 nucleotides upstream from the initiation site of SG RNA2 transcription. This 
DE must base pair with a portion of the core element (CE) located just 5’ to the SG 
RNA2 initiation site (Zhang et al., 1999). Furthermore, another long distance 
interaction between AS2/RS2 has been identified and is essential (along with DE/CE) 
for regulating the production of SG RNA2 (Figure 1.11) (Lin and White, 2004; Wang 
et al., 2008). It is possible that the AS/RS structure could be bound by a protein 
factor that stabilizes them, therefore facilitating the premature termination step of 
RNA copying by the viral replicase. In another plant virus that utilises the premature 
termination mechanism for SG RNA synthesis, a more complex RNA-RNA interaction 
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has been demonstrated. In red clover necrotic mosaic virus (RCNMV), an AS/RS-like 
interaction is also essential for SG RNA transcription from RNA1. However, this 
interaction forms in trans between the two G RNA segments called RNA1 and RNA2 
(Sit et al., 1998). 
 
 In addition to the two well-characterised SG RNA synthesis mechanisms 
described above, there is another more unusual mechanism employed by members 
of the families Coronaviridae and Arteriviridae from the Nidovirales order, known as 
discontinuous transcription. Viruses from these families contain a very large positive 
sense RNA genome (between 15 and 31 kb) and produce a nested set of seven 3’ 
co-terminal SG RNAs. Uniquely, all these SG RNAs contain a 90 nucleotide leader 
sequence derived from the 5’ end of the G RNA. These SG RNAs are synthesised 
from non-contiguous sequences at the 5’ and 3’ ends, respectively, of the viral (+) 
strand genome. The leader and body of SG RNAs are separated by a conserved 
sequence found in the intergenic regions (IG) that can be found at the 3’end of the 
leader and at the 5’ end of the SG RNA body. Discontinuous transcription occurs 
during (-) strand RNA synthesis. Most of the (+) strand RNA template is not copied, 
perhaps because it loops out as the polymerase completes the synthesis of leader 
RNA. The resulting (-) strand RNAs with leader sequences at the 3’ ends, are then 
copied to form the various length SG RNAs (Figure 1.12). 
                 
Figure 1.11 Schematic representations of the TBSV genome, SG RNAs and their 
transcriptional regulatory elements. The synthesis of the SG RNAs of TBSV is 
achieved via premature termination of minus strand synthesis by the viral replicase on 
high order RNA structures which form as a result of long distance RNA-RNA interactions 
on the G RNA template. The AS1/RS1 interaction is involved in SG RNA1 transcription 
while AS2/RS2 and DE/CE interactions are required for SG RNA2 synthesis. This figure 
is adapted from Wang et al., 2008. 
 Amir Yunus PhD Thesis 2012 
47 
 
1.4.2 Transcription and translation of calicivirus SG RNA 
 All caliciviruses produce a SG RNA during their replication cycle in infected 
cells. This SG RNA is 3’ co-terminal with the full-length G RNA, has VPg linked at the 
5’ end and carries a poly-A tail at the 3’ end. Typically, the SG RNAs of caliciviruses 
contains ORF2 and ORF3 (and ORF4 in the case of MNV and some sapoviruses) 
which code for viral structural proteins (VP1 and VP2). The production of a SG RNA 
message may act to delay the production of structural proteins until the initial rounds 
of viral replication have taken place. Both positive and negative sense SG RNA 
intermediates (~2.5 kb in length) can be detected by northern blot analysis of purified 
FCV replication complexes (Green et al., 2002). Importantly, the mechanism that is 
used by caliciviruses to achieve their SG RNA transcription remains unknown. 
Evidence from in vitro studies using RHDV RNA transcripts suggests that the internal 
initiation mechanism is employed (Morales et al., 2004). Data published at the start of 
this project for MNV, also suggested that SG RNA synthesis is likely to involve 
internal initiation. This hypothesis is due to the observation that the presence of a 
conserved small stem loop structure which is slightly more stable on the negative 
strand RNA among calicivirus RNA genomes may play a role as a putative promoter 
(a)    
                 
(b) 
                         
Figure 1.12 Schematic overview of the nested set of nidovirus SG RNAs and 
discontinuous transcription model. (a) Schematic representatives of the nidovirus plus 
(white) and minus (black) strand G RNA and SG RNAs. Only the GRNA (RNA1) and the 
largest (RNA2) and smallest (RNA7) SG RNA are shown. (b) Transcription model 
illustrating the discontinuous step during minus strand nidoviral mRNA synthesis. Only a 
portion of 3’end RNA (+) strand and leader sequence at the 5’end are copied by the 
polymerase and joined together at a conserved intergenic region, forming a (-) strand SG 
RNA which serves as a template for (+) strand SG RNA. This figure is adapted from 
Snijder et al., 1998. 
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for RdRp recognition during initiation of SG RNA transcription (Simmonds et al., 
2008).  
 Following the transcription of MNV SG RNA, the expression of this 
messenger transcript via VPg-dependent translation initiation is achieved as 
described for the G RNA above. The 5’ proximal ORF2, which encodes the major 
capsid protein is first translated when the scanning ribosomal complex encounters 
the first AUG codon, a typical strategy for translation. However, in viruses with 
polycistronic SG RNAs, the translation of their 3’ terminal ORF is not as efficient as 
the preceding ORF. Therefore, many viruses employ several strategies to provide 
sufficient access for ribosomes to downstream ORFs. These strategies include leaky 
scanning of 40S subunits past the start codon of the first ORF, the possession of 
intercistronic internal ribosome entry signal, programmed ribosomal frame-shifting 
during elongation and stop codon suppression at the termination step (Napthine et 
al., 2009). All caliciviruses SG RNA are bicistronic messages. The translation of the 
3’ proximal ORF in this case is achieved by a unique mechanism called termination 
reinitiation. In this mechanism, a proportion of the 40S ribosomal subunit remains 
associated with the mRNA following the translational termination at the preceding 
stop codon. This enables reinitiation at the AUG of a downstream ORF, which is in 
close proximity. This characteristic has been observed for different caliciviruses 
where the initiation codon of VP2 (overlapped with VP1) is only 2 nucleotides away 
from the stop codon of VP1 for RHDV. Meanwhile for Norwalk virus, FCV and MNV, 
the start codon of VP2 is overlapped with the stop codon of VP1 (Meyers, 2003) 
(Figure 1.13a). Other than the close proximity between the stop and start codon, the 
efficiency of termination reinitiation translation is also determined by a stretch of 70 to 
80 nucleotides upstream of the stop-start window which facilitates the transit of the 
ribosome through the stop codon of VP1. This region of conserved sequence is 
termed TURBS (termination upstream ribosome binding site motif). The translation of 
VP2 from the FCV, RHDV and MNV SG RNA is dependent on this TURBS region, 
which is located immediately upstream of the VP1 stop codon (Meyers, 2003; 
Meyers, 2007; Napthine et al., 2009). The TURBS contain two important sequences; 
the 5’ sequence (termed as Motif 1) is proposed to function in binding the 18S rRNA 
(through complementary sequence) (Figure 1.13b) whilst the other sequence is 
thought to be important in tethering the ribosome to enable translation of VP2 at the 
correct site (Luttermann and Meyers, 2007; Napthine et al., 2009). Alternatively, the 
TURBS may also act by interacting with eIF3 or eIF3/40S ribosome complexes 
preventing disassembly of the ribosome following VP1 translation termination. This 
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alternative mechanism is supported by the fact that purified eIF3 is able to stimulate 
translational re-initiation (Poyry et al., 2007). 
 
 
1.5 Project aims 
 The aims of my project were to characterise the role of the RdRp in the MNV 
life cycle and to dissect the mechanisms employed by MNV during SG RNA 
production. The investigations of the MNV RdRp included attempts to identify host 
factors as possible antiviral targets and to identify peptide inhibitors for the viral NS7. 
In order to pursue these aims various new tools and techniques were required. 
Therefore my specific aims for this thesis were as follows: 
 
Development of tools and techniques: 
1. Develop a robust and efficient RNA based reverse genetics system for 
recovery of MNV.  
2. Develop a reporter-tagged MNV replicon system. 
Dissection of the MNV life cycle: 
1. Identify host or viral factors which interact with MNV NS7. 
(a)                 
  
 
(b) 
                   
Figure 1.13 RNA sequences in calicivirus SG RNA that influence the efficiency of 
translation termination reinitiation event for expression of VP2 (ORF3). (a) Relative 
positions of the VP1 stop (italic and underlined fonts) and VP2 start (bold fonts) codon in 
different calicivirus SG RNAs. The grey shaded area represents the ORF3 which codes for 
VP2 protein (Meyers, 2003). (b) TURBS (Motif 1) sequences among caliciviruses with 
complementarity to 18S rRNA. Interaction theoretically prevents the dissociation of 
ribosome from mRNA following termination at the VP1 stop codon. This figure is 
adapted from Luttermann & Meyers, 2007. 
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2. Identify specific peptide-bearing phages which are able to bind and inhibit 
MNV NS7. 
3. Characterise the potential role of RNA secondary structures in the MNV 
genome as putative SG RNA promoter. 
4. Characterise the mechanism of MNV SG RNA production. 
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Chapter 2.0   
Materials and methods 
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2.1  Plasmid construction 
 All the primers used for plasmid generation during the course of this work are 
listed in Table 2.1.  
 The expression plasmids for the production of recombinant MNV NS7 and 
VPg (non-his tagged) were generated by cloning of the NS7 and the VPg encoding 
sequence into the pET26Ub expression plasmid containing a T7 polymerase 
promoter and ubiquitin gene from Saccaromyces cereviciae upstream of the multiple 
cloning site (Gohara et al., 1999).  
 For the tandem affinity purification (TAP) approach to identify proteins that 
interacted with the norovirus NS7 protein, the NS7 coding region from MNV was 
cloned into tetracycline inducible TAP expression plasmids pcDNA4/TO-NTAP and 
pcDNA4/TO-CTAP. The TAP tag used in this study is composed of two Protein G 
units and a streptavidin binding peptide separated by a tobacco etch virus (TEV) 
protease cleavage sequence (Burckstummer et al., 2006). The pcDNA4/TO-NTAP-
MNV NS7 plasmid was generated by Dr Dalan Bailey (Imperial College London) 
previously.  
 Full-length MNV-1 cDNA clones (pT7MNV3’Rz) carrying synonymous 
mutations in the stem loop situated at 6 nucleotides (nts) upstream of the predicted 
initiation site for subgenomic RNA (SG RNA, SL5018 or SLa5045) which either 
destabilised the RNA structure (m53), contained compensatory changes to restore 
the structure (m53r) or contained the m53 mutant suppressor U4922C (m53RevA), 
were generated previously by Dr. Ioannis Karakasiliotis and Dr. Dalan Bailey. The 
m53 mutant suppressors A4914G (m53RevG) and A4967G (m53RevH) constructs 
were generated by overlapping mutagenesis PCR (Table 2.1) using pT7MNV 3’Rz-
m53 as a template. All suppressor mutants (RevA, RevG and RevH) were also 
cloned into the wild type (WT) backbone construct producing WTRevA, WTRevG and 
WTRevH constructs. A panel of further synonymous mutations in the WT and m53 
cDNA constructs were also generated based on RevA and RevG (see Section 2.2).  
 A replication defective full-length cDNA clone (pT7MNV POL-3’Rz) was also 
generated by mutating the NS7 active site from YGDD to YGGG using overlapping 
mutagenesis PCR (Table 2.1). 
 A series of reporter constructs containing the luciferase gene fused to the 
VP2 and separated by a foot and mouth disease virus 2A protease (FMDV 2A) 
coding region were generated by amplifying the Renilla or the Gaussia luciferase 
genes with fusion to the FMDV 2A sequence by PCR. The Renilla luciferase 
expression plasmid, pRL-TK (Promega) was used to amplify the Renilla luciferase 
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gene with a FMDV2A fusion at the C-terminus. For Gaussia luciferase, the 
expression plasmid pCMV-GLuc was used. In order to generate this reporter 
construct, three PCR fragments were successfully generated and combined together 
using overlapping PCR. Fragment 1 (Sac II – Bst BI ; ~1.6 kb) contains part of the 
VP1 coding region bearing the unique Sac II site at its 5’ end and partially Renilla 
luciferase gene sequence with an initiation codon immediately after its 3’end region. 
Fragment 1 was PCR amplified from the MNV infectious cDNA clone with primers 
5052F and IGIC425 (Table 2.1). Fragment 2 (Bst BI – Sbf I ;~1 kb) contained the 
Renilla luciferase gene with a 5’ unique Bst BI restriction site, initiation codon and 
part of VP1 3’end sequence. At the 3’end of fragment 2, the reverse primer was 
engineered to include the in frame insertion of the FMDV 2A encoded gene 
sequence after the Renilla luciferase gene, a unique Sbf I site and part of 5’end 
sequence of VP2. Fragment 2 was PCR amplified using primers IGIC375 and 
IGIC307 (Table 2.1) using a Renilla luciferase expression plasmid pRL-TK 
(Promega) as a template. The last PCR fragment, fragment 3 (Sbf I – Nhe I ; ~0.8 kb) 
was generated by PCR amplification of VP2 region using infectious MNV cDNA clone 
as a template. The forward primer was engineered to include part of 3’ end FMDV 2A 
encoded gene sequence, while the reverse primer was designed to include a unique 
Nhe I site after the poly A sequence (26 nucleotides in length) at the 3’ end of the 
viral genome using primers IGIC308 and IGIC239 (Table 2.1). In order to produce a 
full-length insert for cloning, all three purified PCR fragments were successfully 
combined by overlap-extension PCR. Fragments 2 and 3 were combined first using 
primers IGIC375 and IGIC239. The resulting PCR product was then successfully 
combined with fragment 1 in order to generate a full-length insert using primers 
5052F and IGIC239. This full-length insert was then successfully cloned into the 
MNV infectious cDNA clone after digestion using unique Sac II and Nhe I sites. A 
more clear indication on this construct map can be found in Figure 6.1.  
 Four double stem loop (SLa5045*2) cDNA clones, all based in the 
pT7MNV3’Rz cDNA construct containing the m53 and WT (WT-WT, WT-m53, m53-
WT and m53-m53) were generated by PCR amplification of either stem loop from WT 
(pT7MNV3’Rz) and m53 (pT7MNVm533’Rz) cDNA clones. The second stem loop 
was designed to be outside of the NS7 coding region. In order to generate these 
constructs, the WTSLa5045*2 and the m53SLa5045*2 (both are PCR 1) were PCR 
amplified from the WT pT7MNV3’Rz cDNA using the forward PCR primers IGIC777 
and IGIC779 (containing nucleotides for m53 mutation) respectively with the 6034R 
as a reverse primer (Table 2.1). The 3’end sequence of the NS7 with the introduced 
Cla I site (PCR 2) was amplified from the same cDNA template using primers 
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IGIC778 and 3734F. Subsequently, both PCR 1 products and PCR 2 product were 
digested with Cla I restriction enzyme and ligated together prior to full-length PCR 
amplification using primer 3734F and 6034R. Both the resulted inserts of full-length 
WTSLa5045*2 and m53SLa5045*2 were clone into the WT and m53 backbone 
cDNA by using Afe I and Sac II unique restriction sites. In addition, seven more 
clones based on the Sla5045 construct m53-WT with mutations on the (second) 
introduced stem loop were also generated. The cDNA clones are listed as below: 
(1) m53–m53r   
(2) m53–WT +8 (second stem loop is WT with 8 nucleotides before the SG start site) 
(3) m53–WT+10 (second stem loop is WT with 10 nucleotides before the SG start   
                            site) 
(4) m53–TL-dis (second stem loop is WT with inverted terminal loop sequence) 
(5) m53–SL+ (G-U base pair in the second stem loop on +ve strand only) 
(6) m53–SL- (G-U base pair in the second stem loop on –ve strand only) 
(7) m53–S2+ (second stem loop is WT with disrupted terminal stem) 
The details on constructions of these plasmids are described in Section 7.2.7.1 and 
7.2.7.3. 
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Primers for the generation of protein expression constructs 
Primer name Primer sequence Polarity Description 
Primers for cloning into the E. coli expression plasmid pET26Ub 
IGIC427 CGTCTCCGCGGTGGAGGACCCCCCATGCTTCCC F MNV-1  N-term NS7 into pET26Ub, SacII site 
IGIC428 CCAGAGGATCCTTACTCATCCTCATTCACAAAGAC R MNV-1 C-term NS7 into pET26Ub, stop codon, 
BamHI site 
IGIC429 GGCTCCGCGGTGGAGGAAAGAAGGGCAAGAAC F MNV-1 N-term VPg into pET26Ub, SacII site  
IGIC430 CCAGAGGATCCTTACAAGTTGATCTTCTCGCC R MNV-1 C-term VPg into pET26Ub, stop codon, 
BamHI site 
Primers for cloning MNV NS7 into TAP Tagging plasmid 
IGIC382 AAAATCGATACCATGGGACCCCCCATGCTTCCCCGCCC F MNV-1 NS7 into pcDNA/TO C-terminal TAP tag, 
ClaI site 
IGIC391 TTTCGTACGCTCCTACTCTTACACAAAGACTGC R MNV-1 NS7 into pcDNA/TO C-terminal TAP tag, 
BsiWI site 
Primers for the generation of MNV reporter-tag replicons  
Primer name Primer sequence Polarity Description 
5052F GTGAATGAGGATGAGTGATGGCGCAGCGCCAAAAGCCAATGGC F SacII site, VP1 region (fragment 1) 
 
IGIC425 GGATCATAAACTTTCGAAGTCATTATTGTTTGAGCATTCGGCCTG
TTGCC 
R C-term VP1, initiation codon, BstBI site, N-term 
Renilla luciferase  (fragment 1)  
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IGIC375 GGCCGAATGCTCAAACAATAATGACTTCGAAAGTTTATCATCCA
GAACAAAGG 
F C-term VP1, initiation codon, BstBI site, N-term 
Renilla luciferase (fragment 2) 
IGIC307 CGCTCCAAAAAGAGCACCTGCAGGCCCAGGGTTGGACTCGACGT
CTCCCGCAAGCTTAAGAAGGTCAAAATTCAACAGTTGTTCATTTT
TGAGAACTCG 
R C-term Renilla luciferase, FMDV 2A gene, SbfI site, 
N-term VP2 (fragment 2) 
IGIC308 GACGTCGAGTCCAACCCTGGGCCTGCAGGTGCTCTTTTTGGAGCG
ATTGG 
F Partial 3’ sequence of FMDV 2A, SbfI site, N-term 
VP2 (fragment 3) 
IGIC239  R VP2 region, NheI site (fragment 3) 
IGIC824 AAAAATTCGAAATGGGAGTCAAAGTTCTGTTTGCCCTGATCTG F BstBI site, N-term Gaussia luciferase 
IGIC825 AAAAACCTGCAGGCCCAGGGTTGGACTCGACGTCTCCCGCAAGC
TTAAGAAGGTCAAAATTCAACAGGTCACCACCGGCCCCCTTG 
 
R C-term Gaussia luciferase, FMDV 2A gene, SbfI site. 
Mutagenic primers 
Primer name Primer sequence Polarity Description 
Primers for generating MNV-1 mutant suppressors (in m53 & WT constructs backbone) 
IGIC481 GTATTACAGGGCTGTGGCTTCCCG F m53RevG & WTRevG, A->G position 4914 
IGIC482 CGGGAAGCCACAGCCCTGTAATA R m53RevG & WTRevG, A->G position 4914 
IGIC502 GGATAGATGGTGGTCCCACGCC F m53RevH & WTRevH, A->G position 4967 
IGIC503 GGCGTGGGACCACCATTTCTATCC R m53RevH & WTRevH, A->G position 4967 
IGIC500 GGACTGTGGCCTCCCGTGTCTCC F                      WTRevA,  T->C position 4922                       
IGIC501 GGAGACACGGGAGGCCACAGTCC R                      WTRevA,  T->C position 4922 
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IGIC632 CAGGGTGTGGCTTCCCGTG F 4914 mutant, (m53 Mut1 & WT Mut1),  
ACT->GTT position 4915 (Thr->Val)  
IGIC633 CACGGGAAGCCACACCCTG R 4914 mutant, m53 Mut1 & WT Mut1,  
ACT->GTT position 4914 & 4915 (Thr->Val) 
IGIC634 GTATTACAGGGATGTGGCTTCC F 4914 mutant, (m53 Mut2 & WT Mut2),  
ACT->GAT position 4914 & 4915 (Thr->Asn)  
IGIC635 GGAAGCCACATCCCTGTAATAC R 4914 mutant, (m53 Mut2 & WT Mut2),  
ACT->GAT position 4914 & 4915 (Thr->Asn) 
IGIC636 GGGGTGTGGCTTCCCGTG F 4914 mutant (m53 Mut3 & WT Mut3), 
ACT->GGT position 4914 & 4915 (Thr->Gly) 
IGIC637 CACGGGAAGCCACACCCC R 4914 mutant (m53 Mut3 & WT Mut3), 
ACT->GGT position 4914 & 4915 (Thr->Gly) 
IGIC638 CAGGTCTGTGGCTTCCCGTG F 4914 mutant (m53 Mut4 & WT Mut4), 
ACT->TCT position 4914 (Thr->Ser) 
IGIC639 CACGGGAAGCCACAGACCTG R 4914 mutant (m53 Mut4 & WT Mut4), 
ACT->TCT position 4914 (Thr->Ser) 
IGIC640 CAGGCCTGTGGCTTCCCGTG F 4914 mutant (m53 Mut5 & WT Mut5), 
ACT->CCT position 4914 (Thr->Pro) 
IGIC641 CACGGGAAGCCACAGGCCTG R 4914 mutant (m53 Mut5 & WT Mut5), 
ACT->CCT position 4914 (Thr->Pro) 
IGIC642 CAGGACTGTGGCATCCCGTG F 4922 mutant (m53 T4922A & WT T4922A), 
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T->A position 4922 (Ala -> Ala) 
IGIC643 CACGGGATGCCACAGTCCTG R 4922 mutant (m53 T4922A & WT T4922A), 
T->A position 4922 (Ala -> Ala) 
IGIC644 GACTGTGGCGTCCCGTG F 4922 mutant (m53 T4922G & WT T4922G), 
T->G position 4922 (Ala -> Ala) 
IGIC645 CACGGGACGCCACAGTC R 4922 mutant (m53 T4922G & WT T4922G), 
T->G position 4922 (Ala -> Ala) 
IGIC759 GAGTTCTCCTTCTATGGTGGTGGTGAGGTGGTTTCGACC F MNV-1 active site mutant, YGDD -> YGGG 
A->G position 4573, A->G position 4576,  
C->T position 4577 
IGIC760 GGTCGAAACCACCTCACCACCACCATAGAAGGAGAACTC R MNV-1 active site mutant, YGDD -> YGGG 
A->G position 4573, A->G position 4576,  
C->T position 4577 
3734F GCGAGATCAGCTTAAGCCCTATTCAGAACCACGCG F MNV-1 sequencing, AfeI site, (full-length PCR) 
6034R GGACCTCGATCTCCAGTTGCCCAGAGAAATCGGGGTAACC R MNV-1 sequencing, SacII site, (full-length PCR) 
Primers for generating MNV-1 with double stem loop (SLa5045) mutants 
IGIC777 AAAAAATCGATATGGATGCTGAGACCCCGCAGG 
 
F ClaI site, introduce second wt SLa5045 after NS7  
IGIC778 AAAAAATCGATTCACTCATCCTCATTCACAAAGACTGC R 3’ end MNV-1 NS7, ClaI site (use WT or m53 cDNA 
clone as a template in PCR) 
IGIC779 AAAAAATCGATATGGACGCCGAAACCCCGCAGG F ClaI site, introduce second m53 SLa5045 after NS7 
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3734F GCGAGATCAGCTTAAGCCCTATTCAGAACCACGCG F MNV-1 sequencing, AfeI site, (full-length PCR) 
6034R GGACCTCGATCTCCAGTTGCCCAGAGAAATCGGGGTAACC R MNV-1 sequencing, SacII site, (full-length PCR) 
IGIC902 AAAAAATCGATATGGACGCCGAAACCCCGCAGGAACGTTCGGCG
GTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, introduce second m53r SLa5045 after NS7 
IGIC903 AAAAAATCGATATGGATGCTGAGACCCCGCAGGAACGCTCAGCA 
TTGTCTTT GTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, introduce second WT SLa5045 with 8 bases 
before sg start site  
IGIC904 AAAAAATCGATATGGATGCTGAGACCCCGCAGGAACGCTCAGCA
TTTTGTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, introduce second WT SLa5045 with 10 bases 
before sg start site 
IGIC905 AAAAAATCGATATGGATGCTGAGACCCTGCGGGAACGCTCAGCA
GTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, introduce second WT SLa5045 with terminal 
loop sequence inverted  
IGIC906 AAAAAATCGATATGGAGGGGGGGACCCCGCAGGAACGTTTTTTT
GTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, G-T nucleotides match (G-U base pair in the 
second stem loop on +ve sense only) 
IGIC907 AAAAAATCGATATGGACCCCCCCACCCCGCAGGAACGAAAAAA
AGTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, C-A nucleotides match (G-U base pair in the 
second stem loop on -ve sense only) 
IGIC908 AAAAAATCGATATGGATGCTGAGACCCCGCATTTACGCTCAGCA
GTCTTTGTGAATGAGGATGAGTGATGGCGCAGC 
F ClaI site, disrupt terminal stem 
Sequencing primers 
Primer name Primer sequence Polarity Description 
1F GTGAAATGAGGATGGCAACGCCATCTTCTGCGCCC F MNV-1 sequencing primer 
404F GGAGCCTGTGATCGGCTCTATCTTGGAGCAGG F MNV-1 sequencing primer 
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491R GCCTGGCAGACCGCAGCACTGGGGTTGTTGACC R MNV-1 sequencing primer 
922F GCATTGTCAATGCCCTGATCTTGCTTGCTGAGC F MNV-1 sequencing primer 
1139R GGCGAACTTGCCCATCTCTTGGGCGGCCTTGAGAGCC R MNV-1 sequencing primer 
1540F GCTTTTGCCAAAACCTAGCCAAGAGGATTGCTG F MNV-1 sequencing primer 
1540R CAGCAATCCTCTTGGCTAGGTTTTGGCAAAAGC R MNV-1 sequencing primer 
1954F GGCCCGATTACAGCCACATCAATTTCATCTTGG F MNV-1 sequencing primer 
1954R CCAAGATGAAATTGATGTGGCTGTAATCGGGCC R MNV-1 sequencing primer 
2392F GTGTCAGAAGGATAAAGGAGGCCCGCCTCCGCTGC F MNV-1 sequencing primer 
2392R GCAGCGGAGGCGGGCCTCCTTTATCCTTCTGACAC R MNV-1 sequencing primer 
2616R GCCCCCGGCCCTTCTTGTTCTTGCCCTTCTTTCC R MNV-1 sequencing primer 
2902F GCAAGCCGATCGACTGGAATGTGGTTGGCC F MNV-1 sequencing primer 
2902R GGCCAACCACATTCCAGTCGATCGGCTTGC R MNV-1 sequencing primer 
3394F CGGGCGACTGTGGCTGTCCCTATGTTTATAAGAAGGGTAAC F MNV-1 sequencing primer 
3394R GTTACCCTTCTTATAAACATAGGGACAGCCACAGTCGCCCG R MNV-1 sequencing primer 
3734F GCGAGATCAGCTTAAGCCCTATTCAGAACCACGCG F MNV-1 sequencing primer 
3734R CGCGTGGTTCTGAATAGGGCTTAAGCTGATCTCGC R MNV-1 sequencing primer 
4450F GCCCTTGCACCACACAGCTGAATAGTTTGG F MNV-1 sequencing primer 
4450R CCAAACTATTCAGCTGTGTGGTGCAAGGGC R MNV-1 sequencing primer 
4839R GCAGGGCCATTAGTTGGGAGGGTCTCTGAGCATGTCC R MNV-1 sequencing primer 
5052F GTGAATGAGGATGAGTGATGGCGCAGCGCCAAAAGCCAATGGC F MNV-1 sequencing primer 
5332R GTTCCCAACCCAGCCGGTGTACATGGCTGAGAGGTGGGC R MNV-1 sequencing primer 
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5722R CACGGGCAAGTCGACCATCCGGTAGATGGTTCTCTC R MNV-1 sequencing primer 
6034F GGTTACCCCGATTTCTCTGGGCAACTGGAGATCGAGGTCC F MNV-1 sequencing primer 
6034R GGACCTCGATCTCCAGTTGCCCAGAGAAATCGGGGTAACC R MNV-1 sequencing primer 
6427F GTCTCCTGGTTCGCGTCTAACGCGTTCACCGTGCAGTCC F MNV-1 sequencing primer 
6427R GGACTGCACGGTGAACGCGTTAGACGCGAACCAGGAGAC R MNV-1 sequencing primer 
6733F GCAATTCCATCTCAAATGTTCAAAACCTTCAGGCAAAC F MNV-1 sequencing primer 
6733R GTTTGCCTGAAGGTTTTGAACATTTGAGATGGAATTGC R MNV-1 sequencing primer 
7155F GTGGACACATCCCCTCTACCGATCTCGGGTGGACGCTTGCC F MNV-1 sequencing primer 
7400R 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTAAAATGCATCTAACTAC
CACAAAG 
R 
MNV-1 sequencing primer 
IGIC218 TTATTCGCAATTCCTTTAGTGGTACCTTTC F PCR amplification & sequencing of phage DNA 
IGIC219 GCCCTCATAGTTAGCGTAACGATCTAAAG R PCR amplification & sequencing of phage DNA 
 
Table 2.1. List of the various primers used during the course of this work. The sequences of all primers are depicted in 5’ to 3’ direction. Polarity 
indicates whether the primer was used as a forward (F) or reverse (R) primer in the PCR reaction. For the MNV-1 sequencing primer, the number used in the 
primer name represents the genome position in the full-length MNV-1 cDNA clone pT7MNV3’Rz. 
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2.2 Site directed mutagenesis 
 Based on the identification of the suppressor mutants m53RevA and 
m53RevG as described in Chapter 7, seven additional mutations were generated by 
overlapping PCR mutagenesis. Various mutations were introduced at positions 4922 
(RevA) and 4914 (RevG) (Table 2.2) in the WT and in the m53 full-length cDNA 
clones. Mutagenic primers are listed in Table 2.1. 
 
WT 
A4914G 
(m53RevG)  4914 Mutants 
ACT (Threonine) GCT (Alanine) TCT (Serine) 
    CCT (Proline) 
    GGT (Glycine) 
    GAT (Aspartic acid) 
   GTT (Valine) 
WT 
T4922C 
(m53RevA)  4922 Mutants 
GCT (Alanine) GCC (Alanine) GCG (Alanine) 
    GCA (Alanine) 
 
Table 2.2. Mutations acquired from overlapping mutagenic PCR. Sequence and the 
corresponding amino acid of WT, mutant suppressor m53 A4914G (m53RevG), mutant 
suppressor m53 T4922C (m53RevA) and seven mutants with additional mutations at 
position 4914 or 4922 are listed; the mutations are highlighted in underlined font. U in 
RNA is represents by T in DNA.  
2.3 Bioinformatics tools 
 All the vector maps, in silico primer design and plasmid manipulations were 
generated using the Vector NTI software (Invitrogen). Alignments of MNV sequences 
were performed with Vector NTI using sequences found in GenBank 
(www.ncbi.nlm.nih.gov/Genbank/index.html). Thermodynamic structure prediction of 
the RNA SLa5045 was carried out using mfold 
(frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/RNA-forml.cgi). 
2.4 Polymerase chain reaction (PCR)  
 PCR amplifications were performed using either Go Taq Flexi Polymerase 
(Promega) or KOD Hot Start Polymerase (Novagen) according to the manufacturer’s 
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protocol. All amplifications were carried out in an Eppendorf Mastercycler thermal 
cycler. KOD polymerase was preferentially used for all PCR based mutagenesis. 
PCR amplification products were purified using GFX PCR DNA and Gel Band 
Purification Kit (GE Healthcare). A list of primers used throughout the course of this 
work is listed in Table 2.1. 
2.5 Bacterial stocks, transformation and medium scale 
 plasmid preparation 
 The bacterial strains used during the generation of constructs were E. coli 
DH5α, NEB Turbo (New England Biolabs), α-Select Bronze Efficiency (Bioline) or 
XL10-Gold® Ultracompetent Cells (Stratagene). The bacterial strain used for 
recombinant protein expression was E. coli BL21 DE3 containing the pCG1 plasmid 
expressing a ubiquitin specific protease (Gohara et al., 1999). For phage 
amplification, E. coli ER 2739 (New England Biolabs) were used. All transformations 
were carried out according to the manufacturer’s protocols. Plasmid midi 
preparations were carried out using the Pureyield Plasmid Midiprep System 
(Promega) according to the manufacturer’s instructions. The concentration and purity 
of the plasmid DNA was determined by spectrophotometry.  
2.6  Agarose gel electrophoresis 
 DNA and RNA samples were visualised and analysed by agarose gel 
electrophoresis with percentages varying from 0.8-3.0% run in 0.5X TBE.  
2.7  Viruses and cell lines 
 MNV1 was propagated in the murine leukaemia macrophage cell line 
RAW264.7 grown in Dulbecco modified Eagle medium (DMEM) with 10% (v/v) foetal 
calf serum (FCS), penicillin (100 U/ml) and streptomycin (100 µg/ml) and 10 mM 
HEPES buffer. A fowlpox recombinant virus engineered to express T7 RNA 
polymerase (Britton et al., 1996; Casais et al., 2001) was used in the cDNA based 
recovery system for MNV-1 by infecting BSR-T7 cells prior to transfection with cDNA. 
Baby-hamster kidney cells (BHK-21) expressing T7 RNA polymerase (BSR-T7 cells) 
used during the reverse genetics recovery of MNV from cDNA clones were cultured 
in DMEM (+FCS and without antibiotics) containing G418 at a concentration of 1 
mg/ml. Human embryogenic kidney cells (HEK 293T) used in the RNA based reverse 
genetics system were cultured in DMEM  (+FCS and without antibiotics). The 
pcDNA4/TO-NTAP-MNV NS7 and Tetracycline repressor (pCDNA6/TR) stable 
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expressing RAW264.7 cells were grown in DMEM with 10% (v/v) FCS, 1% (v/v) 
penicillin (100 U/ml) and streptomycin (100 µg/ml), 5 µg/ml blasticidine and 200 µg/ml 
zeocin. The HEK 293T cell lines expressing the Tetracycline repressor protein (T-
REX) stably transfected with tetracycline inducible NTAP and CTAP MNV (in the 
pcDNA4/TO expression plasmid) were grown in DMEM, 10% (v/v) FCS, 1% (v/v) of 
penicillin (100 U/ml) and streptomycin (100 µg/ml), 5 µg/ml blasticidine and 200 µg/ml 
zeocin. All cells were maintained at 37oC with 10 % CO2. 
2.8 Tandem affinity purification 
2.8.1 Purification of NTAP- MNV NS7 in the RAW264.7 T-REX  system 
 RAW264.7 T-REX cells expressing the tetracycline repressor (pCDNA6/TR) 
(stably selected with 5 µg/ml blasticidine) generated previously in the lab were 
nucleofected with linearised pcDNA4/TO-NTAP-MNV NS7 plasmid using AMAXA 
nucleofection kit according to the manufacturer’s instructions. After 48 hour, the 
nucleofected cells were harvested and resuspended in selection medium containing 
10% of conditioned media from log phase parental cells (RAW264.7 T-REX cells 
containing blasticidine at 5 µg/ml with added zeocin at a concentration of 200 µg/ml). 
A serial dilution was made in 10cm tissue culture dishes and cells were replenished 
with selective medium until zeocin-resistant colonies were formed. Thereafter, single 
colonies were selected and grown as clonal cell lines. When sufficient cells had been 
selected, the inducibility of each cell was tested using doxycycline (Sigma) at a 
concentration of 1 µg/ml. After overnight incubation at 37°C, cells were harvested, 
lysed in RIPA buffer, the protein content measured, separated by SDS-PAGE and 
analysed by western blot. The best inducible clone was chosen for continual passage 
and used in TAP pulldown assay.  
 For the TAP purification assay, RAW264.7 T-REX expressing pcDNA4/TO-
NTAP-MNV NS7 clones were grown in 10 T-175 flasks and were induced with 1 
µg/ml doxycycline for 16 hours prior to harvesting. Following induction, the cells were 
either infected with MNV-1 at an m.o.i of 3 (TCID50 per cell) for 12 hours or left 
uninfected. Subsequently the cells were harvested and were frozen at -80°C. Upon 
thawing, cells were pelleted by centrifuge at 1245 x g for 10 minutes at 4oC and 
washed 3 times in ice-cold PBS. Thereafter, cell pellets were lysed in 1 ml lysis buffer 
(50 mM Tris-HCl (pH 7.5), 125 mM NaCl, 5% Glycerol, 0.2% NP-40, 1.5 mM MgCl2, 
25 mM NaF, 1 mM Na3VO4 and protease inhibitors) for 10-15 minutes. Lysates were 
freeze thawed twice (liquid N2 then 37 water bath) and centrifuged in a 4oC centrifuge 
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at 15,000 x g for 10 minutes. A 30 µl sample (sample 1) was kept for subsequent 
analysis.  
 For the first immunoprecipitation, the cleared lysates were added to 60 µl of 
packed rabbit IgG agarose beads (previously washed in lysis buffer) and then 
incubated at 4oC with rotation for 2-3 hours. The reactions were centrifuged at 1245 x 
g and the supernatant removed and kept for western blot analysis. The pelleted 
beads were washed 3 times with 1 ml lysis buffer followed by three washes in TEV-
protease cleavage buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 0.2% NP-40). 
Bound proteins were eluted by the addition of 20 units of TEV protease (2 µl) to the 
remaining beads together with 10 µl 20X TEV buffer (Invitrogen), 2 µl 0.1 M DTT and 
125 µl ddH20. Before the addition of the enzyme, 20 µl of sample (beads included) 
was kept for analysis and the reactions were incubated overnight at 4oC on a rotator.  
 For the second immunoprecipitation, IgG beads were centrifuged at 1245 x g. 
An aliquot of the supernatant (20 µl) containing the cleaved protein was kept for 
analysis and the remainder was added to 250 µl of lysis buffer containing the 
remaining beads. The reaction was resuspended and subjected to centrifugation at 
1245 x g. After that, the beads were retained as sample 5 and the supernatant 
containing the protease cleavage product was incubated with 40 µl of packed 
Ultralink Immobilized Streptavidin Plus (Pierce) beads prepared in lysis buffer at 4oC 
for 2-3 hours. After incubation, the reactions were spun at 1245 x g, the supernatant 
was kept for analysis (sample 6) and the beads were washed four additional times in 
lysis buffer.  
 The streptavidin binding peptide (SBP)-tagged proteins were eluted by adding 
100µl of 1 mM D-biotin in PBS and incubating at 4oC for 1-2 hours. The reactions 
were centrifuged at 1245 x g and the supernatant was retained as the final eluate. 
The remaining streptavidin beads were resuspended in an equal volume of 2X 
reducing SDS sample buffer and retained for measuring the efficiency of biotin 
elution by western blot analysis.  
 15% of the available purified protein (the final eluate) was added to 5x SDS 
sample buffer, heat denatured and separated on a 4-12% gradient NuPAGE Novex 
Bis-Tris Mini Gels (Invitrogen). This gel was then stained with silver stain kit 
(SilverQuest Silver) or Colloidal Blue Coomassie stain kit (both from Invitrogen) 
according to the NuPAGE basic staining protocol by the manufacturer’s kit.  
2.8.2 Purification of TAP-MNV NS7 in the HEK 293T T-REX system 
 Linearised plasmids pcDNA4/TO-NTAP-MNV NS7 and pcDNA4/TO-CTAP-
MNV-NS7 were used to generate the HEK 293T T-REX stable cell lines expressing 
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the TAP NS7 by transfection using the Lipofectamine 2000 transfection reagent 
(Invitrogen, UK) according to the manufacturer’s instructions. The stably expressing 
cells were harvested 48 hours post transfection and re-suspended in 10 ml 
conditioned selection medium (DMEM, 10% FCS, 1% penicillin/streptomycin, 5 µg/ml 
blasticidin, 200 µg/ml zeocin and 20% filtrate medium from log-phase HEK-293 TRex 
growing cells). A clonal selection procedure was carried out as described for 
RAW264.7 cells above and the best inducible clones were selected for TAP 
purification assay. 
  The TAP purification of doxycycline induced NTAP and CTAP MNV NS7 
expressing HEK 293T T-REX clones were carried out as described above for the 
NTAP- MNV NS7 in the RAW264.7 T-REX system (Section 2.8.1). Final eluates were 
separated on a 4-12% gradient NuPAGE Novex Bis-Tris Mini Gels (Invitrogen) and 
subjected to silver and colloidal coomassie blue staining as described above. The 
significant protein bands from colloidal blue staining PAGE gel were excised and sent 
to the Proteomics Services at McGill University and Genome Quebec Innovation 
Centre in Quebec, Canada for mass spectrometry analysis.  
2.9 Phage display 
 Both Ph.D.-12™ and Ph.D.-7TM Phage Display Peptide Library Kits were 
purchased from New England Biolabs (Ipswich, MA, USA) and consisted of a 12-mer 
and 7-mer peptide phage display library. The initial biopanning and phage clone 
characterisation was carried out using the Ph.D.-12™ Phage Display Peptide Library 
Kit and the MNV NS7 His tagged recombinant protein as a target. The Ph.D.-7TM 
Phage Display Peptide Library Kit was used in the latter studies when the non-His 
tagged version of MNV NS7 and VPg recombinant proteins were generated.  
2.9.1 Panning  
 Panning experiments were carried out according to the manufacturer’s 
protocols with a few modifications as described in Chapter 4. In the solution binding 
approach (using the Ph.D.-12 library kit only), Ni-CAM agarose (His-select resin, 
SIGMA) was used to immobilise the target (MNV NS7 His-tagged). Briefly, 25 µl of 
Ni-CAM agarose in TBS + 0.1% [v/v] Tween 20 (TBST 0.1%) was incubated with 5 
µg of MNV NS7 His-tagged protein and blocked with 5 µg/ml BSA in TBST 0.1%. 
Thereafter, the negative selection was carried out by exposing 1.0 x 1011 pfu/ml 
phage library to the Ni-CAM agarose without the NS7. The unbound phage from the 
negative selection was then exposed to the NS7 protein-resin complex. 
Subsequently, the non-binding phage were discarded and protein-resin complexes 
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were washed extensively with TBST 0.1%. The bound phage were then eluted by 
using 200 mM Imidazole and seperated from the protein-resin complexes by using 
SpinX microfiltration columns. The supernatant that contained the phages were 
titered, amplified and purified as described in the manufacturer’s protocol and these 
phage were further used in the successive rounds of panning. In total three rounds of 
panning were performed. For control panning, ultralink streptavidin agarose beads 
were used and the binding phage were eluted by using 0.1 mM biotin.  
 In the plate binding approach, 96-well ELISA plates were used for panning 
experiments according to the manufacturer’s instructions. Briefly, up to 5 µg of His-
tagged MNV NS7 (using Ph.D.-12 library kit) or the non His-tagged derivative (using 
Ph.D.-7 library kit) were used to coat a well of the plate and blocked with 5 mg/ml 
BSA in blocking buffer. Thereafter, 4 x 1010 pfu/ml phage library was added and 
allowed to bind for 1 hour. Then, the non-binding phage were discarded and the well 
was washed extensively with TBST 0.1%. The bound phage were then eluted by 
using a general buffer (0.2 M Glycine-HCl (pH 2.2), 1 mg/ml BSA) and neutralised 
with 1 M Tris-HCl (pH 9.1) or by using specific elution with recombinant VPg, anti 
NS7, or viral RNA (for Ph.D.-7 library system only). Routinely, the phage were titred, 
amplified and purified according to the manufacturer’s instructions and used in the 
successive rounds of panning. Five rounds of panning were performed and in each 
round, a few parameters were varied to increase the stringency of the panning as 
described in the text. The parameters were, increasing the rounds of negative 
selections against BSA, reducing the duration of binding time, increasing the 
concentration of Tween 20 in TBS washing buffer and increasing the elution time (for 
Ph.D.-7 library system only).  
2.9.2 Characterisation of binding clones 
 This process was only carried out for the 12-mer phage display system. 
Plaques from the 3rd (solution binding) and 5th (plate binding) round of panning were 
selected to be characterised, as clones from the third round are often sufficient to 
detect consensus binding sequence (Ph.D.-12™ Phage Display Peptide Library Kit 
manual, New England Biolabs). Single well-isolated blue plaques were selected and 
subjected to plaque PCR in order to amplify the insert DNA sequence for the 
displayed peptide in phage clones by using a primer set IGIC218 and IGIC219 
(sequencing primers in Table 2.1). The PCR product was then purified and sent for 
sequencing (Imperial College MRC Sequencing Service) using the IGIC219 
sequencing primers (Table 2.1). The binding peptides were determined from the 
sequencing results. 
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 Enzyme-linked immunosorbent assays (ELISAs) were carried out in order to 
establish the binding ability of the pool phage from the last round of panning as well 
as the selected peptide phages to the target and to determine whether the selected 
clones were specific to the target or merely plastic binders or other residues. This 
experiment was carried out according to the manufacturer’s protocol with a few 
modifications to optimise the binding condition of the target protein (His-tagged or 
non His-tagged MNV NS7) to the ELISA plate. Briefly, each row of the plate was 
coated overnight with 150 µl of 375 µg/ml MNV NS7, 100 µg/ml streptavidin or 35 
mg/ml bovine serum albumin (BSA) in coupling buffer (NaHCO3, pH 8.6) per well. 
Subsequently, the wells were blocked with BSA for 1-2 hours and washed with TBST 
0.5%. The phage pool or single clone to be characterised was subjected to serial 
dilution (two-fold) in another 96-well plate, which was blocked with BSA previously. 
Thereafter, the diluted phages were transferred to the target coated ELISA plate and 
allowed to bind for 1-2 hours at room temperature. The unbound phage was washed 
extensively with TBST 0.5% and incubated with the diluted HRP-conjugated anti M13 
antibody (in blocking buffer) for 1 hour. After subsequent washes, TMB solution was 
added to each well. Once the blue colour appeared at the required intensity, the 
reaction was stopped by the addition of 0.5 M HCl. The plate was read at 450 nm. 
2.10  Recombinant protein production and purification  
2.10.1 Cloning 
 Expression plasmids already generated in the lab (namely pET26Ub:MNV 
NS7 His and pET26Ub:MNV VPg His),  containing either NS7 or VPg as C-terminal 
histidine  were used as vectors. Both the NS7 and VPg coding region were amplified 
using expression primers as shown in the Table 2.1 using full-length MNV-1 cDNA 
clone (pT7MNV3’Rz) as a template. A stop codon was introduced immediately after 
the last amino acid residue of both the C-terminally tagged NS7 and VPg coding 
regions in order to produce the non-his tagged version of recombinant protein. The 
cloning of both genes was performed by employing the Sac II and Bam HI sites. 
2.10.2 MNV NS7 (non-His tagged) 
 The expression plasmid (pET26Ub:MNV NS7 non His ) was transformed into 
BL21 DE3 + pCG1 bacterial cells (Gohara et al., 1999). The  expression plasmid was 
designed to fuse the ubiquitin to the N-terminus of the desired protein in order to 
increase the expression and the solubility. Co-expression with pCG1 in BL21DE3 
bacterial cells results in the specific removal of the ubiquitin domain, producing a 
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protein with the precise N-terminus as seen in the virus. For induction purposes, the 
transformants were grown for 24 hours in Overnight ExpressTM Instant TB medium at 
37°C in the presence of kanamycin and chloramphenicol. After 24 hours, bacterial 
cells were harvested by centrifugation at 3000 x g and pellets were lysed in buffer A 
(500 mM NaCl, 50 mM Tris-HCl pH 8.0, 5% glycerol, 10 mM 2-mercaptoethanol, 
0.1% NP-40) containing protease inhibitor and lysozyme by single freeze-thaw cycle 
at -80°C and sonication for 2 minutes total. A 0.25% final concentration of 
polyethylenimine (PEI) was added slowly to the lysate and the precipitated nucleic 
acid was removed by centrifugation at 11,000 x g for 30 minutes at 4°C. Ammonium 
sulphate was then added slowly to the PEI supernatant until 40% to 60% saturation 
was reached before being re-centrifuge. The precipitated pellet was then re-
suspended in 100 mM NaCl buffer A and dialysed against the same buffer overnight 
at 4°C. Thereafter, column chromatography was performed by using AKTAprime™ 
Automated Liquid Chromatography System from GE Healthcare according to the 
manufacturer’s manual. Phosphocellulose (PC), heparin and SP Sepharose columns 
were used in a series of purifications. After the removal of nucleic acid, an initial 
ammonium sulphate mediated precipitation and dialysis, the sample of non-his NS7 
in Buffer A+100mM NaCl was first loaded onto a PC column, equilibrated in the same 
buffer and gradient eluted with 100 mM to 1M NaCl Buffer A. SDS-PAGE indicated 
that the MNV NS7 protein did not bind to the PC column under these conditions and 
was found exclusively in the pass through. The collected pass through from the PC 
column was further loaded onto a heparin column and the non-his NS7 was eluted 
around 400 mM NaCl. The cleanest fractions were then pooled, diluted in Buffer A to 
the desired final concentration of NaCl (typically 40-100mM) and subjected to further 
purification by loading onto a SP Sepharose column. The untagged NS7 eluted from 
the SP resin at around 40 mM NaCl. The cleanest fractions were pooled together 
again, diluted with Buffer A and loaded onto heparin column again. The non-his NS7 
was eluted from the column at between 300 and 400 mM NaCl. The cleanest 
fractions were pooled and dialysed against 200 mM NaCl Buffer A without NP-40 
overnight at 4°C. Subsequently, the purified MNV NS7 was concentrated down to 
1/5th total volume using a Vivaspin 500TM column from Vivascience. The protein 
concentration was determined by measuring absorbance at 280 nm in 8 M 
guanidine-HCl, 20 mM K Phosphate Buffer (pH 6.6), and using a calculated molar 
extinction coefficient of 80,780 units. The protein sample was aliquoted and frozen at 
-80°C. 
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2.10.3 MNV VPg (non-His tagged) 
 The MNV VPg (non His-tagged) expression plasmid (pET26Ub:MNV VPg non 
His) was transformed into BL21 DE3 + pCG1 bacterial cells (Gohara et al., 1999), 
induced, lysed and prepared as described for MNV NS7 above. The ammonium 
sulphate precipitated pellet was suspended in 250 mM NaCl Buffer A and dialysed 
overnight against the same buffer. PC and SP Sepharose columns were used for 
MNV VPg purification. The dialysed sample was first loaded onto a PC column 
previously equilibrated with 250 mM NaCl Buffer A. Gradient elution was performed 
with 250 mM to 1.5 M NaCl buffer A and VPg was eluted between 400 to 500 mM 
NaCl. The cleanest fractions were pooled together and diluted with Buffer A to a final 
concentration of around 100 mM NaCl. A SP Sepharose column was then employed 
as a further purification step. The purified VPg was eluted using at gradient at around 
600 mM NaCl in Buffer A. The cleanest fractions containing VPg protein were pooled 
and dialysed overnight against 300 mM buffer A without NP-40. The VPg protein 
concentration was determined as described for NS7 but using a calculated molar 
extinction coefficient of 16,500 units. 
2.11 T7 in vitro RNA transcription, purification and 
 enzymatically capping of RNA transcripts 
 In vitro transcription reactions using recombinant T7 RNA polymerase were 
carried out to produce RNA transcripts of full-length genomic and sub-genomic RNAs 
from various cDNA constructs based on pT7MNV3’Rz. For the production of full-
length genomic viral RNA transcripts, the cDNA clones (WT, mutants or reporter 
tagged) were linearised using the Nhe I site which is situated at the last adenine 
nucleotide of the 26 poly A tail in the cDNA clone, purified and used as a template in 
reactions. For the production of sub-genomic RNA transcripts, purified PCR products 
representing the subgenomic region (with an introduced T7 promoter sequence at 
the 5’ end of sub-genomic region) were used as templates for the reactions.  
Typically, the transcription reactions contained 200 mM HEPES pH7.5, 32 mM 
magnesium acetate, 40 mM DTT, 2 mM spermidine, 7.5 mM of each NTP (ATP, 
UTP, GTP and CTP), 40 unit of RNAse inhibitor (Promega), 250 ng of DNA template 
and 50 µg/ml of T7 RNA polymerase. Reactions were incubated at 37°C for 2-7 h 
and then treated with DNase I at a final concentration of 0.1 unit/µl (New England 
Biolabs) at 37°C for 30 minutes. A subsequent DNA purification step was carried out 
by precipitation using lithium chloride at final concentration of 2.5M and incubation at 
-20°C for 30 minutes. The precipitated RNA were then washed in 70% ethanol and 
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resuspended in RNA storage solution (Ambion). The final concentration of the RNA 
transcripts was determined using a spectrophotometer before being standardised to 
1 µg/µl and kept in -20°C until required.  
 Each purified in vitro transcript RNA used for reverse genetics recovery of 
MNV was subjected to enzymatic capping using the ScriptCap system (Epicenter) 
according to the manufacturer’s instructions. For this reaction, up to 75 µg of  purified 
in vitro transcribed RNA was denatured by heating to 65°C for 10 minutes prior to 
rapid chilling on ice. The enzymatic capping reaction (total volume of 100 µl) was 
then set up by the addition of 10 µl of 10x capping buffer, 10 µl of 10 mM GTP, 0.5 µl 
of 20 mM S-adenosyl methionine, 2.5 µl of Scriptguard RNAse inhibitor and 4 µl of 
ScriptCap enzyme mix. The reaction was incubated at 37°C for 1 h, followed by 
purification using lithium chloride precipitation (method described above). The RNA 
was standardised to a concentration of 1 µg/µl in RNA storage solution (Ambion).  
2.12 In vitro translation of enzymatically capped RNA 
 transcripts 
 In vitro translation reactions of enzymatically capped RNA transcripts were 
performed by using the Flexi rabbit reticulocyte lysate system (RRL) (Promega) 
according to the manufacturer’s instructions. Typically, each 25 µl translation reaction 
contained 16.5 µl of RRL, 20 µl amino acid mixture minus methionine, 100 mM KCl, 2 
mM DTT, 0.5 mM MgOAc, 10 Units of RNAse inhibitor and 11 µCi 35S methionine 
(1000 Ci/mmol) EasyTag™ EXPRESS35S Protein Labeling Mix (Perkin Elmer). The 
reactions were initiated by adding 1 µg of capped RNA and incubated at 30°C for 1.5 
h. After incubation, reactions were stopped by adding an equal volume of 2X SDS-
PAGE sample buffer and heating to 95°C for 2 minutes. Subsequently, 5 µl of each 
sample was resolved on a 15% SDS-PAGE gel, fixed in fixation solution (10% 
ethanol, and 10% acetic acid in ddH2O) and dried on filter paper (Whatman). The 
dried gels were visualised by exposure to a phosphorimager screen followed by 
exposure to x-ray film. For luciferase containing samples, 5 µl of the translation 
products were aliquoted out and diluted in 95 µl 1X Reporter Lysis Buffer (RLB) 
(Promega). 30 µl of these samples were used in a luciferase assay as described in 
Section 2.21. 
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2.13 MNV reverse genetics 
2.13.1 cDNA based system 
 Recoveries of various full-length infectious MNV-1 cDNA clones (based on 
pT7MNV3’Rz) generated during these studies were performed using the reverse 
genetics system previously described (Chaudhry et al., 2007). BSR-T7 cells were 
plated in 6-well plates at a density of 7.5 X 105 cells/well in antibiotic free DMEM 
(10% (v/v) FCS) and incubated overnight at 37oC with 5% CO2. The next day the 
media was removed and the cells were incubated for 1 hour in 700 µl of antibiotic 
free DMEM (10% (v/v) FCS) with fowlpox virus expressing T7 RNA polymerase 
(titred in chick embryo fibroblasts) at a m.o.i. of 0.5 p.f.u. per cell. After 1 hour, 2 ml of 
antibiotic free DMEM (10% (v/v) FCS) was added and the cells were incubated for 
another 1 hour. After 2 washes in antibiotic free DMEM (10% (v/v) FCS), 1 µg of 
each MNV cDNA construct was transfected using Lipofectamine 2000 (Invitrogen) 
according to the manufacturers’ instructions. 
2.13.2 RNA based system 
 Various mutants and WT based MNV-1 cDNA constructs generated through 
out these studies were employed to generate in vitro transcribed enzymatically 
capped RNA and subjected to use in RNA based reverse genetics system. The 
principle of this reverse genetics system is described in Yunus et al 2010. For 
recovery using BSR-T7 and HEK 293T cells, both type of cells were transfected 
using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Cells 
were plated in 6-well plates at a density of 7.5 X 105 cells/well in antibiotic free 
DMEM (10% (v/v) FCS) and incubated overnight at 37oC with 5% CO2. Cells were 
then transfected with 1 µg of an in vitro transcribed and enzymatically capped RNA 
(as described in Section 2.11) complexed with 4 µl of Lipofectamine 2000 for 20 
minutes at room temperature in 200 µl Optimem (Invitrogen) and incubated at 37°C. 
 For recovery using RAW264.7 cells, the Neon electroporation system 
(Invitrogen) was used. 6 X 106 cells were harvested and washed once in PBS 
(Gibco). Cells were then resuspended in 100 µl of resuspension buffer, mixed with 1 
µg of RNA and electroporated at 1725 Volt for 25 millisecond (determined as the 
optimal condition) (Yunus et al., 2010). Cells were immediately transferred to a 35 
mm dish containing pre-warmed antibiotic free DMEM (10% (v/v) FCS) and 
incubated at 37oC with 5% CO2. 
 To detect infectious MNV, the cells were harvested 24 hours post-
transfection. Two freeze–thaw cycles were used to release cell-associated virus 
 Amir Yunus PhD Thesis 2012 
73 
which was subsequently titred by TCID50/ml in the RAW264.7 cells, using 
microscopic visualisation for the appearance of cytopathic effect. Protein expression 
was analysed by harvesting the cells into RIPA buffer and performing western blot 
analysis. 
2.14 Viral growth curves 
 In all cases, growth curves were performed using triplicate samples for each 
time point. RAW264.7 cells seeded at 3.2 X 105 per well of a 24-well plate and 
allowed to grow overnight. After incubation with viruses at a given m.o.i (4 TCID50 
per cell for single-step growth curves), cells were washed in DMEM (10% (v/v) FCS, 
penicillin (100 U/ml) and streptomycin (100 µg/ml). At given time points (typically 0, 6, 
12, 24, 48, 72 h post-infection) samples were frozen at -80oC and upon thawing the 
viral titres were determined by TCID50. Protein samples were also taken at 
equivalent time points, standardised and analysed by western blot. 
2.15 Determination of viral titre (TCID50/ml) 
 The MNV titre was determined by serial dilutions of the virus in a 96-well plate 
using DMEM (10% FCS + pen/strep) as the diluent. The dilutions ranged from 10-1 to 
10-8 in 50 µl DMEM and were subsequently overlayed with 1 X 104 RAW264.7 cells in 
100 µl DMEM.  The wells in each repeat titration were scored for cytophatic effect 
after 5 days and in some cases 7 days where slow growing viruses may have been 
produced. Viral titres were calculated using the standard formula as described in 
Reed and Muench, 1938 (Reed and Muench, 1938). 
2.16 Total RNA extraction and purification 
 Total RNA extraction and purification from infected and transfected cells 
throughout these studies were performed using GenElute™ Mammalian Total RNA 
Miniprep Kit (Sigma Aldrich) according to the manufacturer’s instructions. RNA 
obtained was quantified using spectrophotometer and qualitatively inspected by 
visualisation on agarose gel.  
2.17 Real time quantification PCR (RT-qPCR) 
 The expression level of genomic and sub-genomic RNA for WT and mutants 
MNV were quantified using one step RT-qPCR. The RNA from WT and mutant 
viruses infected RAW264.7 cells were prepared at a given time points post infection 
as described in Section 2.16. A viral standard RNA (genomic and sub-genomic) 
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corresponding to the start site until about 1000 nucleotides for both templates 
(containing 1011 viral genome copies/µl) were previously prepared by in vitro 
transcription reaction and quantified by my colleague Dr Surender Vashist. These 
standard RNAs were subsequently diluted by performing 10-fold serial dilutions in 
RNA dilution buffer (yeast RNA, Ambion Cat #AM7118 diluted 1:100 in nuclease free 
water) to give viral RNA standards ranging between 108 and 103 genome copies per 
µl. For each RNA sample, duplicate qPCR reactions were then prepared in 96-well 
qPCR plates (Thermo Scientific) using the MESA Blue qPCR MasterMix Plus for 
Syber Assay (Eurogentech). 20 ng/µl of the RNA samples or 1 µl of each diluted viral 
RNA standard was placed into 20 µl reactions containing either the MNV genomic 
primers IGIC404 and IGIC491 or MNV subgenomic primers IGIC65 and 5722R. The 
enzyme-containing buffer and ddH2O were added according to the manufacturer’s 
protocol. Reactions containing ddH2O and RNA dilution buffer were used as a 
control. DNA was amplified in an ABI 7900 real time PCR machine using a 10 min 
heat denaturing step (95°C for 10 min) followed by 40 cycles of 94°C for 15 sec, 
58°C for 30 sec and 72°C for 30 sec. 
 Viral genome copy number was calculated by interpolation from the standard 
curve. This was generated using serial dilutions of standard RNA. The detection limit 
was established by setting the threshold of detection to the values seen by qPCR 
reaction of a non-infected negative control mouse. To ensure that these negative 
control values were not due to contamination of the tissue samples with DNA from 
the laboratory, the melting curves of these qPCR reactions were analysed and 
compared to the viral standards. A melting curve measures the melting temperature 
of the product obtained by qPCR. If only one specifically primed product is produced, 
then a single curve corresponding to the melting temperature can be seen. If the 
products are multiple and non-specifically primed, then several curves are seen, 
which do not overlap with the curve of the desired product. 
2.18 Reverse transcription - PCR (RT-PCR)  
 Reverse transcription was carried out on total RNA extracted from RAW264.7 
cells infected with WT and mutants viruses. SuperScript II Reverse transcriptase 
(Invitrogen) was used in the RT reaction according to the manufacturer’s instructions. 
The specific reverse sequencing primers (Table 2.1) were used for the RT reactions. 
The desired or mutated region of the viral genome was then PCR amplified and 
subjected to sequencing by using the MNV-1 sequencing primers (Table 2.1). 
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2.19 Antisera 
 All antibody dilutions stated in this section refer to western blot analysis. A 
monoclonal mouse anti GAPDH (Cat # AM4300) was purchased from Ambion and 
was used at a dilution of 1:20,000.  Antisera to the NS7, NS3, VPg, VP1 and VP2 of 
MNV-1 were generated by immunisation of New Zealand white rabbits by 
Eurogentech. Anti-NS7, VP1, VP2 and VPg sera were used at a dilution of 1:1000.  
Anti- NS3 serum was use at a dilution of 1: 500. 
 Anti-rabbit secondary antibody coupled with HRP (horseradish peroxidase) 
was used at 1:15,000 and anti-mouse antibody coupled with HRP was used at 
1:10,000. Both of these secondary antibodies were purchased from Sigma Aldrich, 
US. 
2.20 Western blot 
 For western blot analysis, cells were lysed in RIPA buffer (50 mM Tris–HCl 
pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and 0.1% SDS). The BCA 
protein assay (Pierce) was used to quantify the protein in the lysates. From each 
lysate, an equal amount of protein was added to SDS sample buffer (reducing) and 
the proteins were separated by SDS-PAGE. Proteins were transferred to a 
polyvinylidene fluoride (PVDF) Immobilon-P transfer membrane (Millipore) for 
detection using Enhance Chemiluminescence (ECL) reagents or to a nitrocellulose 
membrane Protran BA85 for Licor WB system by semi-dry blotting according to the 
manufacturer’s instructions (Biorad). Subsequently, the membrane was blocked with 
PBST (0.1% Tween 20 in PBS) containing 5% (w/v) milk powder. After blocking, the 
membrane was incubated with primary antibody (anti MNV NS3 or NS7 or VP1 or 
VP2 or GAPDH) diluted in PBST, 5% (w/v) milk for 2 hours and was washed 3 times 
in PBST, 5% (w/v) milk. The secondary, horseradish peroxidase (HRP) conjugated 
antibody diluted in PBST, 5% (w/v) milk was applied for 1 hour and the membrane 
was washed twice in PBST and twice in PBS. For the final visualisation, ECL 
detection substrate (Amersham-Biosciences) was used according to manufacturer’s 
instructions.  In some cases an infrared fluorescence detection system (Li-COR) was 
used to obtain better quantification of the signal and required the use of a different 
secondary antibody; either IgG DyLightTM 680 or 800 fluorescent dye-conjugated 
antibody. The diluted antibody in PBST with 5% (w/v) milk was used to soak the 
membrane for 45 minutes and subsequent washing as described in ECL detection 
system. After that, the membrane was dried at room temperature by avoiding 
exposure to light. The fluorescent signal from the secondary antibody was scanned 
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with the Li-COR Odyssey Infrared Imaging System (LI-COR Inc.) and analysed with 
Odyssey software version 3. 
2.21 Luciferase assay 
 For Renilla luciferase assays, cell lysates were prepared by lysing the 
transfected cells in 1X Reporter Lysis Buffer (RLB) according to the manufacturer’s 
instruction (Promega). The protein concentration in each lysates was standardised 
using a BCA assay kit (Pierce) according to manufacturer’s instructions and equal 
amount of protein in each cell lysate was subjected to luciferase assay. For Gaussia 
luciferase, the growth medium in each well of transfected cells was replaced with 
fresh medium and incubated at 37°C for 30 minutes. After incubation, an aliquot of 
growth medium was taken out as a sample for luciferase assay. Growth medium from 
untransfected cells was used as control. 
 The luciferase assays were carried out using diluted (1:500) coelentrazine 
(Promega) in PBS as a substrate. For Renilla luciferase, 30 µg of total protein from 
each cell lysate were mixed with 100 µl substrate and the luciferase activity was 
measured in an auto-injector luminometer according to the manufacturer’s 
instructions (FLUOstar Omega, BMG Labtech). For Gaussia luciferase, 30 µl of each 
sample (growth medium from transfected cells) was mixed with 100 µl substrate. 
 For luciferase assay in the live cell system, the VIVIREN substrate (Promega) 
was used as instructed by the manufacturer. Briefly, the VIVIREN substrate was 
diluted (1:1000) using medium with FCS. The growth medium of transfected cells in 
each well of a 96 well plate was removed and replaced with medium containing 
VIVIREN substrate and the luciferase activity was measured (after at least 2 minutes 
incubation period) using a luminometer. 
2.22 5’ rapid amplification of cDNA ends (RACE) 
 Total RNA preparation from virus infected RAW264.7 cells was subjected to 
cDNA synthesis using 5722R reverse primer. The resulting cDNAs were treated with 
ribonuclease to degrade the viral RNA template prior to column purification. The 
purified cDNAs were then used as a template for RACE assay using the 5’ RACE kit 
from Invitrogen. The assay was carried out following the manufacturer’s instructions. 
Purified cDNAs were first subjected to the 3’end poly(C) tailing reaction catalysed by 
terminal transferase. The resulting 3’ end tailed cDNA was then employed as a 
template for PCR reaction using an anchor primer (which binds to the poly(C) 3’end 
of cDNA) and the 5414R reverse primer. 
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3.1 Introduction 
 After virus entry into the cell, the genome is released allowing translation and 
the subsequent formation of viral replication complexes. As obligate intracellular 
pathogens, viruses require host cell factors for replication. Therefore, protein-protein 
interactions play an essential role in viral genome replication. Calicivirus RNA 
replication occurs after the virus establishes the formation of cytoplasmic membrane-
bound replication complexes in infected cells (Bailey et al., 2008; Hyde and 
Mackenzie, 2010; Hyde et al., 2009). The norovirus NS7 is a RNA-dependent RNA 
polymerase (RdRp) that synthesises new viral RNA and therefore plays a critical role 
in the viral life cycle. The NS7 of MNV and the p76 (NS6/7) of FCV interact with VPg 
(Han et al., 2010; Kaiser et al., 2006; Rohayem et al., 2006a). A direct interaction 
between other viral polymerases and host cell factors has also been demonstrated 
for poliovirus (PV) and hepatitis C virus (HCV) (McBride et al., 1996; Watashi et al., 
2005; Wu et al., 2008). However, for the norovirus polymerase, only a limited or no 
information exists regarding the interaction of this viral RNA replication enzyme with 
other host cell factors. Therefore, as part of my efforts to characterise the NS7 
protein, I undertook studies aimed at the identification of binding partners. My studies 
were aimed at identifying possible host cell derived and viral derived factors to gain a 
better understanding of the functional role of these interactions in viral RNA 
replication. There are several readily available and well established methods as 
possible approaches including the yeast two hybrid system, pull down assays using 
recombinant proteins and immunoprecipitation followed by mass spectrometry 
identification (Williamson and Sutcliffe, 2010). However, the recently developed 
approach known as tandem affinity purification which uses a double-affinity tag 
mediated purification, combined with two specific elution steps in the identification of 
interacting proteins has become a common method of choice (Burckstummer et al., 
2006). The advantage of this system is that protein-protein interactions are 
maintained because the purification of tagged proteins and associated binding 
partners from cells is carried out under mild conditions (Janin and Seraphin, 2003). 
Therefore, this approach was employed to identify host cell and viral factors that may 
interact with NS7. In this case, a TAP tag system was based on a modified version 
developed by Burckstummer et al in 2006. The tag consists of two streptococcal 
immunoglobulin G (IgG)-binding units of protein G and streptavidin binding peptide 
(SBP) separated by a tobacco etch virus (TEV) protease cleavage domain 
(Burckstummer et al., 2006). The purification involves an immunoprecipitation step 
using Rabbit IgG agarose and affinity purification using streptavidin agarose, followed 
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by specific elution with biotin (Figure 3.2). The purified proteins in the final eluate are 
then identified by mass spectrometry. It was envisaged that any binding partner(s) for 
NS7 identified in this study could be further evaluated by functional studies and if 
such interactions are vital for viral replication, an inhibitor that potentially targets this 
interaction could be designed. 
3.2 Results  
3.2.1 Tandem affinity purification 
3.2.1.1 N-TAP NS7 in RAW264.7 TREX cells 
 In an attempt to identify host cell factors and/or viral factors that interact with 
NS7, stable RAW264.7 cell lines expressing an N-terminal fusion of NS7 with the 
TAP tag (pcDNA4/TO-NTAP-MNV NS7) were generated (see Section 2.8.1). The 
parental cell line also expressed the tetracycline repressor (from pCDNA6/TR), which 
regulates the expression of TAP NS7. Induction of selected RAW264.7 cells 
containing the N-TAP NS7 plasmid with doxycycline (a tetracycline substitute with a 
longer half life) resulted in the production of significant amounts of the TAP-NS7 
fusion protein (Figure 3.1b). The N-TAP NS7 protein, approximately 70 kDa in size, 
was readily detected by western blot, however all of the cell clones analysed 
demonstrated substantial leaky expression as there was evidence of high 
background levels of TAP-NS7 expression in the uninduced cells (Figure 3.1b). 
Hence, the induction appeared to have only a small stimulatory effect on the 
expression levels of NTAP-NS7. Despite this, Clone 6 was selected to be used for 
the large-scale tandem affinity purification. 
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 A large scale tandem affinity purification was carried out by inducing stable 
RAW264.7 expressing NTAP-NS7 (clone 6) with 1µg/ml doxycycline for 16 hours. 
Following induction, the cells were either infected with MNV at a m.o.i of 3 TCID50 
per cell for 12 hours or left uninfected. Following incubation, cells were lysed and 
subjected to TAP purification protocol as described in detail in Section 2.8.1. Briefly, 
in the first step of this protocol, the TAP tagged protein was immunoprecipitated by 
binding of the protein G domains to rabbit IgG agarose. The protein G domains were 
(a)                    
 
 
(b)   
                   
   
Figure 3.1 Generation of stable RAW264.7 cell lines expressing N-TAP NS7 (a) 
Diagram showing the construction of the expression plasmid pcDNA4/TO-NTAP-
MNVNS7 used to generate N-TAP NS7 stable RAW264.7 TRex cells expressing the 
tetracycline repressor. Expression of N-TAP NS7 was under the control of a tetracycline 
inducible CMV promoter. Both plasmids were stably maintained in the cell by selection 
with blasticidine (Bl) and zeocin (Zeo). (b) Western blot analysis of induced TAP-tagged 
RAW264.7 cells. Stably NTAP-NS7 expressed cells were generated by nucleofection of 
NTAP-NS7 plasmid into TetR expressing RAW cells. 6 clones were selected, induced 
with doxycycline and lysed after 16 h. All lysates were normalised before resolved in 
SDS-PAGE gel and western blotted with MNV NS7 antisera (NTAP NS7 produced signal 
at ~70 kDa). Clone 6 (red circled) was selected for large scale TAP in infected and 
uninfected cells. 
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then cleaved off by TEV protease and the target protein, along with any associated 
binding partners were further purified via binding of the streptavidin binding peptide to 
streptavidin agarose. The proteins were subsequently eluted with biotin and the 
eluted proteins were then separated by 1D SDS PAGE (Figure 3.2).  
 
 
 
Figure 3.2 Schematic overview of the tandem affinity purification protocol for TAP 
MNV-NS7 protein. Detailed information of the procedure can be found in Section 2.8.1 
and 2.8.2. Various aliquots of sample were taken in each step during the purification to 
analyse the efficiency of purification procedure using western blot (Sample 1 to 7). SBP = 
streptavidin binding peptide, TEV = tobacco etch virus cleavage site, Rb = rabbit, IgG = 
immunoglobulin G. 
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 Western blot analysis was performed in order to determine the efficiency of 
the N-TAP NS7 purification (Figure 3.3a). The final elution products (Sample 7) were 
subsequently resolved in gradient SDS PAGE gel followed by silver staining to 
visualise the protein bands (Figure 3.3b). 
 
 Western blot analysis of all the samples from the TAP experiment indicated 
that the N-TAP NS7 purification was successfully performed (Figure 3.3a). For 
sample 1 and 2, the N-TAP version of NS7 and the native form of NS7 can be 
detected in samples purified from MNV-1 infected cells. By comparing sample 1 and 
sample 2 (before and after binding to IgG beads) it was clear that the majority of the 
tagged NS7 bound to the IgG agarose. The reduction in the molecular weight of the 
NS7 in sample 4 confirmed that the TEV cleavage occurred efficiently, leaving the 
protein G on the IgG agarose. Sample 6 and 7 are from the second affinity 
(a)    
           
 
(b)   
                                              
 
Figure 3.3 Analysis of various samples from tandem affinity purification of MNV N-
TAP NS7 from RAW264.7 TREX cells. (a) Western blot analysis of various samples ; 
S1,S2,S3 (TAP-NS7), S4,S6,S7 (SBP-NS7), taken during the purification process as 
stated in Figure 3.2 using NS7 antiserum as a probe. Samples from cells infected with 
MNV-1 (I) and from uninfected cells (NI) were resolved on an 12.5% SDS PAGE gel for 
subsequent western blot analysis. The asterisk symbol represents the native MNV NS7 
protein from infected cells. (b) Analysis of final elution samples [sample 7 of MNV-1 
infected (I) and uninfected (NI) cells] from tandem affinity purification process by silver 
staining of gradient SDS PAGE. 
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purification with streptavidin agarose. Western blot analysis also confirmed that NS7 
was present in the final eluted sample. 
 The subsequent analysis of the final elution by SDS PAGE and silver staining 
clearly indicated the presence of a protein with the predicted molecular mass of NS7 
protein ~60 kDa in size (Figure 3.3b). Unfortunately there were no other distinct 
proteins detected except the low molecular weight protein which presumably 
represents the contaminating TAP protein in the final elution product. Therefore, it 
can be concluded that no other binding proteins that could potentially associate with 
the N-TAP NS7 were purified under the conditions used in this particular assay.  
 From the western blot data it could be concluded that the NTAP-NS7 
purification protocol was successful in as much as we were able to purify the fusion 
NS7 protein. The western blot analysis also indicated that the TAP-tagged NS7 
lacked the ability to bind to the endogenous NS7 even though the RdRps from 
positive strand RNA viruses are thought to act as homo-oligomeric complexes. 
Oligomeric interaction of HCV NS5B has been shown to be influenced by the 
structural and conformational changes which are critical for the catalytic activity of 
RdRps (Qin et al., 2002). Furthermore, biochemical analysis of human norovirus NS7 
RdRp also revealed that it is active as a homodimer (Hogbom et al., 2009). Recently, 
a structural study of MNV NS7 also revealed that this protein could also form as an 
oligomer (Lee et al., 2011). From these published observations, we might predict that 
the MNV RdRp also has the ability to oligomerise. However in this particular assay, 
any oligomerisation of both fusion and native NS7 was not observed since the native 
NS7 was not pulled down in the final elutions of the infected sample when compared 
to the non-infected sample (Figure 3.3).  
 The inability to pull down any other interacting partner for N-TAP NS7 in this 
study also might be due to misfolding of NS7, which was expressed as a fusion to the 
TAP tag at its N-terminus. From the crystal structure of MNV NS7 (Lee et al., 2011), 
the N-terminus region of this protein is situated on the surface. Fusion of TAP tag at 
this region might interfere with potential protein interactions or cause a misfolding of 
the N-TAP NS7.  
3.2.1.2 NTAP and CTAP NS7 in HEK 293T TREX cells 
 With the unsuccessful outcome of the TAP system in the RAW264.7 cell line, 
another attempt to identify potential NS7 binding partners was carried out by 
employing two different TAP NS7 constructs, the N-terminally and C-terminally TAP 
fusion NS7 (NTAP and CTAP NS7) using the same tetracycline inducible system but 
in a different cell type (Figure 3.4a). In this attempt, stable HEK 293T TRex cell lines 
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expressing either NTAP or CTAP NS7 under the control of a doxycycline inducible 
promoter were generated (see Section 2.8.2). A number of advantages have 
contributed to the selection of this cell line. First of all, HEK 293T TREX cells are well 
known for their high transfection efficiency. These cells also demonstrate good 
expression of exogenous proteins if transfected with a cytomegalovirus (CMV) 
promoter driven expression plasmid. HEK 293T cells cannot be infected with MNV, 
although these cells support MNV genome replication. The purpose of generating 
these stable cell lines was purely to identify any potential host cell proteins, which 
might potentially bind to NS7. Successful clones from each stable cell line were 
selected after analysing the protein expression levels from doxycycline induced (+) 
and uninduced (-) cells of each clone (Figure 3.4b). In this case, the best inducible 
clones with the most tightly regulated expression compared to their uninduced 
counterpart sample in western blot analysis were preferred to be used in subsequent 
TAP purification assays. The clones that were induced with doxycycline displayed a 
stronger NS7 signal on western blot analysis compared to their uninduced 
counterpart. However, all the clones also displayed a high background level of TAP 
NS7 expression in all of the uninduced cells as seen previously in the RAW264.7 
cells (Figure 3.4b). Regardless of this issue, Clone 1 from each N-TAP and C-TAP 
MNV NS7 was selected to proceed with tandem affinity purification based on the 
protein expression levels and the growth characteristics of the cells (Figure 3.4b). 
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 A large-scale tandem affinity purification was carried out by inducing cell lines 
expressing N-TAP and C-TAP MNV NS7 (Clone 1) with 1µg/ml doxycycline. Induced 
cells were lysed 24 hours post induction and cell lysates of N-TAP and C-TAP MNV 
NS7 were purified via TAP purification assay (see Section 2.8.1 and 2.8.2). The final 
elution products were examined on SDS PAGE using silver staining (Figure 3.5). 
Unlike the previous approach using RAW264.7 cells, several potential binding 
partners from host cells were successfully co-precipitated (Figure 3.5). Interestingly, 
more potential cellular binding partners were eluted from the NTAP-NS7 than the 
CTAP-NS7 as observed in the Figure 3.5. This may have been due to the fact that 
the N-TAP tagged protein appeared to purify better and resulted in a greater overall 
final yield. 
(a) 
 
 
(b) 
                        
 
Figure 3.4 Generation of stable HEK 293T TREX cell lines expressing NTAP and 
CTAP-NS7. (a) Schematic representation of the plasmids pcDNA4/TO with N-terminal 
and C-terminal fusion of MNV NS7 gene used to generate stable 293T cell lines 
expressing the tetracycline repressor. Expression of both NTAP and CTAP NS7 were 
under the control of a tetracycline inducible CMV promoter. Stably TAP-NS7 expressing 
cell lines were generated by transfection of NTAP-NS7 or CTAP-NS7 plasmid into TetR 
expressing HEK 293T cells These stable cell lines were maintained by selection with 
zeocin and blasticidine (see Section 2.8.2) (b) Western blot analysis of the induced and 
un-induced TAP-tagged NS7 expressed from the HEK 293T TREX cells. 5 clones were 
selected, induced with doxycycline and lysed after 16 hour post induction. All the proteins 
concentration in the cell lysates were normalised before being resolved in SDS-PAGE gel. 
MNV NS7 antisera was used as a probe for western blot analysis where the TAP-NS7 
produced signal at ~70 kDa. Clone 1 (red circled) from each TAP-NS7 were selected for a 
large scale TAP purification. 
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  Based on these initial observations, the final elution samples were further 
concentrated and resolved in gradient SDS PAGE gel and were stained with colloidal 
coomassie blue. Selected protein bands were excised from the gel and were sent to 
Proteomics Services at McGill University and Genome Quebec Innovation Centre in 
Quebec, Canada for mass spectrometry analysis. The obtained mass spectrometry 
data were then analysed against a custom human and MNV protein database. The 
final data was then analysed using proteomic software Scaffold 2. Based on the final 
data, the identified proteins with high peptide hits and high probability were correlated 
to the original protein bands identified [Figure 3.6 (C-TAP NS7) and Figure 3.7 (N-
TAP NS7)]. The identified proteins were also screened against the list of proteins 
identified from the lysates of the ‘TAP only’ pulldown as a control.  
 
 
 
 
                                            
 
Figure 3.5 Analysis of final elution products from tandem affinity purification of 
MNV N-TAP and C-TAP NS7 doxycycline induced HEK 293T TREX cell lines by 
silver staining of gradient SDS PAGE gel. Cells were harvested and lysed 24 hours post 
doxycycline induction followed TAP purification. The final elution samples were resolved 
on gradient PAGE and visualised by silver staining as described in Section 2.8.2. NS7 
proteins were highlighted with asterisk and lysate from a purification performed on a cell 
line expressing only the TAP tag alone was run on the gel as a control.  
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 All the identified proteins that were co-precipitated from the C-TAP MNV NS7 
were determined to be non-specifically binding proteins to NS7 since these proteins 
were previously identified in the empty TAP purification (TAP only) (previous 
observations within the laboratory). Therefore the interaction of these proteins with 
the C-TAP MNV NS7 protein was determined to be non-specific. Human General 
transcription factor II (GTF2), which had a high peptide score (Figure 3.6b and Figure 
3.7b) was identified in the TAP only pull down as a control. GTF2 has been pulled 
down non-specifically in a previously published TAP purification assay 
(Burckstummer et al., 2006). It is a multifunctional nuclear protein, which plays roles 
in RNA Pol II mediated transcription as well as signal transduction. There are several 
isotypes of GTFs and together these factors are responsible for promoter recognition 
and the formation of transcription preinitiation complex with RNA polymerase II. 
(a)  
       
(b) 
          
 
Figure 3.6 Identification of co-precipitated proteins from TAP purification of the C-
TAP MNV NS7 by mass spectrometry analysis. (a) Analysis of final elution product from 
the C-TAP MNV NS7 TAP purification by SDS PAGE gel and colloidal coomassie blue 
staining. The particular protein bands were excised for mass spectrometry analysis. (b) 
Summary of the identified proteins for the C-TAP MNV NS7 co-precipitated proteins from 
TAP purification by mass spectrometry based on the relatively high peptide hits with the 
highest probability.  
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Although this protein plays a role in cells RNA transcription, it is DNA-dependent and 
interacts with RNA polymerase II, a multisubunit polymerase protein and catalyses 
the transcription process using DNA as a template. The association between RdRp 
with this factor is highly unlikely since all the RdRp’s are RNA-dependent 
polymerases. Furthermore, since the GTFs are nuclear protein, it would be an 
indication that they are not involved in MNV replication. 
 Tubulin, used as the building block of microtubules, is highly expressed and in 
this case, it may simply be co-purified due to the high levels of this protein present in 
cells. In addition, the peptide hit obtained from mass spectrometry was also relatively 
low (Figure 3.6b) and it has been co-purified in the TAP only control as well. 
Microtubules are involved in several basic cellular processes, such as segregation of 
genetic material, intracellular transport, maintenance of cell shape and extracellular 
transport by means of cilia. Interestingly, in vitro mRNA synthesis for Measles virus 
and Sendai virus (a negative strand RNA viruses) is stimulated by tubulin and this 
process has been demonstrated to be inhibited by anti-β-tubulin antibodies (Houben 
et al., 2007). This observation lead to the hypothesis that tubulin might serve as an 
anchoring site on the cytoskeleton for the viral RNA polymerase. Studies on influenza 
virus polymerase supported this hypothesis as it has been shown that the incoming 
viral ribonucleoproteins associate with the cytoskeletal network where they are active 
in RNA synthesis (Klumpp et al., 1997). Assembling the RNA polymerase on the 
cytoskeleton provides focal concentration of the replication components and as a 
result, it increases the rates or efficiency of viral genome replication in infected cells.  
 Compared to the C-TAP NS7, the N-TAP NS7 final elution product from the 
TAP purification process contained a higher number of pulled down proteins (Figure 
3.7). As discussed above, the GTF2 protein was identified in this purification as a 
non-specific binding protein (Figure 3.7b). Furthermore, identification of other 
proteins such as, 60S ribosomal protein, beta globin chain, and proteosomal 
components were considered to be irrelevant since these proteins had been 
identified in the TAP only control purification as well. Therefore these proteins were 
classified as non-specific products that been co-purified during the TAP purification 
process.  
 Intriguingly, additional proteins identified by mass spectrometry analysis with 
a relatively high peptide score were the human guanosine monophosphate reductase 
1 and 2 (GMPR) and N(2)-dimethylguanosine tRNA methyltransferase. (Figure 3.7b). 
Both of these proteins have previously not been identified in the TAP alone control. 
Therefore, it is feasible that these proteins are directly interacting with NS7. The 
human GMPR protein catalyses the irreversible NADPH-dependent deamination of 
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GMP (guanine nucleotide) to IMP (adenine nucleotide), maintaining the intracellular 
balance of nucleotides A and G during cellular differentiation. It plays a role in 
modulating cellular differentiation where overexpression of GMPR2 has been shown 
to promote the monocytic differentation of HL-60 leukemia cells a cancer cell-line 
(Zhang et al., 2003). The N(2)-dimethylguanosine tRNA methyltransferase is involved 
in tRNA processing as it dimethylates a single guanine residue at position 26 of most 
tRNAs using S-adenosyl-L-methionine as donor of the methyl group. These two 
identified proteins also may have other roles that have yet to be determined. The 
interaction between these proteins and MNV NS7 warrants further investigation to 
validate and confirm this observation. 
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(a) 
 
(b) 
     
Figure 3.7 Identification of co-precipitated proteins from TAP purification of the N-
TAP MNV NS7 by mass spectrometry analysis. (a) Analysis of final elution product 
from the N-TAP MNV NS7 purification by SDS PAGE gel and colloidal coomassie blue 
staining. The particular protein bands in bracket were excised out for mass spectrometry 
analysis. (b) Summary of the identified proteins for the N-TAP MNV NS7 from TAP 
purification by mass spectrometry based on the relatively high peptide hits with the 
highest probability. 
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3.3 Discussion 
 Viruses rely heavily on host cells factors in order to achieve efficient genome 
expression and replication by means of protein-protein interactions and also RNA-
protein interactions. As an important protein that plays a major role in viral RNA 
synthesis, a viral RNA polymerase is also expected to interact with other host cell 
proteins. One of the best-studied examples for viral polymerase-host cell proteins 
interactions is that of PV. PV RNA synthesis has been proved to require host cell 
factors. In one particular study, PV RNA was microinjected into oocytes derived from 
the African clawed toad Xenopus laevis. It was observed that poliovirus RNA could 
not replicate in Xenopus oocytes unless it was coinjected with a cytoplasmic extract 
from human cells, indicating a requirement for mammalian proteins that are absent in 
toad oocytes (Gamarnik and Andino, 1996). An indirect binding of PV 3CD (a 
protease-polymerase precursor) with the host cell poly(rC)-binding protein is 
expected since this host cell protein facilitates the binding of 3CD to the opposite site 
of the same cloverleaf-like RNA structure that forms in the first 108 nucleotides of the 
5’ positive strand RNA (Andino et al., 1993). This ribonucleoprotein complex interacts 
with poly(A) binding protein (PABP) which is bound to the viral 3’ poly(A) sequence 
allowing the circularisation of the viral genome that subsequently leads to PV 
negative strand RNA synthesis (Barton et al., 2001; Herold and Andino, 2001). The 
host cell protein, Sam68 (Src-associated in mitosis) has also been shown to 
physically associate with PV 3D polymerase in PV infected cells (McBride et al., 
1996). However, any functional role of this interaction has yet to be determined. 
Sam68, which is located in nucleus, becomes redistributed to the cytoplasm, the site 
of PV viral RNA replication.  
 Host cell protein-viral RdRp interactions have also been demonstrated for 
HCV. Cyclophilin B (CyPB) was found to interact directly with HCV RNA polymerase 
NS5B, stimulating its RNA binding activity (Watashi et al., 2005). CyPs are a family of 
peptidyl-prolyl cis-trans isomerases (PPIase), which catalyze the cis-trans 
interconversion of peptide bonds amino terminal to proline residues, facilitating 
changes in protein conformation (Waldmeier et al., 2003). CyP family members 
function in numerous cellular processes, including transcriptional regulation, immune 
response, protein secretion, and mitochondrial function (Brazin et al., 2002; Rycyzyn 
and Clevenger, 2002; Waldmeier et al., 2003). CyP has a high affinity for the 
immunosuppressant cyclosporin A (CsA). Indeed, the identification of CyPB-NS5B 
interaction begun with the observation that CsA could suppress HCV genome 
replication (Nakagawa et al., 2004). Using CsA as a bioprobe to identify cellular 
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factors involved in HCV genome replication resulted in identification of CyPB as a 
regulator of NS5B RNA binding activity (Watashi et al., 2005). Unpublished data from 
our lab however indicates that CsA does not affect norovirus replication suggesting 
cyclophilins play little to no role in norovirus replication in tissue culture. The HCV 
NS5B has also been demonstrated to specifically bind M2 type pyruvate kinase and 
down-regulation of this host factor resulted in inhibition of HCV replication (Wu et al., 
2008). Pyruvate kinase is a glycolytic enzyme that transfers phosphate from 
phosphoenolpyruvate to ADP generating ATP and pyruvate (Mazurek et al., 2005), 
which are glycolytic intermediate metabolites required during virus replication.  
 Using the TAP approach in this study, we successfully identified the GMPR 
and N(2)-dimethylguanosine tRNA methyltransferase as potential binding partners for 
MNV NS7. Due to time constraints however, validation and investigation of the role of 
these interactions in the norovirus life cycle were not carried out. The interaction of 
NS7 with GMPR could presumably regulate the level of GMP in infected cells. This 
interaction may stimulate the function of GMPR in order to provide sufficient adenine 
nucleotide (A) as a substrate for NS7 to catalyse viral RNA synthesis. Alternatively, 
this interaction also may inhibit the function of GMP in infected cells if the levels of 
IMP in infected cells are higher than the GMP.  
 An interaction of NS7 with the host cell N(2)-dimethylguanosine tRNA 
methyltransferase may occur in order to help stabilise the newly synthesised viral 
RNA. Even though the specific function of N(2)-dimethylguanosine tRNA 
methyltransferase is to dimethylate a single guanine residue in most tRNAs, 
interaction with NS7 during viral infection may stimulate its function to help stabilise 
the structure of newly synthesised viral RNA. However, all these interactions have 
yet to be further confirmed. If any of the identified interactions could be confirmed, 
they would represent attractive targets for antiviral therapeutic intervention. 
3.4 Conclusion  
 In this study, attempts to identify binding partners for MNV NS7 were carried 
out by employing the tandem affinity purification method. No binding partners were 
detected by TAP purification using the RAW264.7 cells stably expressing TAP-tag 
fused NS7. However, western blot analysis clearly showed that the TAP-NS7 was 
successfully purified. Using an alternative approach; the identification of NS7 binding 
partners using the tandem affinity purification approach in stable NS7 expressing 
HEK 293T TREX cell lines was however more successful. A number of unique 
proteins were identified in final lysate after tandem affinity purification. Most of the 
identified proteins by mass spectrometry were predicted to be non-specific binding 
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proteins since these proteins also were identified from the TAP only pull down as a 
control. Intriguingly however, the GMPR and the N(2)-dimethylguanosine tRNA 
methyltransferase protein were classified as potential binding partners to the NS7 
since both of these protein have not been pulled down in the TAP only control 
previously.  However, these findings warrant further investigation to validate and to 
confirm their interaction with NS7. One possible way to investigate these interactions 
is by co-immunoprecipitation assay. If this assay could confirm that the direct binding 
interaction actually exists between any of these proteins and NS7, other functional 
studies, such as knockdown of these host cells proteins using siRNA, could be 
carried out to further investigate the importance of the interaction during MNV 
infection. 
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4.1 Introduction 
 Significant progress in the development of human norovirus vaccines is 
problematic due to the high degree of genetic variation, common to many RNA 
viruses. Furthermore, protective immunity to human noroviruses is also thought to be 
short-lived (Johnson et al., 1990; Parrino et al., 1977). Recent work using MNV as a 
model system revealed that primary high dose infection in mice failed to provide 
protection after re-challenge with homologous virus (Liu et al., 2009a). Quarantine, 
the current mechanism of preventing or limiting virus spread, is often impractical, 
especially in settings where close contact between people cannot be avoided (i.e. 
hospitals and cruise ships). For these reasons, an antiviral therapy represents an 
attractive strategy to allow the control of norovirus outbreaks. The ‘ring fence’ 
treatment of individuals with antiviral drugs would prevent further dissemination of the 
outbreak. To date however, there are no licensed antivirals against noroviruses. 
However, a few in vitro studies have identified potential antiviral drugs against 
norovirus, for instance by targeting the viral genomes using PPMOs (Bok et al., 
2008) and ribavirin (Chang and George, 2007). Potentially, the viral RdRp is a good 
antiviral target since it plays a critical role in the virus life cycle. Antiviral drugs could 
be developed to target this viral enzyme using a small molecule such as a peptide 
inhibitor. These types of peptide inhibitors are also useful as tools to characterise 
viral replication in cell culture and possibly could be employed as reagents for the 
identification of small molecules that bind to the NS7. As an initial approach to 
identify a potential peptide inhibitor, peptide phage display is amongst the most 
popular methods employed. Peptide phage display is a powerful technique that has 
been widely used to identify peptides that bind to specific targets in vitro as well as in 
vivo (Hyde-DeRuyscher et al., 2000; Ramanujam et al., 2002; Trepel et al., 2002). 
Peptide phage display is based on an affinity selection technique in which a library of 
random peptides is genetically fused to a coat protein of a bacteriophage, resulting in 
display of the fused peptides on the surface of the phage virion, while the DNA 
encoding the fusion exists within the virion. By exposing a target to a diverse peptide 
library, it is possible to isolate a binding sequence without prior knowledge of the 
structural and chemical properties of the target. The application of phage display 
technology has progressed considerably in the past decade, examples include the 
identification of enzyme inhibitors (Dennis et al., 2000; Hyde-DeRuyscher et al., 
2000), cell markers (Jensen et al., 2003), receptor ligands (Koivunen et al., 1995; 
Lee et al., 2002; Pasqualini et al., 1995) as well as in drug discovery (Ferrer and 
Harrison, 1999). More significantly for this study, this technique has also been used 
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to identify and select peptides that specifically bind and inhibit the activity of the 
hepatitis C viral RdRp in vitro (Amin et al., 2003; Kim et al., 2008b). The aim of this 
chapter was to use the phage display technique to identify specific peptide 
sequences that specifically bind and inhibit the norovirus NS7. Ultimately, such 
peptide inhibitors could be developed as potential antiviral therapies against 
norovirus infection or used to identify small molecule inhibitors of the norovirus RdRp.  
4.2 Results  
4.2.1 Identification of peptides with NS7-binding activity using the 
 12mer peptide phage display system. 
 In this study, we attempted to identify peptides with an ability to bind 
specifically to the MNV NS7 protein using a phage library of 12-mer peptides 
expressed on the pIII protein of M13 filamentous phage by in vitro selection against 
the MNV NS7. Selections against streptavidin were carried out as a positive control 
during each panning process. 
4.2.1.1 In-solution binding selection 
 The first attempt at identifying NS7 binding peptides used a solution panning 
approach whereby C-terminal his-tagged protein MNV NS7 (NS7-his) was bound to 
Ni-CAM agarose beads before the panning step (Figure 4.1). For a positive control, 
Ultra-linked streptavidin agarose was used as a bait. A total of three rounds of 
solution-binding panning against NS7-his were performed after a negative selection 
against nickel agarose beads (Ni-CAM) at each round of selection. This negative 
selection was performed to remove peptide that would simply display a high affinity 
for nickel resin. After extensive washing to remove unbound phage, bound phage 
were eluted using imidazole when panning against NS7-his, whereas biotin was used 
for elution after panning against streptavidin (see Section 2.9.1 for detailed 
procedure). 
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Figure 4.1 Schematic representations of the in-solution binding approach to identify 
phage with the ability to bind NS7. In step 1 (binding), Ni-CAM agarose beads were 
coupled to the NS7-his protein and blocked with BSA. After the negative selection the 
phage library was exposed to the protein-resin complexes. In step 2 (washing & elution), 
the unbound phage were discarded and protein-resin complexes were washed extensively 
with TBS buffer containing 0.1% Tween 20 (TBST). The bound phage were then eluted 
by using imidazole or biotin and seperated from the protein-resin complexes using SpinX 
microfiltration columns. The supernatants which contained the phage were titered, 
amplified and purified (step 3). These phage were further used in successive rounds of 
panning (step 4). In total three rounds of panning were performed and single clone phage 
were selected (step 5) and subjected to DNA extraction and sequencing (step 6) to 
determine the peptide sequence. The figure is adapted from Ph.D.-12 Phage Display 
Peptide Library Kit manual, New England Biolabs. 
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 It was found that the number of eluted phage increased about 10 to 100 fold 
after each round of panning, suggesting enrichment had taken place (Table 4.1). 
Several single phage clones were isolated from the third round selection and 
subjected to DNA extraction and sequencing. Peptide sequence analysis revealed no 
consensus motifs in all the phage clones that had been isolated (Figure 4.2a). 
However, all of the phage clones isolated were found to contain histidine rich peptide 
sequences, suggesting that they were isolated because of their ability to bind the 
nickel moiety present on the Ni-CAM agarose rather than NS7-his. This observation 
was confirmed using a binding assay in which the phage pool from the 3rd round of 
selection was panned against NS7-his coupled to Ni-CAM beads or Ni-CAM beads 
alone. After extensive washes and specific elution with imidazole, the eluted phage 
was titrated. Similar phage titres were obtained for both selections (data not shown) 
confirming that despite the use of negative selection using Ni-CAM agarose alone, 
the phage clones isolated from this solution binding panning approach did not bind 
specifically to MNV NS7. In contrast, for the positive control using independent 
streptavidin panning, we successfully isolated phage clones with 100% conserved 
peptide sequences, all containing an HPQ core motif (Figure 4.2b). 
Panning Input  
Phage 
NS7 Streptavidin 
Unamplified / 
Eluted phage 
(pfu/ml) 
Amplified 
phage (pfu/ml) 
Unamplified / 
Eluted phage 
(pfu/ml) 
Amplified 
phage 
(pfu/ml) 
1st pan 1 X 1011 2.1 X 108 4.7 X 1012 1.2 X 106 6.0 X 108 
2nd pan 1 X 1011 >1.0 X 109 1.8 X 1013 >1.0 X 107 7.0 X 1011 
3rd pan 1 X 1011 >1.0 X 109 4.7 X 1013 3.5 X 108 2.4 X 1013 
Table 4.1 Solution binding panning against NS7 using the Ph.D.-12mer system. The 
library was panned against NS7-his coupled to Ni-CAM beads and streptavidin agarose 
beads as a positive control after negative selection against Ni-CAM beads only. Elution 
was performed using 200 mM Imidazole or 0.1 mM Biotin in TBS respectively and 
seperated from the protein-resin complexes using SpinX microfiltration columns. The 
eluted phage was then amplified and titered, before being used as the input phage in the 
next round of panning.  
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 These findings are supported by several reports stating that the HPQ core 
motif is the most strongly conserved sequence isolated in streptavidin-binding 
peptides (Devlin et al., 1990; Gissel et al., 1995). It could be concluded that the 
solution-binding panning against NS7 was unsuccessful. However, the peptide phage 
library used in this study was considered reliable since positive isolation of 
streptavidin binding phage with the predominant HPQ core motif was made. . 
4.2.1.2 Plate binding selection approach 
 Since the solution binding approach did not yield any peptides with conserved 
motifs and only produced peptides bound to the Ni-CAM agarose, a plate-binding 
panning approach was then employed using immobilised NS7-his on an ELISA plate. 
In this approach the NS7-his was adsorbed onto an ELISA plate and the library of 
peptide expressing phage was exposed to it (Figure 4.3). The unbound phage was 
then removed by washing (0.1% TBST in first round, 0.3% TBST in second round 
and 0.5% TBST in subsequent round), the bound phage was eluted using a general 
elution buffer (0.2 M glycine-HCl pH2.2, 1 mg/ml BSA) and subsequently neutralised 
with 1 M Tris-HCl (pH 9.1). The eluted phage was then amplified through passage in 
E.coli, purified, re-titrated and used for successive rounds of panning. In total, five 
rounds of selection were carried out. As a positive control, three rounds of panning 
(a) 
 
Clone 1 F Q L P I H V P H P E H 
Clone 2 G K T G H Q H D S Q S R 
Clone 3 Y Q S N H N N H T L H V 
Clone 4 K  M H A V H P G V S L H 
Clone 5 S P L H T H Q S D I D Y 
Clone 6 H H H R G P A D A I N Q 
Clone 7 H P Q L P H P R P Q Q N 
Clone 8 G P V F R N H N M H I P 
Clone 9 T P G N S H H M R I A P 
Clone10 H T H E Q R R D F Y H G 
 
(b) 
 
Clone20 S T Y F D P H G T H P Q 
 
Figure 4.2 Single clone phage peptide sequences from the in-solution binding 
panning. (a) Peptide sequences of phage clones after 3 rounds of solution binding 
selection against the NS7-his. Ten single clones selected for DNA sequencing revealed 
the histidine rich peptide sequences (highlighted in yellow). (b) The streptavidin binding 
peptide phage sequence from positive control panning. All ten single clones selected for 
sequencing contained HPQ motifs (example clone 20 is shown; HPQ highlighted in 
green). 
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against streptavidin immobilised on an ELISA plate was also performed, however 
elution was performed with biotin.  
 
 Table 4.2 summarises the number of phage used for panning (input phage), 
phage recovered after panning (unamplified) and phage amplified after every round 
of panning. It can be seen that the unamplified phage titres for each panning round 
(NS7-his and streptavidin) increased compared to the previous round of panning, 
suggesting that the panning process had selectively enriched phage.  
 
 
 
Figure 4.3 Schematic representation of the plate binding selection approach to 
identify phage with an ability to bind NS7. In step 1 (binding), the NS7-his protein was 
coated onto the ELISA plate and blocked with BSA. After the negative selection the 
phage library was exposed to the protein-coated ELISA plate. In step 2 (washing), the 
non-binding phage were discarded and the well was washed extensively with TBST. The 
bound phage were then eluted by using a general elution buffer (0.2 M glycine-HCl 
pH2.2, 1 mg/ml BSA) and neutralised with 1 M Tris-HCl (pH 9.1). The supernatants 
which contained the phage were titred, amplified, purified and then used in the successive 
rounds of panning (step 4). In total, five rounds of panning were performed and single 
phage clones were selected after the 5th round of panning and subjected to DNA extraction 
and sequencing (step 5) to determine the peptide sequence. Three rounds of panning using 
a streptavidin target were also carried out in parallel as a positive control. The streptavidin 
bound phages were eluted using biotin. A detailed protocol for this assay is described in 
Section 2.9.1. This figure is adapted from Ph.D.-12 Phage Display Peptide Library Kit 
manual, New England Biolabs. 
 Amir Yunus PhD Thesis 2012 
101 
 
4.2.1.2.1 Binding activity of the NS7-selected phage pool 
 An ELISA was carried out to establish whether the phage pool from the 5th 
round of panning against the NS7-his and the 4th round of panning against 
streptavidin could bind to their respective targets (see Section 2.9.2 for detailed 
procedure). Briefly, an ELISA plate was coated with NS7-his, streptavidin or BSA, 
subsequently blocked with BSA for 1-2 hours and washed with TBST 0.5%. The 
phage pools were subjected to serial dilution and were exposed to the target coated 
wells. The unbound phage was removed by extensive washing and bound phage 
were detected with horse raddish peroxidase (HRP)-conjugated anti-M13 antibody. 
Figure 4.4 shows that the selection against both targets during the rounds of panning 
yielded a population of phage with the ability to bind to their respective targets. The 
streptavidin binding phage pool did not bind BSA, clearly indicating that the phage 
selected in the streptavidin panning were specific (Figure 4.4b). In contrast, the 
phage pool generated from panning against the NS7-his also showed some binding 
activity to BSA, although a clear increase in binding to the NS7-his was observed 
(Figure 4.4a). These data suggest that this particular phage pool still contained 
phage that did not specifically bind to the NS7-his. This observation may have been 
the result of using a general elution buffer during the panning against the NS7-his (in 
Panning Input  
Phage 
NS7 Streptavidin 
Unamplified / 
Eluted phage 
(pfu/ml) 
Amplified 
phage (pfu/ml) 
Unamplified  / 
Eluted phage 
(pfu/ml) 
Amplified 
phage (pfu/ml) 
1st pan 1 X 1011 1.2 X 107 7.5 X 1012 1.9 X 108 1.0 X 1013 
2nd pan 1 X 1011 6.0 X 107 2.1 X 1013 8.0 X 107 1.3 X 1013 
3rd pan 1 X 1011 7.6 X 106 1.1 X 1013 2.5 X 106 5.1 X 1012 
4th pan 1 X 1011 5.3 X 106 5.0 X 1012 1.5 X 107 8.3 X 1012 
5th pan 1 X 1011 1.2 X 108 3.1 X 1012 - - 
Table 4.2 Plate binding panning against NS7 using the Ph.D.-12mer system. After 
negative selection against BSA, the library was panned on wells coated with the NS7-his 
or streptavidin as a positive control. Binding was carried out at room temperature for 60 
minutes for the 1st round panning and reduced by 10 minutes in each round of subsequent 
panning. General elution was performed using 0.2 M glycine-HCl (pH 2.2), 1 mg/ml BSA 
(for no more than 10 minutes) and biotin (in TBS, for streptavidin as a target). The eluted 
phage was then amplified, titered and used as the input phage in the next round of 
panning.  
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this case 0.2 M glycine-HCl [pH 2.2], 1 mg/ml BSA), which non-specifically disrupted 
binding interactions. This non-specific binding disruption may result in the isolation of 
all phage which specifically interact with the NS7-his as well as those phage non-
specifically interacting with other components present in the well of the ELISA plate 
i.e. contaminants from E.coli co-purified with NS7-His. In contrast, the elution of 
streptavidin-binding phage was performed using a specific elution with biotin, which 
eluted specific streptavidin-interacting phage only.  
 
4.2.1.2.2 Identification of peptide sequences from single phage clones  
  Thirty single phage clones from the 5th round of selection against the NS7-his 
and ten single phage clones from the last pan against streptavidin were selected for 
sequencing. Sequence analysis of the phage clones isolated from plate-binding 
panning against the NS7-his yielded a complex mixture of peptide sequences (Figure 
4.5a). There were several conserved peptide sequences with two core motifs 
identified among the phage clones isolated. The core motifs were identified as Lys-
Val-Trp and Lys-Val-Phe (KVW and KVF) (Figure 4.5c). The conserved peptide 
sequences were LPQAKVWFPHPR (2 clones), NMKVWTIKHLPA (2 clones), 
NMKVWTRSIFRV (1 clone), VKPNSLKVWTIR (2 clones), NIPHKVFILPSL (1 clone), 
KVWHMTPSKPPL (1 clone) and QAHKVFFPRFHA (1 clone) (Figure 4.5a). 
Intriguingly, peptide sequence NMKVWT was also present in a number of clones. In 
addition, there were also a number of cases where a longer peptide sequence had 
been isolated which indicates the isolated phage clone may contain multiple inserts 
(a)           (b) 
 
Figure 4.4 The binding of phage pool from the 5th round of panning against NS7-his, 
streptavidin and BSA. (a) The amplified phage pool panned against the NS7-his in round 
5 was subjected to binding characterisation against NS7-his as a specific target and BSA as 
a control, by ELISA. (b) The amplified phage pool from panning against streptavidin in 
round 4 was subjected to binding characterisation against streptavidin as a specific target 
and BSA as a control, by ELISA. Binding was detected by HRP-conjugated anti-M13 
phage using TMB solution as a substrate. The reaction was stopped by addition of HCl and 
the plate was then read at 450 nm to measure the absorbance. 
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(NS7∅2 in Figure 4.5c). This observation correlates with the PCR results that 
showed a larger insert (data not shown). This is likely to have occurred during the 
cloning of the insert into the M13 genome, whereby clones in each library picked up 
more than one insert during ligation. This type of phage clone typically contains 2-5 
randomised inserts. Furthermore, information from the supplier would indicate that 
selection of clones with multiple inserts might occur during panning against targets 
which prefer to bind to longer ligands. In contrast, sequence analysis of streptavidin-
binding phage clones yielded only one predominant peptide sequence, the HPQ core 
motif, as shown in Figure 4.5b. 
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(a) 
1     L     P     Q     A     K     V     W     F     P     H    P     R 
4 L P Q A K V W F P H P R 
3 N M K V W T I K H L P A 
19 N M K V W T I K H L P A 
14 N M K V W T R S I F R V 
16 V K P N S L K V W T I R 
25 V K P N S L K V W T I R 
5 N I P H K V F I L P S L 
8 K V W H M T P S K P P L 
23 Q A H K V F F P R F A A 
6 S S P T L S Y S K G P L 
7 N L K L M P A W D L W A 
9 T P P W A S N T V T L G 
12 D A R I M P R P L G P Y 
15 W N L P D H M R F L P N 
21 A P T A N D I T L L W R 
22 V H P S S F N F E F F R 
24 K I W M G P V P G P A R 
26 S W L P G A L S H M N H 
27 S S H S H S W H E H R P 
 
(b) 
SA T M T L P W H P Q R D W 
 
(c) 
NS7∅1  L P Q A K V W F P H P R  
NS7∅2 H F N S S A R T E N L H P D K P Y T D T K Q A K K S E N R K V P F Y S 
H S L G A D R T R D R R H N 
NS7∅3  N M K V W T I K H L P A  
NS7∅16 V K P N S L K V W T I R  
NS7∅8  K V W H M T P S K P P L 
NS7∅14   N M K V W T R S I F R V 
NS7∅5  N I P H K V F I L P S L  
NS7∅23  Q A H K V F F P R F A A  
NS7∅6 S S P T L S Y S K G P L  
 
Figure 4.5 Peptide sequences from single clone phages isolated by plate binding 
selection. (a) Peptide sequences of 30 phage clones derived from panning against the 
NS7-his after the 5th round of selections. Phage clones that contained the same peptide 
sequences (ie: clone 10,11,13,14,17,18,20,28,29 and 30) are not shown (except Clone 2 in 
[c] as representative clone). The numbers at the left side of the figure represent the phage 
clone. (b) Phage library panned against streptavidin as a positive control yielded a 
selection of phage clone with the conserved HPQ motif peptide sequence with 
(represented by SA phage clone). (c) Two different conserved core motifs were found 
(KVW & KVF) among the 30 peptide sequences. Five phage clones (NS7∅1,2,3,5 and 6) 
were randomly selected for further NS7 binding characterisation using ELISA. The 
selected peptide phage clones are highlighted in red. 
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4.2.1.2.3 Binding activity of single clone peptide phage 
   Based on the alignment of the peptide sequences obtained (Figure 4.5), five 
phage clones bearing a specific peptide sequence (highlighted in red in Figure 4.5c) 
were selected for further NS7 binding characterisation by ELISA. As a positive 
control, one streptavidin-binding phage clone (represented by SA in Figure 4.5b) was 
also included and used in an ELISA to test the binding activity against streptavidin. 
All the phage clones selected were subjected to large-scale amplification, purification 
and titration prior to an ELISA test against NS7-his, streptavidin and BSA (Figure 
4.6). 
 
 From the ELISA results, all five phage clones display varying degrees of 
binding to the MNV NS7 protein (Figure 4.6a). A BSA coated ELISA plate was also 
included as a negative control where all the selected phage clones were bound (the 
value in the graph represents an average of this binding). The positive control binding 
clearly indicated that the streptavidin peptide phage clone SA carrying the HPQ motif 
bound specifically to streptavidin (Figure 4.6b). Clone 2 (NS7∅2) was demonstrated 
to have the highest NS7 binding affinity (Figure 4.6a). A more complex binding 
pattern was found for the other clones. The relative order of binding ability of clone 3 
(NS∅3), 5 (NS7∅5) and 1 (NS7∅1) can be categorised as stated below: 
(a)                 (b) 
      
Figure 4.6 Binding ability of single clone peptide phage to NS7, streptavidin and 
BSA. (a) Binding characterisation of single phage clones to NS7. ELISA was carried out 
by immobilising 0.4 µg of the NS7-his or BSA (as a negative control) on an ELISA plate. 
After subsequent blocking, the purified single phage clones were titrated with 2-fold 
dilutions starting from 1 x 10-10 down to 5 x 10-6 and subjected to the binding reaction. 
After extensive washes with TBST, the binding activity was detected using HRP-
conjugated anti-M13 antibody. The TMB solution was used as the substrate. The reaction 
was stopped by addition of HCl and the plate was then read at 450 nm to measure the 
absorbance. NS7∅1-6 represents single phage clones that bind to NS7. (b) Binding 
activity of the streptavidin-binding phage clone to streptavidin and BSA. The 
streptavidin-binding peptide phage clone (SA) bound to 0.4 µg of streptavidin or BSA 
(positive and negative control respectively).  
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NS7∅2 > NS∅3 > NS7∅5 > NS7∅1  
Furthermore, clone 6 (NS7∅6) that contained no conserved peptide sequence or 
core motif had the lowest binding ability to NS7, suggesting that the conserved 
(KVW/F) core motif of peptide sequences among the phage clones may contribute to 
the specific binding ability towards NS7.  
4.2.1.2.4 Specificity of peptide phage clones  
   From the data described above it was apparent that the phage clones 
isolated bound NS7 with varying degrees of affinity. Next, we wanted to confirm the 
binding specificity of all the phage clones isolated against NS7 as our final aim was 
to identify a peptide with high specificity to MNV NS7. Therefore, a cross binding 
assay measuring the ability of each phage clone to bind to a variety of antigens was 
performed by ELISA. In the cross binding assay, 5 X 1011 pfu/ml phage clones were 
exposed to different targets, which were immobilised on the ELISA plate (Figure 4.7). 
From this assay, a more complex binding pattern was observed. All the NS7 phage 
clones have an affinity not only for the NS7-his used during their initial selection, but 
also to the untagged Poliovirus 3D RNA polymerase (PV3D), untagged Lordsdale 
virus VPg (LDV VPg), his-tagged Feline calicivirus protease-polymerase (FCV p76) 
and Cherry tagged MNV VPg-his (VPg). However, they clearly lack the ability to bind 
streptavidin, BSA (a non-recombinant protein) and 4E-BP1 proteins (Figure 4.7). As 
a positive control, the streptavidin-binding phage clone (SA) bound specifically with 
high affinity to streptavidin. A binding pattern to other recombinant proteins similar to 
that observed for the phage selected against NS7 was also observed for streptavidin-
binding phage clone (Figure 4.7). This non-specific binding to the recombinant 
proteins is presumably due to the presence of a certain ‘factor’ that is not present in 
the non-recombinant protein i.e. Streptavidin or BSA. 
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 All the proteins used in the cross binding assay above were recombinant 
proteins previously purified in our lab, except streptavidin and BSA. Since the 
recombinant proteins were expressed and purified from E. coli, there could also be 
contaminants from bacterial proteins that might be co-purified along with the target 
protein. This would then explain the non-specific binding of the isolated phage to 
other recombinant proteins in the cross binding assay. If this was the case, then the 
co-purifying bacterial proteins may be present in some recombinant proteins used in 
this assay. To assess this, all the recombinant proteins (used in the cross binding 
assay) were resolved on a gradient 4–12% PAGE gel and subjected to colloidal 
commassie blue staining, a very sensitive staining method, to visualise the protein 
bands (Figure 4.8). This sensitive method of staining was used to carefully analyse 
whether there were any co-purified contaminant proteins from bacterial cells in each 
purified proteins. Figure 4.8 indicated that there were no obvious commonly co-
purified contaminating proteins from E. coli present in the recombinant proteins 
tested. However, low levels of other contaminants may have been present. The small 
 
Figure 4.7 Cross binding assay of phage clones against different targets. ELISA was 
carried out by immobilising 0.4 µg of MNV NS7-his (NS7), untagged Polio 3D (PV3D), 
untagged Lordsdale VPg (LDV VPg), FCV p76-his (FCV p76), 4E-BP1-his (4E-BP1), 
Cherry MNV VPg-his (VPg), streptavidin (Strep) and BSA across the ELISA plate. 5 x 
1011 pfu/ml of purified single clone phages were subjected to the binding reaction with 
respective targets in the ELISA plate. After extensive washes with TBST, the binding 
affinity was detected using HRP-conjugated anti-M13 antibody. The TMB solution was 
used as the substrate, the reaction was stopped by adding HCl and the plate was then read 
at 450 nm. The streptavidin-binding peptide phage clone (SA) was used as the positive 
control. The reactions were carried out in triplicate and the error bars represent standard 
deviation. 
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multiple bands observed in Figure 4.8 may represent breakdown or degraded 
products from the purified recombinant protein. It is possible that we may have co-
purified some unidentified ‘factors’ other than protein that the phage could bind to. 
Examples include endotoxin (a complex of lipopolysaccharides [LPS]) (Cardoso et 
al., 2007; Feng et al., 2007) or nucleic acid, both of which cannot be detected on the 
SDS PAGE gel. This could possibly explain why all the isolated clones bound to the 
recombinant proteins but not to streptavidin or BSA. Moreover, the streptavidin-
binding clone (SA), despite having specific streptavidin binding actually also bound to 
the various recombinant proteins with the same relative binding pattern as seen for 
the phage specifically isolated against NS7 (Figure 4.7). This suggests that the 
isolated phage bound non-specifically to other factors that may have been co-purified 
during the bacterial protein preparation.  
 
 We concluded that the phage clones isolated by panning against NS7-his 
bind non-specifically to NS7. This may partially be due to the general elution buffer 
used during the panning procedure, which resulted in the elution of the non-specific 
binders from the binding reaction. As a result, it was hypothesised that using a more 
specific elution during the panning process was likely to represent the best method of 
obtaining specific binding phage. Therefore, we decided to use a more robust 
purification procedure to purify untagged forms of recombinant NS7 and VPg then 
use known ligands of NS7 (i.e.; VPg, NS7 antiserum and viral RNA) as a form of 
                                                     
Figure 4.8 Recombinant proteins used in the cross binding assay. SDS PAGE analysis 
of recombinant proteins that were used in the cross binding analysis of the identified 
peptide phage. 5µg of each protein was resolved on a 4 – 12% reducing gradient PAGE 
gel and subjected to colloidal coomassie blue staining. M-marker, NS7-MNV NS7-his 
(58.4kD), PV3D-untagged tagged Polio 3D (50.7kD), LVPg-untagged LDV VPg (15kD), 
p76-FCV p76-his (76kD), MVPg-Cherry MNV VPg-his (26kD), 4E-4E-BP1-his.  
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specific elution during the phage display panning procedure. The purification of 
untagged versions of recombinant NS7 was performed since the use of fusion 
proteins (e.g. GST fusions) as a target in phage display selection has been shown to 
potentially generate false positive results (Murthy et al., 1999).  
4.2.2 Expression and purification of untagged recombinant MNV NS7 
 and VPg 
4.2.2.1 Cloning and expression  
 Unlike the NS7 produced in the context of viral infection, typically recombinant 
proteins produced in E.coli using the standard pET expression system initially contain 
a formylmethionine that is removed co- and/or post-translationally. Furthermore, 
recombinant proteins purified from E.coli using overexpression systems can contain 
up to of 40% formylmethionine and 50% methionine as a first residue at the amino 
terminus (Sandman et al., 1995). By expressing the ubiquitin fusion construct in the 
presence of ubiquitin-specific carboxyl-terminal protease (expressed from the pCG1 
plasmid), it is possible to produce a recombinant protein with any amino acid as the 
first residue without the obligation to add the initiation codon at the N-terminus of the 
protein (Tan and Board, 1996). In order to achieve this, we first generated and 
purified recombinant MNV NS7 and VPg (without the histidine tag at their C-
terminus) by cloning the NS7 and the VPg genes into the expression vector 
pET26Ub (Figure 4.9a and 4.10a). Gohara et al. described this expression vector 
that works by exploiting the ubiquitin carboxyl-terminal specific cleavage site 
upstream of the first amino acid residue of the protein of interest. This method was 
used to produce an authentic form of the PV3D as the first amino acid residue of this 
protein is glycine (Gohara et al., 1999). This strategy can be applied to the MNV NS7 
and VPg since the first amino acid residue of both these proteins is glycine also. The 
cloning and overexpression of both the untagged NS7 and VPg was performed as 
described in Section 2.10. As can be seen in Figure 4.9b & 4.10b, both recombinant 
NS7 and VPg were successfully over expressed in BL21 DE3 cells containing pCG1. 
Furthermore, the untagged version of NS7 can be distinguished by the size of this 
protein as it is slightly smaller than its his-tagged counterpart (Figure 4.9b) 
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(a) 
        
(b) 
                          
 
Figure 4.9 Cloning and large scale expression of non-his tagged recombinant MNV 
NS7. (a) Schematic representation of the expression plasmid pET26Ub:MNV NS7 non 
His. A forward primer which contains the SacII site and part of the N-terminus of the 
MNV NS7 coding region and a reverse primer which contains the BamHI site and the stop 
codon after the last amino acid residue of NS7 were used to amplify the NS7 gene which 
was subsequently cloned into the pET26Ub plasmid. The cleavage site for the ubiquitin-
specific carboxyl-terminal protease is indicated by a vertical arrow. (b) Expression of 
MNV NS7 non-his tagged and its his-tagged version counterpart. Expression plasmids 
were transformed into BL21 DE3 + pCG1 bacterial cells. For induction, the transformant 
was grown for 24 h in Overnight ExpressTM Instant TB medium at 37 ºC. 50 µl samples 
were boiled with 2X loading buffer, run on a reducing 12.5% SDS PAGE gel and 
coomassie blue stained. (+) = induced sample, (-) = uninduced sample, (M) =  prestained 
protein marker Non-his tagged NS7 = ~57.5 kDa and his-tagged NS7 = ~54 kDa 
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(a) 
      
(b) 
                         
 
Figure 4.10 Cloning and large scale expression of non-his tagged recombinant MNV 
VPg. (a) Schematic representation of the expression plasmid pET26Ub:MNV VPg non 
His. A forward primer which contains the SacII site and part of the N-terminus of the 
MNV VPg coding region and a reverse primer which contains BamHI site and the stop 
codon after the last amino acid residue of VPg were used to amplify the VPg gene which 
was subsequently cloned into the pET26Ub plasmid. The cleavage site for the ubiquitin-
specific carboxyl-terminal protease is indicated by a vertical arrow. (b) Overexpression of 
MNV VPg non-his. Expression plasmids were transformed into BL21 DE3 + pCG1 
bacterial cells. For induction, the transformant was grown for 24 h in Overnight ExpressTM 
Instant TB medium at 37 ºC. 50 µl samples were boiled with 2X loading buffer, run on 
reducing 12.5% SDS PAGE gel and coomassie blue stained. (+) = induced sample, (-) = 
uninduced sample, (M) =  prestained protein marker). Non-his VPg = ~14.3 kDa. 
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4.2.2.2 Column chromatography purification  
 Purification of both the untagged recombinant NS7 and VPg was carried out 
as described in Section 2.10.2 and 2.10.3. Briefly, cells were harvested and lysed. 
The lysates were then subjected to nucleic acid precipitation using PEI, ammonium 
sulphate (AS) precipitation to precipitate the protein, dialysis and further subjected to 
several rounds of column chromatography (Figure 4.11a). 
 As shown in Figure 14.11b, the untagged recombinant NS7 and VPg were 
successfully purified after being isolated via several different columns during the 
chromatography process. Compared to the his-tagged protein purification, during 
which the fusion protein binds to a nickel-nitriloacetic acid (Ni-NTA) column and can 
be readily eluted with imidazole, the purification of the non-fusion proteins was more 
complex. After removal of nucleic acid and subsequent dialysis, the protein of interest 
was purified by chromatography on phosphocellulose, heparin and SP sepharose 
resins. Due to the untagged nature of the protein, traditional purification approaches 
were used whereby proteins bound to various resins were eluted using a salt 
(a)                  (b) 
 
 
Figure 4.11 Purification of non-his MNV NS7 and VPg. (a) Flow chart of the protein 
preparation process starting from cell lysis until column chromatography using 
AKTAprime™ Automated Liquid Chromatography System from GE Healthcare. (b) 
Samples from the NS7 and VPg preparation were run on 12.5% and 15% SDS PAGE 
respectively and visualised by comassie blue stain. (S1) = total lysate, (S2) = soluble 
protein, (S3) = supernatant from protein precipitation, (S4) = precipitated protein by 
ammonium sulphate, (S5) = post dialysis of precipitated protein, (S6) = Final purified 
protein after chromatography and dialysis.  
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gradient and the cleanest fractions pooled prior to moving to the next step. The 
optimised procedures are described below. 
4.2.2.2.1 Purification of the untagged recombinant MNV NS7 
 The protocol for column chromatography purification of the untagged NS7 is 
described in further detail in Section 2.10.2. Briefly, after the removal of nucleic acid 
and an initial ammonium sulphate mediated precipitation and dialysis, samples of 
untagged NS7 in Buffer A+100 mM NaCl were loaded onto a Phosphocellulose (PC) 
column, equilibrated in the same buffer, and the gradient eluted with 100 mM to 1M 
NaCl Buffer A. The untagged NS7 was found not to bind to the column under the 
conditions used (data not shown). However by including a PC column separation, 
many nucleases and other nucleic acid binding proteins can be removed along with 
some contaminating proteins. The collected pass through from the PC column was 
further loaded onto a heparin column and the untagged NS7 was eluted at around 
400 mM NaCl (Figure 4.12a). Heparin is a mucopolysaccharide, which contains a 
repeating dimer of hexuronic acid and D-glucosamine. The choice to use this column 
to purify the untagged NS7 was made due its well-known interaction with nucleic 
acid-binding proteins. The cleanest fractions were then pooled, diluted in Buffer A to 
the desired final concentration of NaCl (typically 40-100 mM) and subjected to further 
purification by loading onto a SP Sepharose column. The untagged NS7 protein 
bound weakly to the SP column but it provided a useful resin with which to remove 
substantial contaminants. The untagged NS7 eluted from the SP resin at around 40 
mM NaCl (Figure 4.12b). The cleanest fractions were pooled together again, diluted 
with Buffer A and loaded onto heparin columns again to concentrate the sample and 
remove additional contaminating proteins. The untagged NS7 was eluted from the 
column at between 300 and 400 mM NaCl (Figure 4.12c). Finally, the cleanest 
fractions were pooled together, dialysed and concentrated as described in Section 
2.10.2 The final concentrated untagged NS7 sample (S6) was resolved on a 12.5% 
SDS PAGE. (Figure 4.11b top panel). 
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(a) 
               
 
(b)  
               
 
(c)   
              
 
Figure 4.12 Series of column chromatography purifications for the untagged MNV 
NS7. (a) Chromatography purification of NS7 using the heparin column. The pass 
through NS7 samples from the PC column were collected and loaded onto the heparin 
column and gradient eluted with NaCl containing buffer as described in Section 2.10.2. 
Fractions 14-18 were pooled together and diluted with a buffer solution without NaCl. (b) 
Chromatography purification of NS7 using the SP column. The diluted pooled fractions 
from the heparin column were loaded onto the SP column. Gradient elution was 
performed as described in Section 2.10.2. Fractions 15-30 were pooled together and 
diluted with buffer A with no NaCl and NP-40 (c) Final chromatography purification of 
NS7 using the heparin column. The diluted pooled fractions from the SP column were 
loaded onto the heparin column again and gradient eluted as described in Section 2.10.2. 
Fractions 15-18 were pooled together, dialysed against NaCl containing buffer, 
concentrated down using a spin column	  and subjected to concentration determination as 
described in Section 2.10.2. All protein samples were resolved on 12.5% SDS PAGE and 
visualised using coomassie blue stain. M= protein marker in kDa, L= loaded sample, P= 
pass through sample. 
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4.2.2.2.2 Purification of the untagged recombinant MNV VPg 
    The detailed procedure of column chromatography purification of the 
untagged VPg is described in Section 2.10.3. Briefly, after the removal of nucleic 
acid, ammonium sulphate precipitation and dialysis, the sample was loaded onto PC 
column previously equilibrated with 250 mM NaCl Buffer A. Gradient elution was 
performed with 250 mM to 1.5 M NaCl buffer A and VPg was found to elute between 
400 to 500 mM NaCl (Figure 4.13a). The cleanest fractions were pooled together and 
diluted with Buffer A to a final concentration of around 100 mM NaCl. The SP resin 
was employed as a further ‘untagged VPg purification column’, the sample being 
loaded onto the SP column and gradient eluted at around 600 mM NaCl Buffer A 
(a) 
                
 
(b)  
              
 
Figure 4.13 Series of column chromatography purifications for the untagged 
recombinant MNV VPg. (a) Chromatography purification of VPg using the PC column. 
The dialysed sample was loaded onto the PC column and gradient eluted with NaCl 
containing buffer as described in Section 2.10.3. Fractions 14-18 were pooled together 
and diluted with buffer solution without NaCl. (b) Chromatography purification of VPg 
using the SP column. The diluted pooled fractions from the PC column were loaded onto 
the SP column and gradient eluted with NaCl containing buffer A as described in Section 
2.10.3.	  Fractions 33-39 were pooled together and dialysed against NaCl containing buffer, 
concentrated down using a spin column	  and subjected to concentration determination as 
described in Section 2.10.3. All protein samples were resolved on 15% SDS PAGE and 
visualised using Coomassie Blue stain. M= protein marker in kDa, L= loaded sample, P= 
pass through sample. M= protein marker in kDa, L= loaded sample, P= pass through 
sample. 
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(Figure 4.13b). The cleanest fractions were pooled together, dialysed and 
concentrated down using a spin column as described in Section 2.10.3. The final 
purified and concentrated product of the untagged VPg sample (S6) was resolved on 
a 15% SDS PAGE. (Figure 4.11b bottom panel). 
4.2.3 Characterisation of the purified untagged recombinant MNV NS7 
 and VPg 
 The purification of both untagged versions of the recombinant MNV NS7 and 
VPg was successfully carried out. These two recombinant proteins were further used 
in the subsequent phage display panning experiment where the untagged version of 
recombinant NS7 was used as a binding target while the untagged VPg was used as 
a specific ligand with which to elute phage which potentially bound to NS7. This 
approach was based on the hypothesis that norovirus RdRp interacts with VPg 
during the nucleotidylation process in the protein primed initiation mechanism of viral 
RNA replication in vitro (Belliot et al., 2005; Belliot et al., 2008; Rohayem et al., 
2006a; Rohayem et al., 2006b). The RHDV RdRp also was found to interact with 
VPg in the same manner (Machin et al., 2001). More significantly, a recent study also 
indicating that the VPg is guanylylated by MNV-1 RdRp and the tyrosine residue at 
position 117 in VPg has been determined as a probable target site for guanylylation 
(Han et al., 2010). However from our data in the lab, mutation at this position does 
not affect virus viability however mutation at position 26 (tyrosine also) does affect 
virus viability (Subba-Reddy et al., 2011).  
 To assess whether the purified untagged NS7 could interact with VPg, a 
capture ELISA assay was performed. Briefly, the purified untagged NS7, VPg and 
other recombinant proteins were first treated with ribonuclease and DNase I to 
remove any contaminating nucleic acid present in the proteins. Contaminating 
nucleic acids can influence the outcome of ELISA assays since the proteins involved 
in this assay are known to be nucleic acid binding proteins since they play a major 
role in viral RNA replication. 1 µg of the non-his NS7 was coated onto wells of an 
ELISA plate. Using the same amount, other recombinant proteins available in the lab 
were also used as controls. In this case, the PV3D and MNV Virulence Factor 1 
protein (VF1) were used to see whether the recently purified untagged VPg is able to 
interact with these recombinant proteins. In addition BSA was used as a negative 
control. After blocking with buffer containing BSA, various amounts of the untagged 
VPg were added to each well of the ELISA plate and the reactions were incubated at 
4°C for 90 minutes. After extensive washes with TBST to remove any unbound VPg, 
the diluted antisera against VPg was added and incubated for 1 hour. Subsequently, 
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the secondary HRP conjugated anti-rabbit antibody was added and incubated for 
another 1 hour. After washes with TBST, the TMB substrate was added and the 
reactions were incubated at room temperature for 5 to 10 minutes before being 
stopped by adding 0.5 M HCl. The plate was then read for absorbance at 450 nm 
using a spectrophotometer.  
 As can be seen in Figure 4.14, the highest ELISA signal was obtained from 
the VPg and NS7 reaction suggesting that there was a strong interaction between 
these two purified recombinant proteins in vitro. As expected, the lowest ELISA 
signals observed were in the VPg-BSA and VPg-VF1 reactions indicating that the 
purified untagged VPg does not interact with either of these proteins. However, the 
reaction between VPg and PV3D produced a moderate ELISA signal in all 
experimental repeats. This observation is interesting as both the MNV NS7 and the 
PV3D are viral RNA-dependent RNA polymerases involved heavily in viral RNA 
replication. Both proteins have been shown to uridylylate the respective virally 
encoded VPg during RNA replication (Belliot et al., 2008; Han et al., 2010; Paul et al., 
2003; Paul et al., 1998). A more detailed structural study by Ferrer-Orta et al. 2006 
has shown a direct interaction between foot and mouth disease virus 3D (FMDV 3D) 
and its virally encoded VPg. X-ray structures of two complexes between FMDV 3D, 
VPg1, the substrate UTP and divalent cations, in the absence and in the presence of 
an oligoadenylate of 10 residues were obtained. The genome of FMDV encodes 3 
different VPgs in tandem (Forss and Schaller, 1982), which are active as primers for 
viral RNA replication. The VPg1 was found to fit into the RNA binding cleft of the 
polymerase and projects the Tyr3 residue which is a key residue for 
nucleotidylylation onto the active site of 3D (Ferrer-Orta et al., 2006a).  
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 Cross interaction of viral proteins from different viruses has never been 
demonstrated. The interaction between MNV VPg with PV3D observed in this 
specific in vitro ELISA assay is presumably due to the structural nature of folded 
positive strand RNA virus polymerases (right-handed shape) that provide a natural 
binding pocket for VPg proteins. Furthermore, caliciviruses are genetically closely 
related to the picornaviruses. However it should be noted that the VPg from these 
two viruses differs in size, amino acid sequence and its ultimate role in the viral life 
cycle. The VPg of PV is relatively small (containing only 22 amino acid residues) 
compared to that of MNV, which contains 124 amino acid residues and there is no 
conserved sequence between these two proteins. In terms of the viral life cycle, the 
PV VPg is only involved in initiation of viral RNA replication and not in viral protein 
translation since PV protein translation is initiated at the internal ribosome entry site 
(Belsham and Jackson, 2000). MNV VPg however has been shown to play a role as 
primer for initiation of viral RNA replication (Han et al., 2010), and is also essential for 
translation initiation (Daughenbaugh et al., 2006; Goodfellow et al., 2005). 
                  
Figure 4.14 Interaction of the purified untagged recombinant MNV VPg with NS7, 
PV3D, VF1 and BSA. Capture ELISA was employed to characterise the interaction 
between the purified untagged VPg and NS7. All proteins involved were subjected to 
RNase H and DNase I prior to coating on the ELISA plate and the binding reaction. 1 µg 
of the untagged NS7, the PV3D and the MNV-1 VF1 protein were coated to the wells of 
an ELISA plate by coupling in carbonate buffer + 0.3 M NaCl overnight at 4°C. The 
excess of unbound proteins was then removed and the coated wells were washed with 
TBST 0.5%. The protein coated ELISA plate wells were then subjected to blocking with 
carbonate buffer + 0.5% BSA for 2 h. Two-fold dilutions of the untagged VPg in an 
ELISA diluent (5 µg-highest and 0.08 µg-lowest) were added to the designated coated 
wells on an ELISA plate for 90 minutes. The unbound VPg was then washed away 
extensively with TBST and the bound VPg was detected using VPg antisera as the 
primary, anti-rabbit conjugated HRPO as the secondary and TMB substrate. The reactions 
were stopped by addition of 0.5 M HCl and the plate was read at 450 nm absorbance. The 
reaction was carried out in triplicate and the error bar represents standard deviation. 
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 Importantly, the strong interaction between the purified untagged VPg and 
NS7, as observed in the ELISA assay (Figure 4.14), provided the basis for the use of 
VPg as a specific ligand for the elution of phage against NS7.  
4.2.4 Identification of peptide phage with NS7-binding activity using the 
 7-mer peptide phage display system 
 Using the purified untagged version of recombinant MNV NS7 and VPg, 
another round of peptide phage display panning was carried out using the same plate 
binding approach as before. However, in this attempt a different system was 
employed to increase the potential success rate. The Ph.D.-7 library kit that consists 
of randomized linear 7-mer peptides fused to the coat protein pIII of M13 phage via a 
flexible linker, Gly-Gly-Gly-Ser was used. The first residue of the mature fusion 
protein on the phage coat structure is the first randomised position of the 7-mer 
peptide. This library contains 2.8 x 109 independent clones, sufficient to encode 
most, if not all, of the 207 = 1.28 x 109 possible 7-residue amino acid combinations. 
According to the manufacturer’s information, the Ph.D.-7 library is most useful for 
targets requiring binding elements concentrated in a short stretch of amino acids.  
4.2.4.1 Plate binding panning 
 For the Ph.D.-7 system, the plate binding approach was carried out by 
coating up to 5 µg of the untagged NS7 on wells of the ELISA plate. After a negative 
selection against a mixture of other recombinant proteins (LDV VPg, FCV p76 and 
PV3D at 1 µg each), the phage library was exposed to the target NS7 for selection. 
The unbound phage was then extensively washed away and the bound phage was 
subjected to separate specific elutions using either the untagged VPg (VPg at 10 µg), 
MNV-1 viral RNA isolated from infected RAW264.7 (viral RNA at 10 µg) or antisera 
against NS7 (αNS7 at 1:1000 dilution) in TBS. A general elution (0.2 M glycine-HCl 
pH2.2, 1 mg/ml BSA) was also performed separately. The eluted phage was then 
subjected to amplification, purification and use in successive rounds of panning. In 
total, three rounds of selection were carried out with several changes in parameters 
for each round in order to increase the stringency of selection as shown in Table 4.3. 
Selections against streptavidin were also performed independently with elution using 
biotin as a positive control. 
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 Table 4.4 shows the number of phage recovered after panning (unamplified) 
and phage amplified after every round of panning by using each specific elution or 
general elution. It can be seen that most (but not all) of the phage titres (unamplified) 
for each panning procedure were increased in the last round compared to the 
previous rounds of panning, indicating the panning had selectively enriched the 
bound phage. Amplification was successfully carried out at each round of panning 
which produced around 1012 to 1013 pfu/ml phage enabling a constant amount of 
phage (2 X 1011 pfu/ml) to be used as input in every round of the panning process. 
Round of 
panning 
Amount of 
target (NS7) 
Binding time to 
target at room 
temperature 
(minute) 
Washes (% of 
Tween 20 in 
TBS ) 
Elution time 
(minute) 
1 5 µg 60 0.1 % 30 
2 3 µg 30 0.3 % 30 
3 1 µg 15 0.5 % 45 
Table 4.3 Changes in parameters for each round of panning to increase the stringency 
of selections. 2 X 1011 phage library was subjected to negative selection at each round of 
panning before being exposed to differing amounts of target (NS7) for different lengths 
time. The unbound phage was discarded and the well was washed for 10 times with 
increasing concentrations of Tween 20 in TBS. Each round of panning was eluted with 10 
µg of VPg, 10 µg of viral RNA or antisera against NS7 in TBS for differing lengths of 
time. For general elution, the bound phage was eluted using general elution buffer for 10 
minutes. All elutions were carried out at room temperature.  
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4.2.4.1.1 Binding activity and specificity of phage pool 
 A cross binding assay was carried out using ELISA to establish whether the 
phage pool eluted using various specific elutions and general elution from the 3rd 
round of panning against NS7 were bound specifically or non-specifically to the NS7. 
Streptavidin-binding phage from the 3rd round of panning were used as a control by 
exposing them to the streptavidin and other recombinant proteins too. Briefly, the 
ELISA plate was coated overnight with untagged NS7, LDV VPg, FCV p76, PV3D, 
streptavidin and BSA. Subsequently, the wells were blocked with BSA for 1-2 hours 
and washed with TBST 0.5%. The 1.0 x 1010 phage pools from each elution were 
exposed to the target coated ELISA wells. The unbound phage was washed 
extensively with TBST 0.5% and the bound phage were incubated with the diluted 
HRP-conjugated anti M13 antibody. After subsequent washes, TMB solution was 
added to each well and the reactions were allowed to develop for 5 minutes at room 
temperature. The reaction was stopped by the addition of 0.5 M HCl and the optical 
density was measured at 450 nm using spectrophotometer.  
 From the cross binding test of phage pool obtained by various elutions at the 
3rd round of plate binding selection using the Ph.D.-7mer system, it can be seen that 
 ROUND 1 ROUND 2 ROUND 3 
Eluted 
phage 
Unamplified / 
Eluted phage 
(pfu/ml) 
Amplified 
phage  
(pfu/ml) 
Unamplified / 
Eluted phage 
(pfu/ml) 
Amplified 
phage 
(pfu/ml) 
Unamplified / 
Eluted phage 
(pfu/ml) 
 
Amplified 
phage 
(pfu/ml) 
biotin-
Streptav
idin 
1.0 X 104 1.0 X 1013 2.0 X 105 1.2 X 1013 1.0 X 105 1.2 X 1013 
VPg-
NS7 
3.1 X 106 1.9 X 1013 4.4 X 106 6.7 X 1012 8.7 X 107 1.4 X 1013 
RNA-
NS7 
6.8 X 106 3.1 X 1013 1.6 X 106 1.2 X 1013 2.4 X 107 1.0 X 1013 
α NS7 –
NS7 
1.3 X 106 5.5 X 1012 3.2 X 108 1.3 X 1013 1.1 X 108 1.1 X 1013 
General 7.7 X 105 8.4 X 1013 5.7 X 105 1.6 X 1013 8.2 X 106 3.8 X 1013 
Table 4.4 Plate binding panning against NS7 using the Ph.D.-7mer system. The 7mer phage 
library was exposed to untagged NS7 coated on an ELISA plate wells after been subjected to 
negative selection against a mixture of recombinant proteins. Specific elutions were carried out 
separately using either VPg, viral RNA or αNS7 as described in Table 4.3. General elution was 
also performed separately using 0.2 M glycine-HCl (pH 2.2), 1 mg/ml BSA. The eluted phage 
were then subjected to amplification and titration. A constant (2 x 1011) amount of phage was 
used as an input at each round of panning. Selection against streptavidin was carried out as a 
positive control with specific elution using biotin.  
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the specific elutions employed using untagged VPg, αNS7 and viral RNA were able 
to elute a phage pool that potentially binds to the NS7 protein (Figure 4.15). The 
ELISA signals also indicate that the phage pool obtained by general elution with 
glycine had the lowest binding activity on NS7 when compared to the phage pool 
obtained by specific elution. These observations suggest that the use of specific 
elutions increased the probability of isolating peptide phage that could specifically 
bind NS7, compared to the general elution method. Intriguingly, all the phage pools 
recovered after panning against NS7 were not able to bind either BSA or streptavidin 
(a non-recombinant protein) as observed in panning using the Ph.D.-12mer system 
(Figure 4.7) since the ELISA signals obtained from these reactions were at a 
background level (Figure 4.15). As for the positive control, the phage pool (SA) 
obtained from panning against streptavidin produced a strong binding signal to 
streptavidin indicating that the panning process was carried out successfully. 
Interestingly in this panning experiment using a 7mer peptide system, the SA phage 
pool not only had a strong binding affinity to its target, but also was very specific to 
streptavidin since exposure of this SA phage pool to other proteins only produced a 
background level of ELISA signals (Figure 4.15). This observation is in agreement 
with the manufacturer’s advice that suggests it is more likely to get a strong phage 
interaction using the 7mer system instead of the 12mer.  
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 Unfortunately, when analysing this data for specificity, the recovered phage 
pools generated after panning against NS7 were also found to bind to other 
recombinant proteins (Figure 4.15). This observation indicates that this latter panning 
experiment also was likely to result in the isolation of non-specific binding phage to 
NS7. In order to confirm this observation an in-solution binding assay was employed. 
The phage pool from the 3rd round obtained by VPg specific elution was subjected to 
in-solution selection panning against NS7-his, FCV p76-his and VPg-his. These 
histidine-tagged recombinant proteins were coupled to nickel beads prior to exposure 
to the phage pools. As a negative control, the nickel beads only were subjected to 
exposure with the same amount of phage pool. After extensive washes with TBST 
followed by specific elution with imidazole, the recovered phage were subjected to 
titration. Similar phage titres were obtained from both the experimental and negative 
control, confirming that the phage isolated from the 3rd round of panning using the 
Ph.D.-7mer system bound non-specifically to the NS7.  
4.3 Discussion 
 Norovirus infections are typically treated through quarantine of the infected 
persons to prevent further dissemination of disease and by treatment of the main 
            
Figure 4.15 Cross binding assay of phage pool from the plate binding panning using 
the Ph.D.-7mer system. ELISA was carried out by immobilising 0.4 µg of untagged NS7, 
LDV VPg, FCV p76, PV3D, streptavidin and BSA (represents by the coloured bar) on 
wells of the ELISA plate. 1 x 1010 of phage pool from various elutions (represented by 
glycine, VPg, viral RNA and αNS7 on x-axis of the graph) of the 3rd round of panning 
against NS7 were subjected to the binding reaction. Phage pool obtained from panning 
against streptavidin (SA) was used as a positive control. After extensive washes with 
TBST, the binding activity was detected using HRP-conjugated anti-M13 antibody. The 
TMB solution was used as the substrate and the reactions were allowed to develop for 5 
minutes at room temperature. Subsequently, the reactions were stopped by adding HCl and 
the plate was read at 450 nm.  
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symptoms through antiemetic medication and oral or intravenous rehydration (Glass 
et al., 2009; Gould, 2009; Moe et al., 2001). The development of conventional 
vaccines for norovirus is complicated due to the lack of long-lasting protective 
immunity and the inherent variability of these viruses. A study demonstrated that 
antibody response in human volunteers could be generated using the VLPs derived 
from the capsid proteins of human norovirus and most of this response correlates to 
the generation of IgG1 and IgA (T-helper cell 1 response) (Girard et al., 2006). If 
efficient vaccines are to be developed they must have to stimulate this response and 
should be specific either for all the human noroviruses or at least for the prevalent 
strain. However, with the significant increase of genetic variation and recently 
identified new human norovirus strains, alternative treatment especially antiviral 
therapies provide an attractive area of research. Development of small molecule 
inhibitors that could efficiently inhibit norovirus infection would deliver another level of 
containment (‘ring fence’ treatment) during outbreaks where close person-to-person 
transmission is unavoidable. Therefore, this method could be used as a strategy to 
control viral dissemination. Antiviral therapy using small molecule inhibitors would 
also be of use for immunocompromised individuals where norovirus infection can last 
much longer than in immunocompetent individuals (Gallimore et al., 2004). 
 Currently, there are few studies on the identification of small molecules 
capable of inhibiting norovirus replication. The clinical use of phosphoroimidate 
morpholino oligomers (PMOs) for the treatment of feline calicivirus infection has been 
reported, indicating their potential for future development (Smith et al., 2008). PMOs 
are nucleic acid analogs widely employed to block access of other molecules to 
specific sequences within nucleic acid. PMOs block small regions on the base-pairing 
surfaces of RNA and interrupt RNA-RNA interactions and/or protein-RNA 
interactions. In order for PMOs to be effective, they must be delivered past the cell 
membrane into the cytoplasm of a cell. Once in the cytoplasm, PMOs freely diffuse 
between the cytoplasm and nucleus, targeting a specific RNA causing a ‘knockdown’ 
of gene expression. PMOs, have been effectively used for inhibiting virus replication 
in tissue culture (Deas et al., 2007). There is another improved version of PMO that 
has been reported with increasing stability and efficiency of delivery into the cells / 
tissues namely peptide conjugated PMO. These cells-penetrating peptide conjugated 
PMOs are nuclease resistant and readily enter cells (Amantana et al., 2007). A 
previous study has indicated that PPMOs targeting the norovirus genome lead to 
substantial reduction in norovirus gene expression in tissue culture (Bok et al., 2008). 
This application has yet to be developed onto the clinical stage as it could potentially 
be used as antiviral therapy for norovirus infection.  
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 The use of nucleotide analogs to inhibit RNA virus replication, through mis-
incorporation into newly synthesised viral RNA, is a well known approach for 
inhibiting viral replication. As viral RdRps lack proof reading capacity the 
incorporation of nucleotide analogs can cause mutation catastrophe, pushing the 
viral quasispecies to extinction. The most well characterised nucleotide analog is 
ribavirin. This drug is readily being used in combination with interferon as a clinical 
treatment for hepatitis C virus infections (Di Bisceglie et al., 1995; Feld and 
Hoofnagle, 2005). Using a human norovirus replicon containing cell line, ribavirin has 
been shown to have anti-norovirus properties in vitro (Chang and George, 2007). 
This observation has yet to be applied clinically for the prevention and/or control of 
human norovirus.  
 Norovirus protein synthesis is dependent on the interaction of host cell 
translation initiation factors with the viral VPg linked to the 5’end of the viral genome 
(Goodfellow et al., 2005). One of these interacting host cell proteins, eIF4A, a 
component of the eIF4F cap-binding complex, carries a RNA helicase function. A 
small molecule derived from the sea fan coral Issis hippuris called hippuristanol 
inihibits the RNA helicase activity of eIF4A and was found to affect MNV translation 
in vitro (Chaudhry et al., 2006). Even though an antiviral strategy targeting host 
enzymes may result in adverse side effects this study demonstrates a proof of 
concept for the development of antivirals that specifically target noroviruses protein 
synthesis (Vashist et al., 2009).  
 The RdRp activity of virus polymerases is strictly required for viral replication, 
highlighting this key viral enzyme as a relevant target for antiviral therapy. Extensive 
studies on the development of antiviral drugs targeting the HCV polymerase NS5B 
have been performed. Compounds such as 2-aryl-4,5-dihydroxy- pyrimidine-6-
carboxylate, a class of rhodanine derivatives and a series of benzimidazole 
derivatives that affect HCV NS5B function in vitro have been tested by 
pharmaceutical companies (Walker and Hong, 2002). Other than chemical 
compounds, an inhibitor for viral RdRp could also be developed from peptides that 
posses a high affinity and specific interaction for this viral enzyme (Hyde-DeRuyscher 
et al., 2000). Perhaps, this interaction could inhibit the RdRp activity by blocking 
crucial interactions with viral RNA and other proteins required for replication. 
 The phage display approach provides a method for identifying peptides with 
the ability to interact with target proteins. In vitro studies employing this method have 
successfully identified peptides with inhibitory effects against HCV NS5B (Amin et al., 
2003; Kim et al., 2008b). To identify similar ihbitors the phage library systems (Ph.D.-
12 and 7mer) from New England Biolabs were employed in this study. In both 
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systems random peptide DNA sequences are cloned into the pIII gene and 
expressed as N-terminal fusion peptides on the pIII coat protein of M13 filamentous 
phage. The panning procedures were carried out as illustrated in Figure 4.1 and 4.3.  
 The Ph.D.-12 library that was used in this study has a few advantages. The 
system, which consists of randomised linear 12-mer peptides, contains 1.9 X 109 
independent clones, or only a small fraction (less than 1 millionth) of the 2012 = 4.1 X 
1015 possible 12-mer sequences. This is useful for targets requiring 7 or fewer 
defined residues for binding, but which cannot be contained within the 7-residue 
"window" of the Ph.D.-7 library. Additionally, 12-mers are long enough to fold into 
short structural elements, which may be useful when panning against targets that 
require structured ligands. However, according to the manufacturer, the only caveat 
of using this system is that the increased length of the randomised segment may 
allow the target to select sequences with multiple weak binding contacts, instead of a 
few strong contacts. This fact was supported by our observations that the peptide 
phage clones selected against NS7 have a lower/weak binding affinity when 
compared to the streptavidin-binding peptide phage clone which has a much higher 
binding affinity towards streptavidin (Figure 4.6 and 4.7). Therefore, in the 
subsequent phage display experiment, the Ph.D-7 library, which is the most well-
characterised library according to the manufacturer, was used. With the aid of 
specific elution using untagged recombinant VPg, the phage pool with stronger 
affinity towards NS7 was selected (Figure 4.15). However, in both systems, 
subsequent specificity assays revealed that the isolated phage not only bound to 
NS7 but also to some other recombinant proteins (Figure 4.6 and 4.15). These 
observations have raised the specificity issue for the isolated phage against NS7. 
This non-specific binding presumably contributed by the unidentified ‘factor’ that 
presence during the purification process of recombinant proteins since the tested 
phage were not able to bind any of the non-recombinant proteins (streptavidin and 
BSA) (Figure 4.6 and 4.15).  Alternatively, the observed non-specific binding could 
also be due to the ‘sticky’ character of the phage itself. The surface of M13 phages 
largely consists of about 2700 copies of the major coat protein (P8) that contains 
several negatively charged residues (Glu and Asp). These negatively charged 
residues contribute to the overall large negative charge of the phage particle. As a 
result, the M13 phages are more likely to bind non-specifically to proteins with a high 
pI value and therefore greater total positive charge (Lamboy et al., 2009). The VPg 
protein used in the cross binding assay in Figure 4.7 has a very high pI value (around 
9.0) which could explain the high non-specific binding affinity of phage to this protein. 
However, this pI effect may not be the only factor that could contribute to the non-
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specific binding activity observed for the isolated peptide phage, since the binding to 
FCV p76 was also found to be relatively low even though this protein has a moderate 
pI value at around 7.0. To test this hypothesis, the identified peptide sequences 
containing the core conserved motif of KVW/F could be synthesised as fusions to a 
reporter protein and the specific binding with NS7 tested.  
4.4 Conclusion 
 In this study two different phage display systems were employed. In the first 
system, the Ph.D.-12mer phage display was used in 2 different panning approaches. 
The solution-binding panning approach failed to identify peptides that are able to bind 
to NS7. Selection using NS7-his coupled to nickel agarose beads resulted in 
selection of histidine rich peptide phage that bound to nickel beads. However, the 
same approach was successful in identifying specific clones for streptavidin using 
Ultralink-Streptavidin beads. By employing specific elution with biotin, a high affinity 
binding peptide phage to streptavidin was selected. Subsequent sequencing analysis 
identified peptide-phage clones with HPQ motifs, which are well known to bind 
streptavidin with high affinity (Devlin et al., 1990; Gissel et al., 1995). This result 
indicates that the employed phage display system was reliable. This system was able 
to select specific peptides with binding activity to the targets when a library was 
exposed to the target.  
 In the plate-binding panning approach, several peptide phage with a core 
motif of KVW and KVF were successfully selected. However, all of the isolated 
peptide phage clones also appeared to bind a number of other recombinant proteins 
when tested by specificity assay, indicating that these peptide phage clones most 
likely bound non-specifically to the NS7. The use of histidine fused NS7 and a 
general elution buffer were among the issues identified which could have contributed 
to this outcome. Therefore, an untagged version of MNV NS7 and VPg was 
successfully purified and used to select peptide phages that potentially have a 
specific binding affinity for NS7. To increase the success rate in selecting peptides 
with strong binding affinity, the Ph.D.-7 mer phage display system was employed. A 
plate binding approach using a range of known ligands as specific elution agents to 
displace phage with affinity to NS7 was carried out. Unfortunately the recovered 
phage pools that were selected against NS7 again appeared to non-specifically bind 
other recombinant proteins. Even though the identified peptide phage were bound 
non-specifically to NS7, further examination on their binding capacity using a more 
accurate assays were unable to be carried out due to time constraints. These assays 
include a production of fusion protein (i.e GST) with the identified peptide sequence 
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to test for a specific interaction with NS7 using capture ELISA. It would also be 
possible to generate a GFP fusion protein with the identified peptide sequence and 
examine their localisation in infected cells.  
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Chapter 5.0  
Development and optimisation 
of RNA-based MNV-1 reverse 
genetics system 
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5.1 Introduction 
 Reverse genetics has long been recognised as a powerful tool to investigate 
many aspects of virus replication and pathogenesis as it has allowed an ability to 
examine the effect of mutations in the viral genome on virus replication in tissue 
culture and pathogenesis in the natural host. In some cases this has led to the 
development of rationally attenuated viruses i.e. coronavirus, respiratory syncytial 
and parainfluenza virus (Cavanagh et al., 2007; Murphy and Collins, 2002) or 
improved vaccine candidates for polio and dengue viruses (Blaney et al., 2007; 
Macadam et al., 2006). RNA based reverse genetics systems using capped in vitro 
transcribed RNA from cDNA clones have been successfully developed for several 
members of the Caliciviridae family, namely feline calicivirus (Sosnovtsev and Green, 
1995; Thumfart and Meyers, 2002) and porcine enteric calicivirus (Chang et al., 
2005). Furthermore, transfection using in vitro transcribed uncapped RNA from 
RHDV was also able to recover virus when transfected into permissive cells (Liu et 
al., 2006). As for MNV, previous attempts to use capped in vitro transcribed RNA as 
a possible reverse genetics system failed to recover any infectious virus (Chaudhry 
et al., 2007). Until recently, the reverse genetics system for MNV has relied on the 
transfection of a full-length cDNA construct of MNV-1 under the control of a T7 
promoter into cells previously infected with fowl pox virus expressing T7 RNA 
polymerase (FPV-T7) (Chaudhry et al., 2007). This system was subsequently used to 
address many aspects of the norovirus life cycle including the identification of RNA 
structures important for norovirus replication (Simmonds et al., 2008), as well as 
mapping virulence determinants in the viral capsid protein (Bailey et al., 2008) and 
the 3’ untranslated region of the viral genome (Bailey et al., 2010b). An RNA 
polymerase II (Pol-II) promoter based reverse genetics system for the recovery of 
MNV has also been described (Ward et al., 2007), although published yields appear 
to be more than 10 fold lower than those obtained using FPV-T7; ~103 plaque 
forming units/ml versus >5 X 104 TCID50 per 35 mm dish for the Pol-I and FPV-T7 
based systems respectively. Even though the previously described cDNA based 
MNV recovery system is being used to recover virus and investigate various aspects 
of the virus lifecycle, there is a demand to develop a more efficient system as the 
currently used system yields are quite low in comparison to the reverse genetics 
system for other RNA viruses (i.e. picornaviruses where transfection of 1 µg of viral 
RNA can lead to the production of ~107 infectious units). Due to this reason, this 
chapter aimed to develop and optimise the RNA-based reverse genetics system for 
MNV by employing the in vitro transcribed and enzymatically capped viral RNA which 
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is transfected into MNV replication permissive cells to produce higher yield infectious 
particles. As highlighted above, attempts to recover MNV by transfecting in vitro 
transcribed co-transcriptionally capped or uncapped RNA into replication permissive 
cells failed to recover any infectious virus (Chaudhry et al., 2007). The poor stability 
of RNA and the inability of the host cell translation machinery to efficiently translate 
uncapped or wrongly capped MNV RNA were the possible reasons why infectious 
virus was unable to be recovered (Grudzien et al., 2004; Pasquinelli et al., 1995). 
This is due to the inefficiency of conventional methods used to generate the capped 
in vitro transcribed RNA via co-transcriptional incorporation of cap analogues. Even 
though most RNAs produced by this manner are capped, there is also a significant 
percentage of RNA which either remains uncapped or/and is capped in the wrong 
orientation (Meis, 2007). This phenomenon can be overcome by employing the 
capping enzyme guanyltransferase that posseses the ability to incorporate the 
authentic cap structure at the 5’ end of in vitro transcribed RNA, producing a cap-0 
structure with up to 100% efficiency (Martin and Moss, 1975).  
5.2 Results  
5.2.1 In vitro transcribed enzymatically capped MNV RNA 
 translates efficiently in vitro 
 The inefficient capping of the in vitro transcribed RNA that led to the poor 
translation of the viral proteins was hypothesised to hinder the ability in recovering 
any infectious MNV particle using RNA based reverse genetics system (Chaudhry et 
al., 2007). In this chapter, employing the enzymatic capping reaction to produce 
capped viral RNA post-transcriptionally, the ability of in vitro transcribed and 
enzymatically capped or uncapped MNV G RNA and SG RNA to be translated was 
examined in vitro as an initial step before looking into their ability to produce any 
infectious virus. Enzymatically capped and uncapped RNA transcripts were subjected 
to a cell free in vitro translation system using rabbit reticulocyte lysates. For this 
purpose, an infectious cDNA clone of MNV-1 (pT7MNV3’Rz) and its replication 
defective derivative (pT7MNV 3’Rz F/S) which contains a frame-shift mutation in the 
NS7 RNA polymerase coding sequence as described in Chaudhry et al., 2007 
(Figure 5.1a) were used to produce in vitro transcribed RNA. A unique Nhe I 
restriction site after the 27 nucleotide long poly-A tail was used to linearise the 
plasmids before they were transcribed as described in Section 2.11. The SG RNA 
was generated by in vitro transcription of a PCR product with a T7 promoter 
introduced at the 5’ end and a 30 nucleotide long 3’end poly-A tail. Capped RNA 
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transcripts were then generated using the ScriptCap enzymatic capping system 
(Epicenter) and the integrity of the purified RNAs were determined on a 0.8% 
agarose gel (Figure 5.1b). An in vitro translation was carried out by programming 
rabbit reticulocyte lysates with either capped or uncapped RNA and the efficiency of 
translation for each RNA was examined by analysing the level of protein synthesis 
using SDS PAGE and visualised by phosphorimaging. From the phosphorimage 
result, it is clear that the uncapped MNV G RNA and SG RNA failed to translate 
efficiently (Figure 5.1c). The enzymatically capped G RNA and SG RNA transcripts 
were efficiently translated and typically produced a significant increase in protein 
synthesis in vitro when compared to the uncapped transcripts (Figure 5.1c).  
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Figure 5.1 Analysis of the efficiency of viral protein synthesis from the enzymatically 
capped and uncapped viral RNA transcripts, by in vitro translation assay. (a) A 
schematic representation of the infectious cDNA clone of MNV used to generate the T7 
polymerase driven in vitro transcribed RNA highlighting the position of the four open 
reading frames, the T7 RNA polymerase promoter and the position of the 3’ ribozyme 
sequence. The asterisk highlights the position of the frame shift used to generate the 
mutated non-infectious cDNA clone pT7MNV3’Rz F/S. (b) The integrity of the 
enzymatically capped in vitro synthesised RNA transcripts of MNV genomic (m7G) and 
subgenomic (m7SG). RNA was in vitro transcribed and enzymatically capped as described 
in Section 2.11. The purified capped RNA transcripts were quantified using a 
spectrophotometer and the same amount resolved on a 0.8% agarose gel, stained with 
EtBr and visualised under UV. (c) In vitro translation of uncapped G and SG RNA 
transcripts of MNV as well as the enzymatically capped (m7G, m7SG and m7F/S) 
counterparts using rabbit reticulocyte lysates as described in Section 2.12. Samples were 
resolved on 15% SDS-PAGE prior to exposure to a phosphorimager screen. NS7* 
represents the truncated NS7 product generated as a result of the frame shift introduced in 
pT7MNV3’RZ F/S  
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5.2.2 In vitro transcribed enzymatically capped MNV RNA is 
 infectious in cell culture 
 Given that the enzymatically capped in vitro transcribed MNV RNA was 
efficiently translated in vitro compared to the uncapped RNA transcripts, we then 
examined the ability of this RNA to produce virus when transfected into permissive 
cells. In order to achieve this aim, human embryonic kidney cells (293T) or baby 
hamster kidney cells expressing T7 polymerase (BSR-T7) were transfected using 
Lipofectamine 2000 (Invitrogen) with either capped or uncapped viral RNA transcripts 
as described in Section 2.13.2 and the levels of viral protein examined by western 
blot 24 hours post transfection. From the western blot analysis in Figure 5.2a, the 
uncapped MNV G RNA and SG RNA transcripts did not produce any detectable 
levels of viral proteins (NS7 and VP2) after transfection of either 293T or BSR-T7 
cells. However, transfection of enzymatically capped RNA resulted in efficient viral 
protein synthesis (Figure 5.2a). High levels of the viral NS7 protein were readily 
detected when capped viral G RNA (m7G) was transfected into either cell type, 
whereas transfection of the viral SG RNA (m7SG) led to high levels of VP2 synthesis 
upon transfection of 293T cells only (Figure 5.2a). The presence of infectious virus in 
the cultures was also examined by subsequent titration on the highly permissive 
murine macrophage cell line RAW264.7. At 24 hours post transfection, the cells were 
subjected to one freeze thaw cycle and the precleared supernatants were subjected 
to titration. High levels of infectious virus were readily detected in cultures transfected 
with capped viral genomic RNA only. Transfection of this RNA resulted in yields of >6 
X 106 TCID50 per 35 mm dish (1.5 X 105 cells) (Figure 5.2b). These virus yields are 
over 10 fold higher than our previously reported DNA based recovery system 
(Chaudhry et al., 2007) and >100 fold higher than a previously reported Polymerase 
II (Pol II) based system (Ward et al., 2007). Even though the 293T and BSR-T7 cells 
are competent for MNV genome replication, they are not permissive to subsequent 
infection by the packaged viral particles from the initial replication cycle, presumably 
due to the lack of a compatible receptor. Therefore, the yield of virus obtained from 
capped RNA transfection into these cells represents a single cycle of replication only, 
due to the absence of subsequent amplification by re-infection. Due to this character, 
this approach may therefore appropriately be used to accurately quantify the effect of 
specific mutations in the viral genome as virus yield is the result of a single round of 
virus replication only.  
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5.2.3 Optimisation of Neon mediated transfection conditions for 
 RAW264.7 cells 
 Previous attempts to recover infectious MNV directly by transfecting capped 
or uncapped RNA into the highly permissive RAW264.7 murine macrophage cell line 
had been unsuccessful partly due to the nature of this macrophage cell line 
(Chaudhry et al., 2007). This cell line is more refractile to lipid based transfection and 
subsequently has very low transfection efficiency. Therefore, in this study, a more 
efficient nucleic acid delivery system has been employed based on the Neon 
electroporation system (Invitrogen). In order to obtain high efficiency transfection of 
RAW264.7 cells without compromising the viability of the cells, optimum conditions 
for the delivery of DNA were first examined by electroporation of the pGFPmax 
control plasmid (Lonza). A variety of conditions were examined by electroporation of 
1 µg of the pGFPmax. All of these optimisation works were performed by my 
(a)  
         
 
(b) 
                                                
 
Figure 5.2 Recovery of murine norovirus using lipid base transfection of in vitro 
transcribed and enzymatically capped RNA transcripts into heterologous cells. (a) 
Western blot analysis of baby hamster kidney cells (BSR-T7) or human embryonic kidney 
cells (293T) transfected with in vitro transcribed murine norovirus RNA. Cells were either 
transfected with in vitro transcribed uncapped (G, SG) or enzymatically capped RNA 
(m7G, m7SG or m7F/S) as described in Section 2.13.2. At 24 hour post transfection, cells 
were lysed using RIPA buffer and samples were prepared for western blot using antisera 
to the viral NS7 and VP2 proteins. (b) Duplicate samples were also harvested by one 
freeze thaw cycle and subsequently analysed for the presence of infectious virus by 
TCID50 on RAW264.7 cells. Virus yield is shown as TCID50 per transfection (1.5 X 106 
cells). 
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colleague, Ms Liliane Chung. Briefly, RAW264.7 cells were transfected using the 
Neon electroporation system under various conditions as detailed in Figure 5.3a and 
assayed after 48 hours. For analysis, cells were first observed by bright field and 
fluorescence microscopy prior to harvesting and analysis by flow cytometry. The 
percentage of GFP positive cells was determined at 48 hours post transfection and 
based on this analysis optimum conditions for DNA based delivery were determined 
to be 1700V with a 25ms pulse length (Figure 5.3a). Under these conditions ~95% of 
viable cells were GFP positive (Figure 5.3b).  
 To identify the optimal conditions for delivery of viral RNA, various 
transfection conditions were examined again. RAW264.7 cells were transfected with 
MNV VPg-linked viral RNA obtained from a total RNA preparation of MNV infected 
cells. The virus yield from this transfection was determined 24 hours later (Figure 
5.3a) by subsequent titration on RAW264.7 cells as described in Section 2.15. 
Typical yields of infectious MNV after a single cycle of replication, namely 24 hours 
post transfection, were in excess of 1 X106 TCID50 per transfection (6 X 106 cells). 
The optimal conditions for virus recovery from RNA was identified as 1725V with a 
25ms pulse length and under these conditions typical yields were 3.4 X 107 TCID50 
at 24 hours post transfection of viral VPg-linked RNA (Figure 5.3a). 
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Figure 5.3 Optimisation of Neon mediated transfection conditions for RAW264.7 
cells. (a) Determination of the optimum conditions for Neon mediated transfection of 
RAW264.7 cells. RAW264.7 cells were transfected with either GFP encoding DNA 
(pGFPmax) or murine norovirus VPg-linked RNA (from total RNA prepared from MNV-
1 infected cells). Cells were transfected with 1µg of plasmid or viral VPg-linked RNA 
using the conditions detailed in the figure. The percentage of cells expressing GFP was 
determined at 48 hours post transfection using flow cytometry by Ms Liliane Chung. 
Virus yield was determined as TCID50 per 6 X 106 cells at 24 hours post transfection. (b) 
Bright field and fluorescence imaging of RAW264.7 cells transfected with pGFPmax 
using conditions 4, 5 and 6 (1700V at 15, 20 and 25ms) 48 hours post transfection 
showing GFP positive cells. 
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5.2.4 Optimisation of recombinant MNV recovery from RAW264.7 
 cells 
 In order to develop an efficient and robust reverse genetics system for the 
recovery of MNV from transfection of capped RNA into RAW264.7 cells, the optimum 
quantity of in vitro transcribed enzymatically capped RNA required for maximum yield 
of virus was determined. Using the optimised Neon mediated transfection conditions 
various amounts of capped RNA were transfected into RAW264.7 cells by the Neon 
electroporation system. The yield of virus for each transfection was determined by 
TCID50 at 24 hours post transfection (Figure 5.4a). This result shows that the 
maximum yield of virus obtained after transfection of ~1µg of in vitro transcribed and 
enzymatically capped RNA was 7.68 X 105 TCID50 per 6 X 106 cells (Figure 5.4a). At 
concentrations above 1µg, increased cytopathic effect was observed, and decreased 
yields of infectious virus were obtained. This observation was most likely due to 
substantial over-expression of the viral proteins (Figure 5.4b), prior to viral RNA 
replication, which resulted in premature cell death and reduced virus yield.  
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5.2.5 Kinetics of recombinant MNV recovered from RAW264.7 cells 
  Given that the optimised condition and optimum amount of RNA for 
transfection into RAW264.7 cells were obtained, we next determined the kinetics of 
recombinant virus recovery in comparison to authentic viral VPg-linked RNA. Using 
the same amount of in vitro transcribed enzymatically capped RNA or VPg-linked 
RNA (at 1 µg), Neon mediated transfection into RAW264.7 cells was carried out and 
viral titres were determined at a given time point. Rapid recovery of infectious MNV 
was observed when RAW264.7 cells were transfected with viral VPg-linked RNA. An 
excess of 107 TCID50 was recovered as early as 12 hours post transfection with 
peak viral titres obtained at 48 hours where >108 TCID50 could be detected (Figure 
5.5). The transfection of in vitro transcribed post-transcriptionally capped MNV RNA 
resulted in slower recovery. About 103 TCID50 could be recovered by 12 hours post 
transfection with peak titres being obtained at 72 hours post transfection where 
(a) 
               
(b)  
         
  
Figure 5.4 Optimisation of murine norovirus recovery from RAW264.7 cells. (a) The 
virus yield obtained 24 hours post transfection of RAW264.7 cells using varying amounts 
of in vitro transcribed MNV RNA. RAW264.7 cells were transfected by Neon 
electroporation using the optimised conditions determined for virus recovery (1725V, 
25ms). Virus yield is expressed as TCID50 per 6 X 106 cells and represents the average of 
three repetitions. The asterisk highlights that no infectious virus was obtained but that the 
detection limit was ~50 TCID50. Error bars represent the standard deviation. (b) Western 
blot analysis of RAW264.7 cells transfected with various amount of in vitro transcribed 
murine norovirus RNA, lanes correspond to labels in Figure 5.4a. After 24 hour post 
transfection, cells were lysed using RIPA buffer and samples analysed by western blot 
using antisera to the viral NS7 protein. 
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maximal virus yields reached >109 TCID50 per 6 X 106 cells (Figure 5.5). This result 
indicates that the transfected VPg linked viral RNA produced rapid viral recovery 
presumably because the RNA was VPg-linked and therefore translates more 
efficiently compared to the in vitro transcribed RNA, because it represents the 
authentic viral translation mechanism. However, by combining the efficient delivery 
and post-transcriptionally capped in vitro transcribed MNV RNA, into RAW264.7 
cells, recovery of recombinant virus can be achieved with higher titre, when 
compared to the other currently available MNV reverse genetics system. This system 
is superior to the previously reported cDNA systems (Chaudhry et al., 2007; Ward et 
al., 2007) but not as immediately efficient as VPg-linked RNA transfection.  
 
5.2.6 The 5’- end cap-1 structure boosts MNV RNA translation in 
 tissue culture 
 The use of the Vaccinia virus capping enzyme in a capping reaction produces 
RNA with a 5’end cap-0 structure (m7GpppNpNp…) (Meis, 2007). Most eukaryotic 
and viral mRNAs naturally possess this type of cap. However, simultaneous 
modification by 2’-O methylation at the 5’end penultimate nucleotide produces a cap-
1 structure (m7Gppp[m2’-O]NpNp…) (Meis, 2007). This modification is catalysed by 
the inclusion of the Vaccinia virus derived 2´-O-Methyltransferase in the normal 
enzymatic capping reaction of in vitro transcribed RNA. This methylation has been 
demonstrated to improve the in vivo translation efficiency of many natural and 
unnatural cap structures. A study by Meis et al. 2007, demonstrated that transfection 
                   
                    
Figure 5.5 Time course analysis of MNV recovery from RAW264.7 cells.  The virus 
yield from RAW264.7 cells transfected with 1 µg of either in vitro transcribed post-
transcriptionally capped MNV RNA or purified viral VPg-linked RNA. At various times 
post transfection, cells were freeze-thawed to release infectious virus and the yield of 
virus determined by TCID50. Virus yield is expressed as TCID50 per 6 X 106 cells and 
represents the average of three repetitions. Error bars represent the standard deviation. 
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of cap-1 firefly luciferase encoded mRNA into various cells resulted in an additional 
20 – 25 % boost in translational efficiency when compared to cap-0 structure 
containing mRNA. To examine whether the enzymatic incorporation of cap-1 
structure onto the in vitro transcribed MNV RNA could boost viral protein production 
and increase virus recovery, 1 µg of cap-0 and cap-1 MNV RNA were transfected 
into BSR-T7 and RAW264.7 cells using Lipofectamine 2000 and the Neon mediated 
transfection system respectively as described in Section 2.13.2. At 24 hours post 
transfection, cells were harvested and lysed for western blot analysis. For virus yield 
analysis the infectious particles were harvested and subjected to TCID50 as 
described in Section 2.13. The NS7 frame shift mutant capped RNA was used as a 
negative control in all transfections.  
 There was ~2-fold increase in viral protein production for the cap-1 MNV RNA 
transfected in both type of cells when compared to the cap-0 MNV RNA transfected 
cells. This is highlighted in the western blot analysis for NS7 viral protein with 
GAPDH as a loading control (Figure 5.6b). However, there were no comparable 
differences between virus yield after cap-0 and cap-1 MNV RNA had been 
transfected into cells. Virus recovery from cap-0 and cap-1 transfections were in 
excess of 105 at 24 hours post transfection, which corresponded to the virus 
recovered from previous optimisation studies. These data indicate that the boost to 
viral protein production does not have a significant impact on the amount of virus 
recovered. Perhaps, only certain minimal levels of initial viral proteins are required by 
the virus in order to establish an efficient life cycle, especially to drive replication. It is 
also likely that the additional non viral methylated G residue in cap-0 and subsequent 
2’-O methylation in cap-1 type RNA at the 5’ end of MNV RNA may affect the 
infectivity of the RNA compared to the authentic VPg linked MNV RNA. However, in 
this RNA based MNV reverse genetics system, the non viral residue at the 5’end of 
the in vitro transcribed enzymatically capped RNA may partially be compensated for 
by the lack or reduced interferon induction achieved by transfection of such RNAs 
compared to the uncapped RNA which posseses a 5’ end triphosphate that could 
trigger the interferon response in cells. 
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Figure 5.6 Virus recovery and protein expression of cap-0 and cap-1 MNV RNA 
transfected into BSR-T7 and RAW264.7 cells. (a) The virus yield from BSR-T7 (BSR) 
and RAW264.7 (RAWS) cells transfected with 1 µg of either cap-0 or cap-1 in vitro 
transcribed post-transcriptionally capped MNV RNA. At 24 hour post transfection, virus 
was harvested and the yield was determined by TCID50 as described in Section 2.15. 
Virus yield is expressed as TCID50 per 6 X 106 cells and represents the average of three 
repetitions. Error bars represent the standard deviation. The C-0 or C-1 represents 
different cap structures of transfected RNA. (b) Western blot analysis of BSR-T7 and 
RAW264.7 cells transfected with 1 µg of either cap-0 or cap-1 in vitro transcribed MNV 
RNA corresponds to Figure 5.6a. After 24 hour post transfection, cells lysates were 
prepared in RIPA buffer and western blot was carried out using antisera to NS7 and 
GAPDH. WT represents RNA transcript prepared from in vitro transcription of wild type 
MNV cDNA while POLFS represents RNA transcript prepared from in vitro transcription 
of frame shift NS7, a defective derivative of the cDNA clone. 
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5.3 Discussion 
 Before 2007, the only reverse genetics systems available for calicivirus 
research were from FCV (Sosnovtsev and Green, 1995), porcine enteric calicivirus 
(Chang et al., 2005) and RHDV (Liu et al., 2006). The absence of norovirus reverse 
genetics system and the non-cultivatable nature of human norovirus in tissue culture 
had hindered the molecular research progress for viruses in this genus. The 
identification of MNV in 2003 (Karst et al., 2003) ignited a more rapid progression in 
the norovirus research field especially with the subsequent significant discovery of a 
tissue culture system to efficiently propagate this virus in vitro (Wobus et al., 2004). 
In 2007, two studies on reverse genetics system for MNV were described (Chaudhry 
et al., 2007; Ward et al., 2007). Both systems utilise the CW1 strain derived from the 
original MNV isolate (Karst et al., 2003).  
 The first reported reverse genetics system demonstrated the used of three 
separate mechanisms to recover MNV by employing a Pol II-driven system (Ward et 
al., 2007). The first mechanism employed the baculovirus system, where two 
separate bacmid constructs are used to generate baculovirus stocks capable of 
driving expression of the MNV genome in cells. The first baculovirus (BACTETMNV) 
contains the MNV genome under the control of the minimal cytomegalovirus (CMV) 
promoter that is linked to the tetracycline (tet) operator / repressor (tetO / tetR). The 
second baculovirus (BACTETtTA) contains the tetR/VP16 transactivator under the 
control of a Pol II driven promoter. Co-infection of human hepatocellular liver 
carcinoma (HepG2) cells with BACTETMNV and BACTETtTA produced MNV which was 
subsequently amplified in RAW264.7 cells. Typical primary yields from this 
baculovirus system are reported to be 2 X 102 pfu/ml (Ward et al., 2007). An 
alternative to the first system, a simpler approach achieved through transfection of 
eukaryotic cells with both cDNA constructs used to generate the baculoviruses 
described above also results in the recovery of MNV. Generation of a construct 
similar to BACTETMNV but under the control of a minimal CMV promoter was initiated 
due to the observation that HEK 293T cells produced virus after transfection with 
BACTETMNV alone. Transfection of HEK 293T cells using this construct produced 
recoverable virus with typical yields of 5 X 103 pfu/ml.  
 In the same year, another reverse genetics system for MNV was also 
developed in our lab (Chaudhry et al., 2007). This system is based on T7 RNA 
polymerase promoter-driven expression from a MNV cDNA clone (pT7MNV). In this 
system, the T7 polymerase used to drive the expression of MNV cDNA is provided by 
pre-infection of permissive cells with a recombinant fowlpox virus expressing T7 
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polymerase (FPV-T7). This recombinant virus had no deleterious effect on MNV 
replication compared to the previously tested vaccinia recombinant MVA-T7 where 
no MNV recovery was detected (Chaudhry et al., 2007). By employing this later 
system, infectious MNV was generated at yields of 2 X 103 TCID50/35 mm dish as 
determined by titration in RAW264.7 cells. Based on the hypothesis that the 
sequence of the 5’ and 3’ end of the viral genome is important for viral replication, 
this simple system was further improved by the addition of a hepatitis delta ribozyme 
sequence at the 3’end of the RNA genome to ensure accurate cleavage of viral RNA 
transcripts right after the poly(A) tail. This MNV clone (pT7MNV3’Rz) was found to 
generate a much higher virus yield (average of 3.56 X 104 TCID50/35 mm dish). 
Even though a direct side by side comparison of the efficiency of both systems has 
not been performed, the obtained data indicate that the yield of recovery of infectious 
virus from the T7 RNA polymerase-promoter driven system is typically >10 fold 
higher than that obtained using the Pol II-driven system. In order to develop a much 
simpler reverse genetics system without compromising the recovery yield, 
transfection of in vitro transcribed viral RNA into permissive cells provides the best 
solution. However, previous attempts to recover MNV by transfection of in vitro 
transcribed RNA were, as mentioned previously, found to be unsuccessful (Chaudhry 
et al., 2007).  
 Synthetic capped RNA transcripts are usually generated in vitro by co-
transcriptional incorporation of cap analogues including m7G(5')pppG into RNA 
(Yisraeli and Melton, 1989). The addition of an excess of cap analogue into in vitro 
transcription reactions results in the RNA produced containing an artificial 5’ Cap 
structure (m7G(5')pppG(pN)). Even though capping efficiencies of 75-80% can be 
achieved, the remaining 20-25% of RNA could still contain a triphosphorylated 5’ end 
(Meis, 2007). Furthermore, in many transcripts, the cap analogue incorporates in the 
incorrect orientation (G(5')pppm7G(pN)) and causes the RNA to be translated 
inefficiently (Grudzien et al., 2004; Pasquinelli et al., 1995). The use of anti-reverse 
cap analogues (ARCA) can overcome some of these limitations as due to the lack of 
one of the 3’ OH groups, incorporation can occur in the correct orientation only 
(Grudzien et al., 2004; Stepinski et al., 2001). However, it is still impossible to obtain 
100% capping efficiencies and therefore some RNA prepared in this manner remains 
uncapped and possessing a triphosphorylated 5’ end. These observations have 
limited the efficiency of RNA transcripts to be translated and partly hindered the 
previous attempts to recover the MNV. However this has been addressed through 
the use of a recently available system for enzymatically capping RNA, generated by 
the addition of an authentic cap structure at the 5’ end of in vitro transcribed RNA by 
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using the tri-functional Vaccinia virus capping enzyme or guanyltransferase (Martin 
and Moss, 1975). This system, which is commercially available from Epicentre as the 
ScriptCap capping system (Meis, 2007), could overcome the translation efficiency 
issues that arose with the previous capping systems. In this enzymatic capping 
system, the 5’ end of in vitro transcribed RNA is converted into a cap-0 structure 
post-transcriptionally, with efficiencies that approach 100% (Meis, 2007). RNA 
produced in this manner typically translates with a >5 fold increased efficiency in 
cells compared to RNA generated using traditional cap analogues or >3 fold greater 
efficiency than RNA produced using ARCA cap analogues (Meis, 2007). The efficient 
translation activity was also clearly demonstrated in this study (Figure 5.1c) where 
translation of enzymatically capped RNA was at higher levels to that of uncapped 
RNA, being >10-fold different. 
 In addition to the translation efficiency issue, which hindered the previous 
attempt to recover MNV by transfection of an in vitro transcribed capped RNA using a 
cap analogue, the other limiting factor identified is the innate immune response. 
Uncapped RNA transcripts possess a 5’- end triphosphate which has been shown to 
trigger the induction of the interferon response in transfected cells. Studies on the 
characterisation of innate immune responses to virus infection have highlighted that 
5’ phosphorylated RNA can stimulate the interferon system via the cellular retinoic 
acid inducible gene I (RIG-I) protein (Pichlmair et al., 2006). Furthermore, base-
paired RNA sequences have also been shown to be required for interferon induction 
by RIG-I and protein kinase-R (PKR) (Hornung et al., 2006; Nallagatla et al., 2007; 
Pichlmair et al., 2006). Given the reported sensitivity of MNV to the interferon 
response (Changotra et al., 2009; Karst et al., 2003; Mumphrey et al., 2007), any 
induction of the interferon response is likely to result in a significant reduction in virus 
yield. In previous reports, the MNV genome has been shown to possess base-paired 
RNA structures at the 5’ end of the viral genomic RNA (Simmonds et al., 2008), 
hence, although not directly assayed in the current report, transfection of 5’ 
triphosphorylated MNV will inevitably result in interferon induction. Recent work has 
highlighted how type I and II interferon can have a dramatic effect on MNV protein 
synthesis (Changotra et al., 2009). By employing the Vaccinia virus capping enzyme 
to introduce an authentic cap structure at the 5’end of the in vitro transcribed RNA, 
100% capping efficiency in the correct orientation only is achieved. The in vitro 
transcribed and enzymatically capped RNA produced in this manner was not only 
translated efficiently, but also could presumably overcome the interferon response 
issue in transfected cells.  
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 In contrast to the majority of electroporation systems which use a cuvette 
based chamber, the Neon transfection system used in this study is based on the use 
of a pipette tip chamber which produces a more uniform electric field, resulting in 
higher cell viability (Kim et al., 2008a). Using this system, transfection efficiencies of 
>95% were achieved and optimal conditions for the recovery of MNV determined 
(Figure 5.3a). In combination with optimised nucleic acid delivery systems into 
RAW264.7 cells, the efficient recovery of MNV into permissive cells was successfully 
developed and a higher virus yield was achieved.  
5.4 Conclusion 
 By employing transfection of in vitro transcribed enzymatically capped MNV 
RNA into BSR-T7 and 293T cells, significantly more virus was recovered compared 
to the other reverse genetics systems currently available for MNV. This system also 
does not require any pre-infection of cells with helper virus. By combining the 
optimised nucleic acid delivery system, namely Neon electroporation, and the 100% 
efficient ScriptCap enzymatically capping system for in vitro transcribed MNV RNA, a 
successful viral recovery system was achieved in RAW264.7 cells. Transfection of 
capped RNA into this cell produced a significantly high titre of virus. Even though the 
kinetics analysis showed a slower viral recovery when compared to  VPg linked RNA, 
the transfection of capped RNA into RAW264.7 cells was able to produce 
comparable titres to authentic MNV infection at the later stages (presumably due to 
subsequent rounds of re-infection in RAW264.7 cells). This system also resolved the 
translation efficiency, innate immune response and nucleic acid delivery issues which 
led to the earlier failure of similar approaches. Furthermore, we have shown that 
boosting viral protein production in tissue culture by transfecting cap-1 structure 
incorporated in vitro transcribed MNV RNA does not increase the levels of virus titre 
in recovery. To conclude, we have successfully generated a new method for 
norovirus reverse genetics, which allows the rapid and robust recovery of genetically 
defined viruses in tissue culture. This method, when combined with mutational 
analyses, provides an additional tool with which to uncover the molecular 
mechanisms of norovirus translation, replication and ultimately virulence, aiding our 
understanding of this group of significant pathogens.   
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Chapter 6.0 
MNV-1 reporter tagged replicon 
as a tool to study viral 
replication 
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6.1 Introduction 
 To date, studies on human norovirus replication have been limited by the 
absence of reliable tissue culture systems to cultivate this virus. Some replication and 
inhibition studies for this virus have been demonstrated using cell lines expressing 
replicon systems (Chang and George, 2007; Chang et al., 2006) or the transfection 
of a full-length cDNA clone of human norovirus (under the control of a T7 promoter) 
into MVA-T7 infected cells (Asanaka et al., 2005). Viral replication in both of these 
systems is monitored by RT-PCR, qRT-PCR, northern blot or western blot analysis 
for the presence of viral proteins. Replicon systems are commonly employed in 
replication studies for many viruses that replicate inefficiently in tissue culture. The 
availability of an infectious cDNA clone for many viruses has allowed molecular 
manipulations to the viral genome. For instance the viral structural protein encoded 
genes can be replaced/inserted with a reporter or an antibiotic resistant gene which 
would allow an easy quantifiable expression of reporter protein that directly 
represents viral replication. A hepatitis A virus (HAV) replicon system has been 
developed by replacing the structural proteins with luciferase (Gauss-Muller and 
Kusov, 2002). More recently, the respiratory syncytial virus (RSV) replicon, which 
lacks all the three of its glycoproteins but contains an additional GFP gene and 
antibiotic resistance gene in the virus genome, has been generated (Malykhina et al., 
2011). In the case of HCV, where replication is well characterised, the insertion of the 
neomycin phosphotransferase gene in place of the structural envelope genes in a 
HCV cDNA clone led to the development of a prototype HCV subgenomic cell 
bearing replicon system (Lohmann et al., 1999). The transfection of this construct 
has allowed the selection of cell clones that stably express the HCV subgenomic 
replicon. Note that this approach has also been employed to develop a cell bearing 
replicon system for HuNv (Chang et al., 2006). Since then further progress on the 
study of HCV replication has been made by employing the initial prototype replicon 
system to develop various improved replicon systems.  The replicon system has 
contributed to the elucidation of other aspects of the viral life cycle, especially 
interactions with the host cell, and this system could potentially lead to the 
development of specific antiviral drugs. In the case of MNV, the availability of robust 
and efficient reverse genetics and tissue culture systems has made a significant 
impact on the progression of research on noroviruses in general. Given that a robust 
and optimised RNA based reverse genetics system for MNV had been successfully 
developed (as discussed in the previous chapter), I used this as a basis on which to 
develop MNV replicons as a tool for investigating various aspects of the MNV 
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replication cycle. This chapter describes the generation of a reporter tagged MNV 
replicon system containing luciferase as a marker to accurately quantify MNV 
genome replication in permissive cells.  
6.2 Results 
6.2.1 Construction of a reporter tagged full-length MNV cDNA clone 
 In this chapter a reporter tagged MNV cDNA clone was generated using the 
full-length infectious MNV cDNA clone pT7MNV3’Rz as a backbone. A gene 
encoding luciferase followed by the FMDV 2A protease was inserted into the 
subgenomic region of the MNV genome, the region of the genome that contains the 
ORF2, ORF3 and ORF4 (Figure 6.1). It is worth noting that the initial aim of this study 
was to generate a recombinant luciferase expressing infectious virus in order to 
quantify replication by simply measuring the expression of the luciferase gene in the 
viral genome upon infection into permissive cells.  
  Full detail on the construction of this reporter replicon is described in Section 
2.1. Briefly, in order to construct this replicon, three PCR fragments were 
successfully generated and combined together using overlapping PCR. All the 
cloning processes were carried out employing the engineered unique restriction sites 
as shown in Figure 6.1. The correct plasmid clones were confirmed by sequencing of 
the entire MNV subgenomic region using sequencing primers (Table 2.1) and by 
analysis using restriction enzyme digestions (data not shown). Identical reporter 
tagged constructs were also successfully generated in the NS7 FS (POLFS) and NS7 
active site mutant (POL-) backbone of full-length MNV cDNA clones. The functions of 
these two mutated constructs in various assays are discussed in Section 6.2.3 and 
6.2.4.1 of this chapter. 
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6.2.2 In vitro transcribed, enzymatically capped RNA from reporter 
 tagged MNV constructs translates correctly in vitro 
 Once the reporter tagged full-length infectious MNV cDNA clones were 
successfully constructed, the expression of viral proteins and the introduced Renilla 
luciferase in these constructs was examined in vitro using rabbit reticulocyte lysates. 
The translation profile of the reporter tagged constructs (RL2A-VP2WT and RL2A-
VP2FS) was compared to the respective translation profile of the original full-length 
MNV infectious cDNA clone (WT) and its truncated NS7 mutant derivative (FS). The 
translations of the in vitro transcribed and enzymatically capped full-length genomic 
(G) and subgenomic (SG) RNA of the WT or replicon constructs were carried out as 
described in Section 2.12. To confirm the production of active Renilla luciferase 
protein from the reporter tagged RNA, samples of the in vitro translation reaction 
were also subjected to a luciferase assay as described in Section 2.12 and 2.21. As 
expected, the translation profiles of the in vitro transcribed full-length genomic RNA 
from either RL2A-VP2WT and RL2A-VP2FS were identical to the profile of the original 
full-length infectious WT and FS MNV RNAs respectively (Figure 6.2a). This outcome 
was expected since the Renilla luciferase was inserted in the subgenomic region of 
MNV. This observation also directly confirmed the ability of reporter tagged 
constructs to express all the ORF1 MNV proteins correctly. Analysis of the 
 
Figure 6.1 Schematic representation of the Renilla luciferase-FMDV2A-VP2 fusion 
(pT7MNV-RL2A-VP2-3’Rz) of full-length MNV-1 cDNA clone. All the 4 open reading 
frames (ORF) with their encoded proteins, the T7 RNA polymerase promoter and the 
position of the 3’ ribozyme sequence are highlighted in the full-length genomic (G) 
construct. The Renilla luciferase gene and nucleotide sequence which encodes the 16 
amino acids residues of FMDV 2A protease with its specific cleavage site were inserted 
into the subgenomic region of MNV genome in the full-length infectious cDNA clone 
pT7MNV3’Rz using the unique Sac II and Nhe I sites. These proteins were translated as 
N-terminus VP2 fusion proteins and were co-translationally “cleaved” at the specific 
FMDV 2A cleavage site to release both Renilla luciferase-2A and VP2. In subsequent 
studies, the template DNA for generation of the synthetic subgenomic (SG) transcript 
from this construct was generated by PCR using primers IGIC18 and 7400R (Table 2.1). 
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translational products from the SG RNA showed a different profile between WT and 
RL2A-VP2WT. There was an additional protein band, corresponding to the expected 
size of Renilla luciferase-FMDV 2A fusion protein (~38 KDa) in the translational 
profile of reporter SG RNA, in addition to VP1, VP2 and ORF4 proteins (Figure 6.2c). 
This observation confirmed that the “cleavage” activity of the FMDV 2A peptide in the 
reporter fusion was almost 100% efficient, resulting in the release of the Renilla 
luciferase-2A protein from the fusion to VP2. Further to this, the luciferase assay 
analysis in Figure 6.2c confirmed that the translated Renilla luciferase protein from 
the reporter tagged MNV RNA was enzymatically active. The high luciferase signal 
obtained from the translation of the reporter tagged SG RNA (Figure 6.2c) indicates 
that the Renilla luciferase was translated from the bicistronic SG RNA of MNV via the 
translation termination-reinitiation mechanism (Napthine et al., 2009). This 
translational feature is also employed by FCV (Herbert et al., 1996; Poyry et al., 
2007) and other positive strand viruses which generally produce a polycistronic SG 
RNA (Powell et al., 2008). On the other hand, the luciferase signals obtained from 
the G-WT and G-POLFS RNA of reporter tagged constructs (Figure 6.2c) were 
presumably due to either sequences (TURBs) in the polymerase region (ORF1) 
which direct the reinitiation of VP1 (ORF2) translation after termination on ORF1 or 
simply as a result from ribosomal read through. Of note, the translation termination-
reinitiation mechanism between ORF1 and ORF2 is employed by bovine norovirus 
during expression of its capsid protein (McCormick et al., 2008). The putative 
nucleotide sequence of the translational upstream ribosome binding sites (TURBs) 
typically present at the end of ORF2 in noroviruses were found at the end of ORF1 in 
bovine norovirus (McCormick et al., 2008). This discovery suggested that a low level 
translation of the capsid protein could be achieved without the production of SG 
RNA. 
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6.2.3 Translation of reporter tagged MNV genome in tissue culture 
 Since in vitro translation analysis had confirmed that the reporter constructs 
generated were able to produce viral proteins and Renilla luciferase protein, the 
constructs were then examined in cell culture using two different reverse genetics 
systems. The MNV replication permissive cells, BSR-T7, which are used in both 
systems, allows viral protein expression and a single cycle of MNV replication 
(Chaudhry et al., 2007; Yunus et al., 2010). However they lack a suitable viral 
receptor to enable reinfection and multi-cycle virus replication. In the cDNA based 
(a)                                                                 (b) 
            
 
(c) 
                            
Figure 6.2 In vitro translation of Renilla luciferase gene in MNV genome from full 
length genomic and subgenomic of in vitro transcribed capped reporter tagged MNV 
RNAs. (a) In vitro translation of full length MNV genomic (G) (WT and FS) and Renilla 
luciferase-FMDV 2A-VP2 fusion (RL2A-VP2WT and RL2A-VP2FS) capped RNA. (b) In 
vitro translation of WT and RL2A-VP2 WT capped SG RNA. In both cases (a and b), the 
enzymatically capped in vitro transcribed RNA were prepared and used in in vitro 
translation using rabbit reticulocyte lysates as described in Section 2.12. The translation 
products were resolved on 15% SDS PAGE, dried and exposed to phosphorimager for 
visualization. (c) Luciferase activity quantification of reporter RNAs translation products. 
The in vitro translation products from full length G RNA (G – WT, G – PolFS) and SG 
RNA of reporter construct were diluted in reporter lysis buffer (RLB) and subjected to 
luciferase assay as detailed in Section 2.21. The luciferase activity was measured as 
relative luminescene unit (RLU). The error bars represent standard deviation.  
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recovery system, the reporter tagged MNV cDNA was transfected into FPV-T7 
infected BSR-T7 cells and protein samples analysed for luciferase activity. Western 
blot analysis was used to detect viral protein expression and virus production was 
assayed by TCID50 at 48h post transfection. The luciferase activity analysis in Figure 
6.3a shows the presence of active Renilla luciferase in the lysates from the 
transfected cells confirming the expression of reporter tagged MNV cDNA in cell 
culture. The detection of equal levels of MNV NS7 and NS3 proteins in the western 
blot analysis of all the protein samples confirms that the BSR-T7 cells were 
transfected at the same transfection efficiency (Figure 6.3b). Given the protein levels 
were the same in the POLFS and POL- mutants, we can conclude that the protein 
level observed in this assay were only a reflection of viral RNA transfection rate 
rather than replication competency. Therefore, the increased luciferase activity 
obtained from the WT replicon compared to the POLFS and POL- was presumably 
due to replication of the viral genome in the transfected cell. By comparing the 
Renilla luciferase signal obtained from POL- and POLFS, the high signal from POL- 
could be due to the internal reinitiation of translation. This event is less likely to occur 
in POLFS because the stop codon introduced in NS7 in this construct (Chaudhry et al., 
2007) is far upstream from the start of the ORF2 and presumably the ribosome 
dissociates at an earlier point. Even though the reporter tagged constructs were able 
to translate efficiently, there were no infectious virus particles detected by TCID50 
analysis, except for those samples from the full-length MNV infectious cDNA clone 
transfected cells (Figure 6.3c).  
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(a)                  (b) 
 
(c)  
        
 
Figure 6.3 Translation of Renilla luciferase from reporter tagged MNV constructs in 
tissue culture by cDNA based reverse genetics system. (a) Renilla luciferase activity of 
protein lysates obtained from reporter plasmids transfected BSR-T7 cells previously 
infected with recombinant FPV-T7. The cDNA based reverse genetics system was carried 
out as described in Section 2.13.1 by transfecting full-length WT, NS7 frame shift (FS) and 
active site mutant NS7 (POL-) of pT7MNV-RL2A-VP2-3’Rz constructs. Transfection of 
full-length MNV infectious cDNA clone was carried out as a control. At 48h post 
transfection, the transfected cells were harvested and subjected to lysis in reporter lysis 
buffer (Promega) before a luciferase assay was carried out as described in Section 2.21. 
The error bars represent standard deviations and the luciferase activity was measured as 
relative luminescene unit (RLU). Statistical differences compare to the WT (calculated by 
one way ANOVA with Tukey’s post test) are represented by the P-values P < 0.05 (*) and 
P < 0.01 (**). (b) Western blot analysis of reporter tagged construct transfected BSRT7 
cells. The same protein samples obtained in (a) were used in western blot using antisera to 
the viral NS7 and NS3 and GAPDH as a loading control. (c) TCID50 of the recoveries 
from reporter tagged construct transfected cells and full-length infectious MNV cDNA 
clone. Samples were harverted at 48h post transfection by one freeze thaw cycle and the 
cleared supernatants were titrated onto RAW264.7 cells. The TCID50 was carried out in 
triplicate with the titre values represented being the mean virus titre observed (asterisk 
symbol in figure). Standard deviation around the mean is also given in brackets.  
  In addition to the cDNA based recovery system, the RNA based reverse 
genetics system was also performed to further examine the translation and 
replication of full-length reporter tagged replicon MNV RNA in tissue culture. The full-
length in vitro transcribed and enzymatically capped MNV reporter tagged RNA was 
again transfected into BSR-T7 cells. As a control for virus recovery, the full-length in 
vitro transcribed and enzymatically capped RNA from the infectious cDNA clone of 
MNV (Yunus et al., 2010) was also included in the recovery assay. At 24h post 
transfection,  protein samples were prepared and subjected to luciferase assay and 
western blot analysis. Comparative transfection efficiencies were achieved in all the 
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transfected RNA samples, as indicated by western blot analysis in Figure 6.4b. 
Active Renilla luciferase protein was detected in protein samples from all reporter 
tagged RNA transfected cells as indicated in the luciferase assay in Figure 6.4a. 
Again, the WT reporter tagged RNA transfected BSR-T7 cells produced the highest 
luciferase signal compared to its POLFS and POL- derivatives. This observation 
suggested that the transfected WT reporter tagged RNA of MNV from in vitro 
transcription was able to replicate in BSR-T7 cells while transfection of replication 
defective reporter tagged in vitro transcribed RNA (POLFS and POL-) resulted in no 
replication. The lower luciferase signal obtained from the transfection of these 
replication defective reporter tagged RNA was presumably as a result of translation 
reinitiation at the ORF2 in the viral genome of the input capped RNA transcript in the 
transfection reactions. This obervation will be further discussed in section 6.2.4.1 of 
this chapter. As observed in the cDNA based reverse genetics system previously, 
recoveries from RNA based reverse genetics also failed to produce any detectable 
level of recombinant reporter virus, as shown by TCID50 analysis (Figure 6.4b). 
 
 
(a)           (b)
   
 
Figure 6.4 Translation of Renilla luciferase from in vitro transcribed and 
enzymatically capped reporter tagged MNV RNA in tissue culture by RNA based 
reverse genetics system. (a) Renilla luciferase activity measurement and western blot 
analysis of protein samples (targeting NS7) from reporter tagged MNV RNA transfected 
BSR-T7 cells harvested at 24h post transfection. The protein samples for luciferase assay 
were prepared in RLB as described in Section 2.21, while the protein samples for western 
blot analysis were prepared in RIPA buffer as described in Section 2.20.  The error bars 
represent standard deviation and the luciferase activity was measured as relative 
luminescene unit (RLU). Statistical differences compared to the WT (calculated by one 
way ANOVA with Tukey’s post test) are represented by the P-values of P < 0.05 (*) and 
P < 0.01 (**). (b) TCID50 of the recoveries from the in vitro transcribed and 
enzymatically capped reporter tagged RNA and full length infectious MNV RNA 
transfected into the BSR-T7 cells.  Virus samples were harverted at 24h post transfection 
and titrated using RAW264.7 cells. The TCID50 was carried out as described in Section 
2.15 in triplicate with the mean titre values presented here (asterisk symbol in figure) and 
standard deviations shown in brackets. 
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6.2.4 Reporter tagged MNV genome replicates in tissue culture 
 Preliminary luciferase data obtained from cDNA based and RNA based 
reverse genetics systems (Figure 6.3a and 6.4a) indicated that the transfection of the 
WT MNV reporter tagged construct plasmid or its in vitro transcribed and 
enzymatically capped RNA into BSR-T7 cells resulted in reporter tagged MNV 
genome replication due to the higher luciferase activity, when compared to the other 
replication defective reporter tagged constructs (POLFS and POL-). A series of assays 
to examine this hypothesis and to further characterise the reporter tagged replicon for 
MNV has been carried out successfully as described below.  
6.2.4.1 Replication kinetics analysis of the reporter tagged MNV replicon using 
 DNA and RNA based reverse genetics systems 
 The replication of WT reporter tagged replicon was determined by comparing 
the translation rate of Renilla luciferase from the WT and replication defective POLFS 
and POL- constructs. By employing both of the reverse genetics systems, equal 
amounts of RL2A-VP2 cDNA constructs or the equivalent in vitro transcribed and 
enzymatically capped RNAs were transfected into BSR-T7 cells (detailed in Section 
2.13.1 and 2.13.2) and the production of active Renilla luciferase over the course of 
transfection was measured by luciferase assay (as described in Section 2.21). 
Western blot analysis of the MNV ORF1 protein (NS7) was carried out in order to 
determine the transfection efficiency. In the cDNA based reverse genetics system, 
the Renilla luciferase activity was found to be the same from all the transfected 
constructs at 3h post transfection indicating that equal amount of DNA was 
transfected into the BSR-T7 cells (Figure 6.5a). The luciferase activity in the WT 
RL2A-VP2 construct transfected cells increased over the time course, peaking at 48h 
post transfection before it dropped down at 72h post transfection. With the same 
transfection efficiency was obtained from all the transfected constructs (Figure 6.5b), 
the high luciferase activity in WT RL2A-VP2 when compared to the POLFS and POL- 
RL2A-VP2 was determined to be due to replication of the MNV genome.  
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 A more profound difference in replication kinetics by WT RL2A-VP2 was 
observed in the RNA based reverse genetics system where transfection of equal 
amounts of in vitro transcribed enzymatically capped reporter tagged RNA into BSR-
T7 cells resulted in robust replication, as represented by luciferase activity (Figure 
6.6). While the luciferase activity from the replication defective in vitro transcribed 
RNA from POLFS RL2A-VP2 and POL- RL2A-VP2 started to drop down at 12h post 
transfection, the signal from reporter tagged WT RNA continuously increased up to 
24h post transfection (Figure 6.6a). This observation clearly indicates the WT RL2A-
VP2 replicon RNA was replicating in the transfected cells since the transfection 
efficiency was equivalent in all reactions (Figure 6.6b). To confirm this observation, 
the replication kinetics analysis using the RNA based reverse genetics system was 
repeated as described previously, but Renilla luciferase activity was measured over a 
longer time-course (6, 24 and 48h post transfection). The western blot analysis and 
Renilla luciferase activity as depicted in Figure 6.7 confirmed that the WT RL2A-VP2 
RNA was actively replicated compared to the other replication defective RNAs. 
(a) 
                           
(b) 
                  
 
Figure 6.5 Analysis of replication kinetics and western blot analysis of Renilla 
luciferase tagged MNV cDNA constructs by MNV cDNA based reverse genetics 
system. (a) Time course analysis of Renilla luciferase activity of MNV reporter tagged 
constructs. The cDNA based reverse genetics system was carried out as described in 
Section 2.13.1 by transfecting the equal amount of cDNA plasmids from WT, POLFS and 
POL- of RL2A-VP2. At the given time points, the transfected cells were harvested and 
lysed in RLB. The luciferase activity measurement was carried out as described in Section 
2.21. The error bars represent standard deviation and the luciferase activity was measured 
as relative luminescene unit (RLU). (b) Western blot analysis of the transfected reporter 
tagged cDNA plasmids using NS7, NS3 and GAPDH antisera to determine the 
transfection efficiency in cDNA based reverse genetics system. 
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(a) 
                          
(b) 
          
 
Figure 6.6 Analysis of replication kinetics and western blot analysis of in vitro 
transcribed and enzymatically capped RNA from Renilla luciferase tagged MNV 
constructs using RNA based reverse genetics system. (a) Time course analysis of 
Renilla luciferase activity from the transfected reporter tagged in vitro transcribed MNV 
RNAs. The RNA based reverse genetics system was carried out as described in Section 
2.13.2 by transfecting an equal amount of in vitro transcribed RNA from WT, POLFS and 
POL-. At the given time points, the transfected cells were harvested and lysed in RLB. The 
luciferase activity measurement was carried out as described in Section 2.21. The error 
bars represent standard deviation and the luciferase activity was measured as relative 
luminescene unit (RLU). (b) Western blot analysis of the transfected reporter tagged 
RNAs using NS7, NS3 and GAPDH antisera to determine the transfection efficiency in 
RNA based reverse genetics system. 
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6.2.4.2 Reporter tagged MNV replicon RNA is replication competent in tissue 
 culture 
 Kinetics analysis in Section 6.2.4.1 had shown that the replication of reporter 
tagged MNV replicon in permissive cells was indeed active. Further investigation was 
carried out in order to characterise the reporter tagged MNV replicon. We 
hypothesised that the replication of reporter tagged replicon could lead to the 
production of the infectious VPg linked MNV replicon RNA in cell culture. To examine 
this hypothesis, the optimum amount of in vitro transcribed and enzymatically capped 
reporter replicon RNA to produce the highest Renilla luciferase signal in a single 
cycle of replication in BSR-T7 cells was determined by transfection (as described in 
Section 2.13.2). The total RNA preparation was performed from this transfection at 
24h post transfection (as detailed in Section 2.16) and this total cellular RNA (5 µg) 
was subsequently used to transfect BSR-T7 cells as illustrated in Figure 6.8a. 
Transfection of 5 µg of in vitro transcribed reporter replicon RNA produced the 
highest Renilla luciferase signal as shown in Figure 6.8b and subsequent transfection 
using the total RNA, prepared from this initial transfection 24 hours post the initial 
transfection, into BSR-T7 cells also produced the highest Renilla luciferase activity as 
(a) 
                          
 
Figure 6.7 Confirmation of replication of the transfected in vitro transcribed and 
enzymatically capped RNA of MNV WT RL2A-VP2 in tissue culture using RNA 
based reverse genetics system. Top panel: graph shows the luciferase activity of the 
transfected capped reporter tagged RNA transcripts at early, middle and late time points 
during the course of transfection. All the cell lysates were prepared in RLB at the given 
time points and subjected to luciferase activity measurement as described in Section 2.21. 
The error bars represent standard deviation and the luciferase activity was measured as 
relative luminescene unit (RLU). Bottom panel: western blot analysis of cell lysates taken 
at 24h post transfection by using NS7 antisera. The cell lysates for western blot analysis 
were prepared in RIPA buffer as described in Section 2.20. 
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shown in Figure 6.8c. The detection of high Renilla luciferase signal after the 
transfection of BSR-T7 cells with total RNA prepared from WT replicon transfected 
cells relative to the signals obtained from POLFS and POL- indicated that the 
replication of WT reporter replicon in permissive cells lead to the production of VPg-
linked replication competent replicon RNA (Figure 6.8c). 
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(a)  
                 
(b)          (c) 
 
 
Figure 6.8 Transfection of in vitro transcribed and enzymatically capped reporter 
tagged MNV replicon into BSR-T7 cells produces a replication competent reporter 
tagged MNV RNA. (a) Schematic overview of the experimental procedure to determine 
whether the reporter tagged replicon MNV RNA is capable of producing replication 
competent RNA in tissue culture. Optimum levels of in vitro transcribed and 
enzymatically capped reporter replicon RNA to produce Renilla luciferase signal in BSR-
T7 cells were determined by initial transfection. At 24h post transfection, the luciferase 
activity of reporter replicon was measured as described in Section 2.21 and total RNA was 
extracted by column purification as detailed in Section 2.16. These total RNAs (at 5 µg) 
were re-transfected into BSR-T7 cells and the measurement of Renilla luciferase signals 
were done at 24h post transfection. (b) Renilla luciferase levels detected at 24h post 
transfection of in vitro transcribed and enzymatically capped reporter replicon RNA. 1 µg, 
5 µg and 10 µg of reporter tagged replicon RNA from WT, POLFS and POL- RL2A-VP2 
were transfected into BSR-T7 cells as described in Section 2.13.2. At 24h post 
transfection the Renilla luciferase activity was measured by harvesting the cell lysates as 
described in Section 2.21 (c) Renilla luciferase levels observed after re-transfection of 
total RNA extracted from the initially transfected cells with varying concentration of in 
vitro transcribed RNAs in (a). The cell lysates and luciferase activity measurement were 
carried out as described in Section 2.21. The error bars represent standard deviation and 
the luciferase activity was measured as relative luminescene unit (RLU). 
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6.2.4.3 Replication competent replicated reporter tagged MNV replicon RNA is 
 VPg linked   
 One of the characteristics of the replication of infectious MNV RNA in tissue 
culture is the production of VPg linked RNA. Therefore, transfection of the in vitro 
transcribed and enzymatically capped reporter replicon RNA into permissive cells 
was hypothesised to lead to a production of a replication competent VPg linked 
replicon RNA. To examine this hypothesis, 5 µg of in vitro transcribed and 
enzymatically capped reporter replicon RNAs were transfected into BSR-T7 cells and 
at 24h post transfection, the total RNA from the transfected and untransfected 
(UnTFN) cells was prepared as described in Section 2.16. 60 µg of these RNAs were 
then subjected to proteinase K treatment before been re-purified and transfected 
back into fresh BSR-T7 cells (10 µg of treated RNA). The replication competent 
reporter replicon was found to be present in total RNA prepared from initially 
transfected BSR-T7 cells with the WT in vitro transcribed and enzymatically capped 
reporter replicon RNA but not the POL- RNA as shown by Renilla luciferase signals 
obtained in Figure 6.9a. Treatment of this total RNA (WT) with proteinase K resulted 
in the loss of luciferase activity from lysates of the transfected cells when compared 
to the untreated RNA (Figure 6.9b). These observations indicate that the production 
of the VPg linked infectious RNA was the result of replication of the MNV reporter 
replicon in cell culture. Removal of the VPg from RNA (by proteinase K) had caused 
the loss of replication competence. Work on FCV and MNV VPg showed a decrease 
in translation of genomic RNA upon the removal of VPg from the viral RNA 
suggesting an integral role for the calicivirus VPg in viral protein translation 
(Chaudhry et al., 2006; Herbert et al., 1997). Further work on this confirmed that an 
interaction between FCV VPg and the host protein eIF4E is required to initiate the 
translation of viral RNA (Goodfellow et al., 2005). In vitro studies have also shown 
the role of MNV VPg in viral genome replication whereby initiation of RNA synthesis 
is achieved via a protein primed mechanism (Han et al., 2010; Rohayem et al., 
2006b). Therefore, the removal of VPg from the VPg linked MNV reporter tagged 
replicon RNA (in the total cellular RNA preparation), through proteinase K treatment, 
had resulted in the loss of its translation and replication competence as can be seen 
in luciferase activity data from WT+pK in Figure 6.9b bottom panel. 
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6.2.5 Recombinant reporter tagged MNV is not recovered using 
 reverse genetics 
 As mentioned at the early part of this chapter, the initial aim of this study was 
to recover recombinant reporter tagged MNV from the generated reporter tagged 
cDNA construct. However, attempts to recover the aforementioned recombinant 
reporter virus from both reverse genetics systems were unsuccessful (Figure 6.3c 
and 6.4b). Recombinant virus was undetectable even after 5 blind passages in 
RAW264.7 cells. Two hypotheses were raised regarding this and various assays 
were carried out to examine them. The first one was regarding the potential inhibitory 
(a)                                                              (b) 
      
       
Figure 6.9 The MNV reporter replicon is replication competent in tissue culture and 
its replication leads to the production of VPg linked RNA. (a) Top panel : Total RNA 
prepared from the BSR-T7 cells which had been transfected with 5 µg of in vitro 
transcribed and enzymatically capped reporter replicon RNAs or from untransfected 
(UnTFN) cells at 24h post transfection. Bottom panel : Renilla luciferase activity 
measurement to confirm the presence of replication competent MNV reporter replicon in 
the total RNA preparation. 5 µg of total RNAs prepared in the upper panel were 
transfected into fresh BSR-T7 cells and the luciferase activity of the transfected cells was 
determined as described in Section 2.21 at 24h post transfection (b) Top panel : The 
proteinase K treatment of the total RNA prepared in (a, top panel). 60 µg of the total RNA 
was treated or untreated with Proteinase K (+ or - pK) and subjected to re-purification 
using columns as described for total RNA preparation. All the prepared RNAs were 
resolved in 0.8% agarose gel, stained with EtBr and visualised under UV light using a 
DNA ladder. Bottom panel: Renilla luciferase activity measurement of the lysates from 
BSR-T7 cells transfected with proteinase K treated or untreated total RNA as depicted in 
the top panel. 10 µg of total RNAs from the upper panel were transfected into BSR-T7 
cells and lysates were harvested at 24h post transfection prior to luciferase assay as 
described in Section 2.21. The values on the graph are represented by the raw data minus 
the background luciferase levels. The error bars represent standard deviation and the 
luciferase activity was measured as relative luminescene unit (RLU). 
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effects of the luciferase gene product in transfected cells and the second hypothesis 
was based on a defect in virion assembly.  
6.2.5.1 Expression of the luciferase protein does not inhibit MNV recovery  
 Whilst unlikely we were unable to formally exclude the possibility that the 
presence of luciferase protein in transfected cells during the recovery of recombinant 
reporter tagged MNV inhibited virus production. To test this hypothesis, the RNA 
based reverse genetics system was employed. This entailed the co-transfection of 
full-length infectious in vitro transcribed and enzymatically capped RNA of MNV (WT 
G) with a luciferase expression plasmid, namely pRL-TK (Promega) for Renilla 
luciferase or pGLuc (Nanolight) for Gaussia luciferase (discussed in further detail 
under Section 6.2.6.1). As a positive control, the transfection with capped infectious 
MNV transcripts synthesised in vitro alone was also performed. At 24h post 
transfection, the protein samples and cell culture medium, containing any secreted 
luciferase (for Gaussia luciferase), were prepared for luciferase assay (Section 2.21) 
and western blot analysis. TCID50 was carried out on samples from these recoveries 
as described in Section 2.15. Co-transfection of WT G RNA transcript with pRL-TK or 
pGLuc expression plasmid resulted in robust expression of both luciferase proteins in 
the cell lysates (Figure 6.10a). Interestingly, virus was also detected by TCID50 from 
each co-transfection reaction and the titre was close to the typical titre obtained from 
the MNV RNA recovery system using BSR-T7 cells (Figure 6.10b). These data 
indicate that the presence of both luciferase proteins in the MNV reverse genetics 
system does not inhibit virus recovery and protein production (Figure 6.10c).  
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(a)                                                              (b) 
          
 
 
(c) 
          
 
Figure 6.10 Co-transfection of in vitro transcribed and enzymatically capped full-
length genomic MNV RNA (WT G) with Renilla or Gaussia luciferase expression 
plasmid using the RNA based reverse genetics system. (a) Renilla and Gaussia 
luciferase activity measurement of lysates from BSRT7 cells transfected with either 
expression plasmid and in vitro transcribed MNV RNA. The RNA based reverse genetics 
system was carried out by co-transfecting the in vitro transcribed and enzymatically capped 
MNV RNA (WT G) with either Renilla or Gaussia expression plasmid. The cell lysate (for 
Renilla) or cell culture medium (for Gaussia) were harvested at 24h post transfection and 
subjected to luciferase assay as described in Section 2.21. The error bars represent standard 
deviation and the luciferase activity was measured as relative luminescene unit (RLU). (b) 
TCID50 of the recoveries from the RNA based reverse genetics system. The full-length in 
vitro transcribed MNV RNA was co-transfected with either Renilla or Gaussia luciferase 
expression plasmid into BSRT7 cells. Samples were harvested at 24h post transfection and 
titrated onto RAW264.7 cells as described in Section 2.15. The titre values are presented as 
a mean (asterisk symbol in figure) and standard deviations are shown in brackets. (c) 
Western blot analysis of the transfected cells using NS7 and GAPDH antisera to determine 
the transfection efficiency in RNA based reverse genetics system. This analysis was 
carried out as described in Section 2.20. UnTFN represents lysate from untransfected cells. 
 
6.2.5.2 Provision of VP2 in trans does not aid reporter tagged recombinant MNV 
 recovery 
 Another possible reason why the reporter tagged recombinant MNV could not 
be recovered from the revere genetics system using the RL2A-VP2 cDNA construct 
or RNA is because of minor differences in the VP2 protein. The authentic MNV VP2 
(and the MNV VP2 from the pT7MNV3’Rz) contains a methionine as its first amino 
acid residue at the N-terminal end of its polypeptide sequence. However, in the 
RL2A-VP2 construct, the VP2 is being translated as a Renilla luciferase fusion 
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protein (Figure 6.1). The co-translational “cleavage” event at the specific FMDV 2A 
cleavage site, which was designed in the construct to release the Renilla luciferase 
and FMDV 2A from the VP2 fusion, leaves an additional proline as the first amino 
acid residue at the N-terminus of the VP2 protein (in addition to the methionine). The 
presence of proline as the first amino acid residue at the N-terminal of VP2 would 
possibly affect the folding and function of the VP2. Since VP2 has been shown to 
contribute to the stabilisation of VP1 in NV virus-like particles (Bertolotti-Ciarlet et al., 
2003b) and therefore may have a possible role in viral assembly, any modification to 
its peptide sequence may disrupt the production of the intact virion. This observation 
also had been demonstrated for FCV where transfection of cells with replication-
competent RNA defective in full-length expression of VP2 resulted in no infectious 
particles being produced. However, trans-complementation of FCV VP2 in the cells 
transfected with this construct was shown to lead to the production of FCV viral 
progeny in tissue culture (Sosnovtsev et al., 2005). For these reasons, the trans-
complementation of VP2 by co-transfection of the MNV VP2 expression plasmid 
(pcDNA3 VP2) with full-length reporter constructs was performed using the cDNA 
based reverse genetics system (as detailed in Section 2.13.1) in order to examine 
the recovery of recombinant virus. The expression of VP2 in trans from the co-
transfected pcDNA3-VP2 plasmid in BSR-T7 cells was clearly demonstrated in 
western blot analysis of the cell lysates Figure 6.11c. Renilla luciferase signal 
detected from the WT samples indicated that the replication of the reporter tagged 
replicon was active in both samples transfected with (+VP2) or without (–VP2) the 
VP2 expression construct (Figure 6.11a) when compared to the same transfection 
using the POLFS reporter construct. However, the TCID50 data in Figure 6.11b 
suggested that the recombinant reporter MNV still can not be recovered, even though 
trans-complementation of VP2 was provided in the recovery system. As a positive 
control, recovery using full-length infectious MNV cDNA clone produced a typical 
yield of MNV (WT G in Figure 6.11b). 
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 This observation was further confirmed by using RNA based reverse genetics 
system. The co-transfection of in vitro generated full-length genomic reporter tagged 
RNA and wild type length subgenomic RNA (to provide the wild type VP2 in trans) 
into BSR-T7 cells was performed and samples for TCID50 and luciferase assay were 
taken at 24h post transfection. The transfection of in vitro transcribed full-length 
reporter tagged RNA with (+SG) or without (-SG) subgenomic length wild type RNA 
(produced in vitro) resulted in replication of the RNA in the transfected BSR-T7 cells. 
This observation is represented by the Renilla luciferase signal from the WT which 
was in ~ 2-fold excess compared to the POL- derivative RNA controls (Figure 6.12a). 
As observed in the cDNA based recovery system above, TCID50 analysis of 
recoveries for reporter tagged samples from this RNA based system failed to detect 
infectious virus particles (Figure 6.12b). This TCID50 data suggested that the 
(a)                                                                 (b) 
 
   
 
(c) 
         
 
Figure 6.11 Co-transfection of reporter tagged replicon constructs with VP2 
expression plasmid (pcDNA3 VP2) in cDNA based recovery system. (a) Renilla 
luciferase activity measurement of lysates from BSR-T7 cells transfected with reporter 
tagged cDNAs and VP2 expression plasmids (+VP2) or reporter tagged cDNAs only (-
VP2). The cDNA based reverse genetics system was carried out as described in Section 
2.13.1. The cell lysates were harvested at 48h post transfection and subjected to luciferase 
assay as described in Section 2.21. The error bars represent standard deviation and the 
luciferase activity was measured as relative luminescene unit (RLU). (b) TCID50 of the 
recovery samples from the cDNA based reverse genetics system in (a). Samples were 
harvested at 24h post transfection and titrated onto RAW264.7 cells as described in 
Section 2.15. The titre values are presented as averages (asterisk symbol in figure) and 
standard deviations are shown in bracket. (c) Western blot analysis of the transfected cells 
using NS7 and VP2 antisera to determine the transfection efficiency. Cell lysates were 
prepared in RIPA at 48h post transfection. This analysis was carried out as described in 
Section 2.20. 
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expression in trans of the wild type VP2 from the co-transfection of subgenomic 
length RNA does not aid infectious MNV particle production. Note that the co-
transfection of full-length in vitro transcribed and enzymatically capped MNV RNA 
from the infectious cDNA clone with its subgenomic-length RNA (G WT + SG) 
produced a lower yield of virus, as observed in the RNA based reverse genetics 
study (Yunus et al., 2010) (Figure 6.12b).  
 
 With these observations in mind (from both reverse genetics systems), it can 
be suggested that the inability to recover recombinant reporter tagged MNV was not 
because of the proline residue in VP2 since trans complementation of wild type VP2 
in transfected cells did not result in detectable virus being produced. However, there 
is one caveat to the detection of infectious particles by TCID50 in this particular type 
of assay. TCID50s require multiple cycles of replication before c.p.e can be seen, 
especially at higher dilutions. The RAW264.7 cells used in this assay are themselves 
not trans-complemented with VP2. Therefore, even if infectious particles were made, 
they might not necessarily be seen by TCID50 since this assay relies on the 
development of c.p.e. Due to time constraints, follow-up experiments to investigate 
this were unable to be carried out. Other factors could also presumably contribute to 
the mentioned observation. The insertion of exogenous Renilla luciferase gene into 
MNV genome might affect the RNA folding of the reporter replicon and the resulting 
(a)     (b) 
 
   
 
Figure 6.12 Co-transfection of in vitro transcribed and enzymatically capped full 
length genomic reporter tagged RNA with the in vitro generated wild type 
subgenomic (SG) length RNA. (a) Renilla luciferase activity measurement of lysates 
from BSR-T7 cells transfected with in vitro generated reporter tagged RNAs (WT and 
POL-) and wild type subgenomic RNA (+SG) or reporter tagged RNAs only (-SG). The 
RNA based reverse genetics system was carried out as described in Section 2.13.2. The 
cell lysates were harvested at 24h post transfection and subjected to luciferase assay as 
described in Section 2.21. The error bars represent standard deviation and the luciferase 
activity was measured as relative luminescene unit (RLU). (b) TCID50 of the recovery 
samples from the RNA based reverse genetics system in (a). Samples were harvested at 
24h post transfection and titrated onto RAW264.7 cells as described in Section 2.15. The 
titre values are presented as averages (asterisk symbol in figure) and standard deviations 
are shown in bracket. 
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increased genome size could also affect efficient encapsidation inhibiting the 
production of virus progeny.  
6.2.6 Development of a rapid and robust system to measure the 
 replication of a reporter tagged MNV replicon 
6.2.6.1 Generation and characterisation of a Gaussia luciferase tagged MNV 
 reporter replicon 
 The availability of a Renilla luciferase reporter tagged replicon for MNV could 
facilitate the development of an easy monitoring system for the replication studies of 
MNV in tissue culture. However, being able to measure luciferase activity in live cells 
would exclude the requirement to lyse the cells prior to luciferase activity 
measurement. In order to develop a rapid and robust system for replication studies 
using the MNV reporter tagged replicon, I have generated a similar reporter construct 
by replacing the Renilla luciferase in pT7MNV-RL2A-VP2-3’Rz with the Gaussia 
luciferase gene. The Gaussia luciferase gene was amplified by using the engineered 
IGIC824 and IGIC825 (Table 2.1) primer set to include the BstBI and SbfI unique 
sites at the 5’ and 3’ends respectively. The resulting PCR product was then cloned 
into the WT, POLFS and POL- backbone of pT7MNV-RL2A-VP2-3’Rz plasmids by 
employing the BstBI and SbfI unique sites. The correct constructs namely WT, POLFS 
and POL- pT7MNV-GL2A-VP2-3’Rz were confirmed by sequencing the subgenomic 
region and by restriction enzyme digestion (data not shown). The replication kinetics 
of the generated Gaussia luciferase reporter replicon were tested in tissue culture by 
using both cDNA and RNA based reverse genetics systems (Figure 6.13). Since the 
Gaussia luciferase product is naturally secreted from the transfected cells, the 
measurement of luciferase activity was achieved by collecting the growth medium of 
the transfected cell. This method produced a rapid and accurate measurement of the 
luciferase activity. The measurement of luciferase activity for the Gaussia luciferase 
tagged MNV replicon from cDNA and RNA based reverse genetics systems was 
carried out as described in Section 2.21. Based on Figure 6.13a and 6.13b, the 
replication of Gaussia luciferase tagged reporter MNV replicon was active in both 
reverse genetics systems. Transfection of the WT GL2A-VP2 into BSR-T7 cells using 
both reverse genetics systems resulted in an increase in Gaussia luciferase activity 
over the time course when compared to the replication defective POLFS and POL-.  
The drop in signal observed at 72h post transfection in the RNA based system was 
presumably due to cell death. Also note that there was no detectable recombinant 
virus recovered from the reverse genetics system for this construct despite been 
passaged for 4 times on RAW264.7 cells.  
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6.2.6.2 Rapid measurement of Renilla luciferase in live cells using the ViViRen 
 system 
 A combination of the ViviRen™ Live Cell Substrate (Promega), the Renilla 
luciferase tagged MNV reporter replicon and the RNA based reverse genetics system 
could allow the development of high throughput (HTS) assays to study replication of 
MNV. The ViviRen live cell substrate is a proprietary compound that generates 
Renilla luciferase luminescence from live cells under normal growth conditions. By 
using this system, a rapid and accurate measurement of Renilla luciferase activity in 
Renilla luciferase tagged reporter MNV replicon was achieved. As a preliminary 
study, optimisation of the transfection in 96 well format was carried out using various 
amounts of in vitro transcribed and enzymatically capped RL2A-VP2 RNAs. The 
number of BSR-T7 cells, and the amount of transfection reagents used were scaled 
(a)       (b) 
 
                   
 
Figure 6.13 Replication kinetics analysis of the Gaussia luciferase tagged reporter 
replicon using cDNA and RNA based MNV reverse genetics systems. (a) Top panel: 
The time course analysis of Gaussia luciferase activity of MNV reporter tagged 
constructs. The cDNA based reverse genetics system was carried out as described in 
Section 2.13.1 by transfecting an equal amount of cDNA plasmids from WT, POLFS and 
POL- of pT7MNV-GL2A-VP2-3’Rz. At 30 minutes prior to the given time points, the 
growth medium was replaced with fresh medium and aliquoted out after 30 minutes for 
luciferase assay as described in Section 2.21. The error bars represent standard deviation 
and the luciferase activity was measured as relative luminescene unit (RLU). Bottom 
panel:  Western blot analysis of the transfected cells using NS7 antisera to determine the 
transfection efficiency. Cell lysates were prepared in RIPA at the given time post 
transfection. This analysis was carried out as described in Section 2.20. (b) Top panel: 
Time course analysis of Gaussia luciferase activity from the transfected reporter tagged in 
vitro transcribed MNV RNAs. The RNA based reverse genetics system was carried out as 
described in Section 2.13.2 by transfecting an equal amount of in vitro transcribed RNA 
from WT, POLFS and POL- of pT7MNV-RL2A-VP2. At 30 minutes prior to the given 
time points, the growth medium was replaced and aliquoted out for luciferase assay as 
above. Bottom panel: Western blot analysis of the transfected cells using NS7 antisera to 
determine the transfection efficiency. Cell lysates were prepared in RIPA at given time 
post transfection as above. 
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down appropriately. At 24h post transfection, the Renilla luciferase activity was 
measured as described in Section 2.21 using the ViViRen live cell substrate system. 
Transfection of 100 ng RNA of WT Renilla luciferase tagged reporter replicon per 
well of BSR-T7 cells in a 96 well plate produced the highest luciferase activity when 
measured using the ViViRen live cell substrate system (Figure 6.14). Due to the 
rapidity and accuracy of this system, this data again confirmed the replication of WT 
RL2A-VP2 in the transfected cells. Further analysis could be carried out to develop 
this RL2A-VP2 MNV reporter replicon into a HTS assay as has been reported for the 
dengue virus reporter system (Zou et al., 2011). However, the ratio of replication 
competent to incompetent replicon was small (~3 to 4 fold increase). Whilst this 
observation was reproducible, it does not provide a large dynamic range therefore 
further optimisations of the replicon may be required.  
 
 
 
 
 
 
 
 
 
                        
Figure 6.14 Optimisation for transfection of in vitro transcribed and enzymatically 
capped Renilla luciferase reporter tagged MNV replicon RNA in 96 well format 
assay. Various amounts of in vitro transcribed and enzymatically capped RNA of Renilla 
luciferase tagged MNV replicon were transfected into 4 x 104 BSRT7 cells in wells of a 96 
well plate by using a scaled down amount of transfection reagents. At 24h post 
transfection, the growth medium of the transfected cell in 96 well plate were removed and 
the diluted ViViRen live cell substrate was added prior to the measurement of Renilla 
luciferase activity as described in Section 2.20 and 2.21 of Chapter 2. The error bars 
represent standard deviations from triplicate transfections. The luciferase activity was 
measured as relative luminescene unit (RLU). 
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6.3 Discussion 
 The accumulation of noroviruses subgenomic RNA is often used as a 
surrogate to indicate the occurrence of viral replication in permissive cells. Northern 
blot analysis from MNV infected dendritic and macrophage cells (Wobus et al., 2004) 
and Norwalk virus RNA (from stool sample) and cDNA transfected cells (Asanaka et 
al., 2005; Guix et al., 2007) showed an increase in subgenomic RNA level over a 
period of time in infected or transfected cells. Due to this characteristic, the reporter 
tagged replicon for MNV was designed by inserting the luciferase gene into the 
subgenomic region via fusion to ORF3. This reporter replicon was also generated to 
facilitate studies on the characterisation of putative MNV subgenomic promoters 
which will be discussed in a later chapter of this thesis (Chapter 7). Since the 
translation of MNV structural proteins from ORF2 and ORF3 are mainly from the 
subgenomic RNA, the presence of luciferase could accurately represent the 
production of this RNA.  
 Expression of this ‘easily quantifiable’ luciferase as a fusion protein to VP2 is 
through the translation termination reinitiation mechanism. Studies on MNV have 
identified a specific nucleotide sequence motif called TURBS at the N terminus of the 
VP1 coding region. This sequence is thought to be complementary to 18S rRNA and 
functions by preventing ribosome disassembly during termination, thereby allowing 
the ribosomes to reinitiate at the overlapping stop and start codon of ORF2 and 
ORF3 of MNV (Napthine et al., 2009). Since the reporter replicon in this study was 
designed as a VP2 fusion protein upon expression, this replicon also could be used 
in further characterisation of TURBS.  
 Incorporation of foreign sequences into the viral genome resulted in their 
expression as part of the viral proteins. It requires an efficient cleavage in order to 
release the fusion of this foreign protein from the viral proteins in order to maintain 
the function of viral proteins. Since the Renilla luciferase in this MNV reporter 
construct was design to be expressed as a fusion protein with VP2, a mechanism to 
enable efficient cleavage is required to release this protein from VP2. The FMDV 2A 
protease sequence (Figure 6.1) has been widely used to express a foreign sequence 
in viral genomes. Amongst them, it has been used to create a stable luciferase 
dengue virus (Zou et al., 2011) and delivery of foreign antigen in an attenuated 
poliovirus vector (Mattion et al., 1996). This is due to its characteristic that does not 
require the presence of other specific FMDV sequences and can mediate efficient 
cleavage in the presence of heterologous sequences (Ryan and Drew, 1994; Ryan et 
al., 1991). The FMDV 2A mediates the co-translational “cleavage” event as defined 
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by a “StopGo” case (Atkins et al., 2007). Ribosomes pause at the end of the 2A 
coding sequence, specifically at the glycine and proline residue (Doronina et al., 
2008). Peptide bonding between these two residues is ‘skipped’ resulting in the 
release of the nascent chain including the glycine residue while the downstream 
polypeptide starts with a proline residue (Donnelly et al., 2001; Ryan and Drew, 
1994). In vitro translation analysis from the in vitro transcribed SG RNA of RL2A-VP2 
showed that this cleavage occurred efficiently, resulting in the release of Renilla 
luciferase from the VP2 (Figure 6.2b).  
 The replication of RL2A-VP2 was confirmed in tissue culture by a reverse 
genetics system. The high luciferase activity obtained from WT RL2A-VP2 in the 
replication kinetics analysis when compared to the POLFS and POL- RL2A-VP2 
clearly indicated that the signal in WT was due to replication (Figure 6.5a, 6.6a and 
6.7). The kinetics in the cDNA based reverse genetics system showed that the 
Renilla luciferase signal was delayed until 48h post transfection. Whereas in the RNA 
based system, the Renilla luciferase signal peaked at 24h post transfection. In the 
cDNA based system the transfection of a reporter construct under T7 promoter 
control results in transcription occuring before translation (Chaudhry et al., 2007). 
This explains the delay in the Renilla luciferase signal obtained from the cDNA based 
reverse genetics system. However, in the RNA based system, the transfection of in 
vitro transcribed and enzymatically capped reporter tagged RNA results in robust 
expression as the Renilla luciferase signal peaked at 24h post transfection. Clearly 
the transfected RNA was immediately translated and subsequently replicated when 
the necessary viral proteins became available, more akin to a natural infection. This 
explained the robustness of the RNA based reverse genetics system (Yunus et al., 
2010). Subsequent assays found that the transfected Renilla luciferase tagged MNV 
replicon was VPg linked. These observations again confirmed that the MNV reporter 
tagged replicon generated in the laboratory is able to replicate in tissue culture. Since 
the requirement for VPg during translation initiation and replication is one of the key 
characteristics of caliciviruses (Goodfellow et al., 2005; Han et al., 2010), the removal 
of this protein from the Renilla luciferase tagged MNV genome abolished reporter 
genome translation and replication.  
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6.4 Conclusion  
 By cloning the Renilla luciferase gene with the FMDV 2A sequence at its C-
terminus into the subgenomic region of full-length MNV infectious cDNA clone 
(pT7MNV3’Rz), the Renilla luciferase-FMDV2A-VP2 fusion tagged reporter construct 
(RL2A-VP2) was successfully generated. The in vitro translation profile for this 
construct confirmed the expression of Renilla luciferase and its release from the VP2 
by co-translational cleavage at the specific FMDV 2A peptide sequence. Combined 
with the reverse genetics system available in the lab, replication of reporter tagged 
replicon for MNV in tissue culture was confirmed. The subsequent assay using the 
RNA based reverse genetics system confirmed that the VPg linked reporter tagged 
RNA was produced as a result of replication. However, fully infectious virus particles 
were not detected. Passages of these recoveries several times in RAW264.7 failed to 
produce any infectious recombinant viruses. The presence of the luciferase product 
in transfected cells was shown not to cause any inhibitory effects on viral production. 
Perhaps, the overall limiting factor, in terms of infectious virus production, is due to 
defects in recombinant viral genome packaging. Provision of the exogenous VP2 by 
trans-complementation in the reverse genetics systems did not result in the recovery 
of recombinant reporter tagged infectious particles. However, any further conclusions 
on whether or not the defect was due to sequence differences in VP2 cannot be 
drawn since the TCID50 assay does not provide VP2 in trans and therefore the 
development of c.p.e may not be feasible. In addition the insertion of relatively large 
exogenous sequences in the MNV subgenomic region might interrupt authentic viral 
assembly. The generation of similar constructs using Gaussia luciferase gene has 
enabled the development of a rapid and accurate tools to measure MNV replication 
in tissue culture. Using this system or the ViViRen live cell substrate to measure 
Renilla luciferase could allow the development of a high throughput assay to monitor 
MNV replication. In conclusion, the reporter replicon system for MNV has been 
successfully developed and characterised. This system could potentially aid MNV 
replication inhibition studies in the future.  
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promoter element for the 
synthesis of MNV-1 subgenomic 
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7.1 Introduction 
 The genomes of positive strand RNA viruses often contain more than one 
open reading frame (ORF). Some viruses have evolved novel mechanisms to 
regulate the synthesis of the other open reading frames that in some cases involves 
the production of a subgenomic RNA or RNAs (SG RNA). HuNv and MNV as well as 
all other caliciviruses, produce such a SG RNA during replication (Asanaka et al., 
2005; Wobus et al., 2004). In addition, the RHDV and FCV SG RNA have been 
reported to be encapsidated (Meyers et al., 1991b; Neill, 2002). The MNV SG RNA is 
~2.4 kb in length and shares the same 3’ UTR as the genomic RNA (G RNA). Similar 
to the G RNA, the SG RNA is thought to be covalently linked to VPg at its 5’end and 
also has a poly A tail at the 3’ end (Wobus et al., 2004). The SG RNA encodes the 
major (VP1) and minor (VP2) capsid proteins from ORF 2 and ORF 3 respectively. 
An additional alternative reading frame is also present in the SG RNA of MNV 
(ORF4) and it is encodes a protein crucial for virulence in the host (VF1) (McFadden 
et al., 2011). The mechanism of SG RNA synthesis has been studied more 
extensively in plant than animal viruses (Chen et al., 2000; Miller et al., 1985; 
Schirawski et al., 2000) as a greater percentage of plant viruses produce SG RNAs. 
With their smaller genomes and efficient replication, plant viruses are often more 
amenable to the study of RNA replication mechanisms than animal viruses (Miller 
and Koev, 2000).  
The mechanism of norovirus SG RNA synthesis is currently unknown. There 
are however two widely accepted mechanisms for SG RNA synthesis predicted by 
analogy to other RNA viruses. The first is internal initiation (Figure 7.1). In this case, 
the viral RdRp binds at a promoter sequence/structure that is present internally in the 
negative strand G RNA produced during genome replication, and subsequently 
initiates positive strand SG RNA synthesis (Miller et al., 1985; Siegel et al., 1998; 
Sztuba-Solinska et al., 2011). It is possible that after internal initiation has occurred to 
produce newly synthesised VPg-linked SG RNA, this RNA may then be picked up by 
the viral replication machinery and replicated in a similar manner to the G RNA, 
effectively producing a negative strand SG RNA molecule. In vitro promoter mapping 
analysis using a panel of nested negative sense RNA templates that included the 
region before the start of ORF2, demonstrated that the RHDV RdRp requires 60 
bases upstream of the start of the SG RNA transcription start site in order to produce 
SG RNA (Morales et al., 2004). This finding indicates the existence of a promoter site 
upstream of the SG RNA start site that internally initiates the SG RNA synthesis on 
the negative strand G RNA. In the case of MNV, mutational analysis of an 
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evolutionarily conserved RNA stem loop structure using the available reverse 
genetics system has highlighted that the stability of this RNA structure is critical for 
MNV replication (Simmonds et al., 2008). Thus, such a structure was hypothesised to 
play a role as the putative SG RNA promoter for the synthesis of MNV SG RNA. 
 
 The second possible model for viral SG RNA synthesis implicates premature 
termination of the negative strand G RNA during genome replication (Figure 7.2). In 
this model, the elongation of negative strand G RNA by RdRp terminates at a stop 
signal in a region upstream of the start codon of ORF2 resulting in a subgenomic 
length negative strand RNA being produced (Sit et al., 1998; Sztuba-Solinska et al., 
2011). This subgenomic length of negative strand RNA then acts as a template for 
end-to-end positive strand SG RNA synthesis. 
 
By implementing the reverse genetics and the reporter RNA replicon systems 
that were developed during this study, this chapter was aimed to dissect the role of 
such a putative promoter for SG RNA synthesis of MNV.  
                 
Figure 7.1 Internal initiation mechanism of subgenomic RNA synthesis. Viral RdRp 
binds at the promoter sequence on the full length negative strand RNA and internally 
initiates the synthesis of positive strand VPg-linked subgenomic RNA. Red lines represent 
negative strand RNA (Adapted from Putics et al. 2010). 
 
             
Figure 7.2 Premature termination mechanism of subgenomic RNA synthesis. 
Elongation of negative strand template prematurely terminate at a region upstream of start 
codon ORF2, producing subgenomic length negative strand RNA which serves as a 
template for the synthesis of positive strand SG RNA. Red lines represent negative strand 
RNA. (Adapted from Putics et al. 2010). 
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7.2  Results  
7.2.1  Identification and characterisation of the potential norovirus 
 subgenomic RNA promoter 
 Previous work in the lab has shown that the MNV genome contains regions of 
highly structured and evolutionarily conserved RNA at the 5’ and 3’ extremities of the 
viral genome (Simmonds et al., 2008). The RNA secondary structure was also 
consistently detected exactly 6 nucleotides upstream of the SG RNA start site in all 
caliciviruses on both the positive (SL5018) and negative strand RNA (SLa5045) 
(Figure 7.3)(Simmonds et al., 2008). This observation implies that these RNA 
secondary structures may accommodate a functional role in viral SG RNA synthesis. 
Furthermore, the stem loop structure was generally found to be more stable on the 
negative strand genome (SLa5045) than the positive strand. Therefore, this small 
stem loop is illustrated on the negative strand in most cases in this chapter. 
 
A previous member of the group established an initial investigation on the 
functional role of this small stem loop structure prior to the start of this project. A 
mutant cDNA clone containing a series of non-coding mutations called m53 (Figure 
7.4) that destabilised the RNA structure was generated previously, as published by 
Simmonds et al., 2008. These mutations were designed to destabilise the stem loop 
structure by weakening the base pairing without affecting the NS7 coding sequence. 
 
 
Figure 7.3 Conserved RNA secondary structures upstream of the subgenomic 
transcript predicted by Alifold programme for the 5 calicivirus genera. The stable 
small secondary stem loop structure was consistently found 6 nucleotides upstream of the 
MNV SG RNA initiation site. The stem loop is shown in its antisense orientation 
(SLa5045). Grey filled boxes represents the SG RNA start site and black boxes represents 
the ORF2 initiation codon. The unpaired 6 nucleotides sequences between the predicted 
structure and the subgenomic start site are underlined (Figure is taken from Simmonds et 
al. 2008). 
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This mutated cDNA clone was used in the DNA-based reverse genetics system and 
reported to cause a lethal phenotype effect, whereby no infectious virus can be 
detected by TCID50 in the recoveries. However, by compensating the initial m53 
mutations to restore the base pairing within the stem loop structure (called m53r) 
(Figure 7.4), a viable virus was recovered with a titre close to that of the wild type 
virus. This series of experiments concluded that the RNA stem loop structure is 
important for viral replication and might function as part of the SG RNA promoter 
(Simmonds et al., 2008).  
 
7.2.2 Identification and characterisation of m53 mutant suppressor 
 and revertant viruses  
Even though the m53 mutation disrupting SLa5045 caused a lethal 
phenotype, serial “blind” passage of the recoveries (from the DNA based reverse 
genetics system) in RAW264.7 cells often produced viable viruses. Sequence 
analysis revealed that these viable viruses contained two types or classes of 
mutation. The first class were revertant viruses where nucleotide changes were 
identified that resulted in partial reformation of the stem loop structure. Figure 7.5 
summarises the nucleotide changes in the stem loop structure found in the revertant 
viruses. The ability to isolate revertant viruses that repaired the defective RNA 
structure was not unexpected as the stem loop structure is predicted to play an 
                               
    
Figure 7.4 The destabilisation and compensation mutations of the predicted SLa5045 
of MNV. The introduced non-coding mutation at position 5018, 5021 and 5025 (red fonts) 
called m53 mutations, caused a lethal phenotype to the virus while the compensatory 
mutations (blue fonts) m53r restored the replication and produced virus with yield closed 
to the wild type virus as observed by the DNA based MNV reverse genetics system. The 
RNA structure is shown in its antisense orientation. (Figure is adapted from Simmonds et 
al. 2008). 
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important role in viral replication. This observation indicates that the m53 mutation in 
the viral genome results in poor viral genome replication in tissue culture. Revertant 
mutations arise in tissue culture and those that promote replication are favoured and 
amplified during the serial “blind” passage until they become dominant. Another type 
of mutation observed were suppressor mutations, whereby the m53 mutation in the 
SLa5045 was still present, but changes outside the stem loop structure, within the 
NS7 coding region, were also identified. These suppressor mutations were subjected 
to further investigation (see characterisation as described in Section 7.2.3).  
 
7.2.3 Identification of individual revertants from a heterologous pool  
A number of viruses were identified (from serial “blind” passage of three m53 
recoveries) which, retained the m53 mutation (Y2, Y3, Y5 – Figure 7.5), yet they 
were able to replicate in tissue culture. However, further analysis including full 
genome sequencing of the virus population failed to detect any predominant changes 
outside the stem loop structure. The most likely explanation for this was that instead 
of generating a single revertant or suppressor, a mixed population of revertant or 
suppressor mutations was generated during a series of “blind” passages. Limiting 
dilution of the mixed population of viruses present in the Y2 isolate (Figure 7.5) 
allowed the isolation of single viral clones that were characterised by sequencing. 
The viruses in isolated wells with cytophatic effect were selected and amplified by 
                        
 
Figure 7.5 Identification of revertant and suppressor viruses from recoveries of m53 
mutation after a serial “blind” passage in RAW264.7 cells. Cells infected with viruses 
in supernatant from recoveries were subjected to RNA extraction, MNV-1 specific RT-
PCR and sequencing analysis around the SL5045 region. The blue colour font represents 
the wild type nucleotide while the red colour represents the m53 mutations nucleotide. 
Single asterisk indicates a m53 suppressor mutant viruses while double asterisk represent 
a revertant virus with nucleotide change at the other side of stem loop (nucleotide at 
position 5042 which base pairs with nucleotide at position 5021).  
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infecting RAW264.7 cells. Total RNA was extracted, subjected to RT-PCR and the 
region around the m53 mutation was sequenced. As previously seen, the Y2 virus 
population consisted of revertant viruses, which mutated to reform and stabilise the 
stem loop structure in their genome (Figure 7.8). More interestingly, we also found 
another two m53 mutation suppressor viruses, referred to herein as m53RevG and 
m53RevH. The m53RevH virus contains a single nucleotide change at position 4967 
from A to G (positive strand) / U to C (negative strand). This change did not result in 
any alteration of the amino acid sequence in NS7. The m53RevG carries a single 
nucleotide change at position 4914 from A to G (positive strand) / U to C (negative 
strand). This single change is adjacent to the alteration observed previously in 
m53RevA (at position 4922), both in the NS7 coding region. However, the mutation in 
the m53RevG results in a coding change in NS7, which changes a threonine to 
alanine at position 459 (Figure 7.8). The identification of a coding change in NS7 
region suggests that there might be a direct interaction between the stem loop region 
and the viral polymerase. However, at this stage it was still unknown whether the 
changes in the nucleotide or amino acid level were responsible for the phenotypic 
suppression of the m53 mutation. Further characterisations of these suppressor 
mutant viruses are detailed in a later section of this chapter (Section 7.2.5).  
 
Previous work in the lab had already identified one m53 mutation suppressor 
(m53RevA) which possessed a single non-coding mutation from U to C (on positive 
             
 
Figure 7.6 Individual revertant viruses from the heterologous pool obtained by 
limiting dilution.  Viruses mutated to partially re-form the initially destabilised stem loop 
structure are listed with a red colour background. Two m53 mutation suppressor viruses 
were also identified (listed in blue background), one of which (m53RevG)* changes 
amino acid threonine to alanine at position 459 in the peptide sequence of MNV NS7. 
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strand) / A to G (on negative strand) at position 4922 in the MNV genome 
(Karakasiliotis, 2008) (Figure 7.6a). Partial characterisation of this mutant virus, 
previously performed in the lab, indicated that this single nucleotide change when 
added into the m53 cDNA clone led to the production of virus. Preliminary data (from 
a mutli-step growth curve) indicated that this virus exhibits slower growth kinetics 
when compared to the wild type virus, while plaque assay showed that this virus has 
a small plaque phenotype (Karakasiliotis, 2008). In order to further characterise this 
m53 mutation suppressor virus, a single step growth curve assay was performed to 
examine the growth kinetics and protein expression profile of this mutant virus. As 
can be seen in Figure 7.6a, m53RevA exhibits slower growth kinetics compared to 
the WT virus. Furthermore, western blot analysis of NS7 and VP1 protein levels 
during infection was also performed (Figure 7.6b). The protein production of 
m53RevA virus was found to be reduced compared to that of the WT virus.  
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(a)  
(b)                         
(c)                         
                            
                              
Figure 7.7 Characterisation of suppressor mutant m53RevA virus. (a) Diagrammatic 
representation of RNA sequence and structure illustrating the position of single nucleotide 
change in suppressor mutant m53RevA virus at position 4922 in positive (U to C) and 
negative (A to G) strand RNA. The nucleotide changes for the m53 mutation are 
highlighted in red and the grey shaded sequence represents the unpaired 6 nts before the 
SG start site. (b) Single step growth curve of MNV-1 WT and m53RevA virus. 
RAW264.7 cells were infected at a m.o.i of 4 TCID50 per cell and virus was harvested at 
given time points by one freeze thaw cycle then subjected to TCID50 as described in 
Section 2.15. Assays were carried out in triplicate. The error bar represents standard 
deviation. (c) Western blot analysis of protein samples from WT and m53RevA virus 
infected RAW264.7 cells at given time points during the single step growth curve. All 
protein samples were prepared in RIPA as described in Section 2.20 and detected with 
NS7 and VP1 antisera. 
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From the western blot analysis, it was expected that both G RNA and SG 
RNA levels in m53RevA virus would also be produced at lower levels compared to 
the WT virus. To assess this, absolute quantification of RNA levels was performed 
using one-step real time quantitative PCR (RT-qPCR) (as described in Section 2.17). 
The RNA samples from the log phase of a single step growth curve were used as a 
template. The RT-qPCR analysis confirmed that the G RNA and SG RNA level of 
m53RevA were lower than the WT level during the log phase of growth kinetics 
(Figure 7.7a and 7.7b).  
 
(a) 
                             
 
(b) 
                              
 
Figure 7.8 Real time quantification of viral RNA using RT-qPCR assay. (a) G RNA 
quantification and (b) SG RNA quantification of viral RNA from WT and m53RevA virus 
infected RAW264.7 cells at a given time points. Absolute quantification was used in this 
one step RT-qPCR assay using primer set IGIC404 and IGIC491 for G RNA and IGIC65 
and 5722R for SG RNA as detailed in Table 2.1. Standards consisted of in vitro 
transcribed G RNA and SG RNA. Equal amounts of RNA samples for both viruses at 0, 6 
and 9 hour post infection (early and log phase) were used to quantify the G RNA and SG 
RNA level for each virus. The assay was carried out as described in Section 2.17 in 
triplicate for each RNA sample and the error bars represent standard deviation. Statistical 
differences (calculated by two-way ANOVA with Bonferroni post-tests) are represented 
by the P- values. P values of P<0.01 and P<0.05 are represented as ** and * respectively. 
Non-significant differences (P>0.5) are represented as ns. 
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 From all these assays (Figure 7.6 and 7.7), it can be concluded that the 
inclusion of the single nucleotide change at position 4922 is sufficient to compensate 
for the defect in the m53 virus. However this suppressor mutant, m53RevA, has a 
slower growth rate and slower protein production compared to the wild type virus. 
The mechanism by which this m53 suppressor mutant functions to restore the defect 
in the m53 virus is still unknown. Possible mechanism of suppression will be 
discussed later in this chapter. 
7.2.4 Analysis of the effect of m53 suppressor mutations on MNV 
 replication  
In order to confirm the m53 suppression phenotype, individual nucleotide 
changes were introduced into the WT and the m53 backbone of MNV-1 cDNA clone 
and the ability to recover virus from these cDNA using reverse genetics was 
examined. The RevA (U4922C) mutation was introduced into the WT backbone 
cDNA (a m53RevA construct was already available in the lab), while the RevG 
(A4914G) and the RevH (A4967G) were introduced into both the WT and the m53 
backbone cDNA constructs using overlapping PCR and standard cloning strategies 
as described in Section 2.1. The cDNA constructs were then subjected to the DNA 
based reverse genetics system. As can be seen in Figure 7.9, all the cDNA 
constructs allowed recovery of infectious virus except for m53, which was below the 
detection limit. The suppressor mutations in a WT backbone plasmid yielded a titre 
similar to that of the WT cDNA clone i.e. around 103 to 104 TCID50/ml (Figure 7.9 
upper panel). In the case of suppressor mutants in the m53 backbone, the virus 
yields were typically ~10 fold lower than that of the WT backbone mutant (Figure 7.9 
upper panel). Furthermore, western blot analysis of viral NS7 showed approximately 
comparable levels of transfection rates were achieved for all the reactions except for 
the WT (Figure 7.9 bottom panel). This observation also indicates that the individual 
coding changes in NS7 did not have a gross effect on the polymerase stability. 
Therefore, the difference in viral yield was assumed to be significant. Subsequently, 
all the recovered viruses from the DNA based reverse genetics system were 
amplified by infecting RAW264.7 cells in order to obtain a high titre stock of virus for 
use in viral yield assays. In addition, the viral RNA from all passage 1 viruses was 
sequenced and confirmed to carry the correct introduced mutation (data not shown). 
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A virus yield assay was then carried out by infecting the RAW264.7 cells at a 
m.o.i of 0.01 TCID50 per cell. Viruses were harvested at 24h and 48h post infection 
and the protein samples from the respective infected cells were also prepared at the 
given time point to examine the expression of the NS7 protein. The western blot 
analysis shows that the expression of NS7 from WTRevA and WTRevH was slightly 
higher when compared to their counterpart viruses in m53 backbones (m53RevA and 
m53RevH) viruses (Figure 7.10a and 7.10b, bottom panel). This observation 
indicates that the protein expression in m53 suppression viruses is slower compared 
to the mutant in WT backbone viruses. In RevG however, the protein expression in 
m53 backbone was slightly higher compared to WT backbone virus at both 24 and 48 
h.p.i.  
Data from the TCID50 assay demonstrated that mutant viruses in the WT 
backbone produced a comparable virus yield to WT virus at 24 and 48 h.p.i (except 
for the WTRevG at 24 h.p.i) (Figure 7.10a and 7.10b, top panel). A typical TCID50/ml 
viral yields of WT virus at 24 and 48h post infection was ~107 and ~108 respectively. 
In contrast, infection of mutant viruses in m53 backbone produced ~0.5 to ~1.0 log 
                                
Figure 7.9 Recovery of m53 mutation suppressor viruses with single nucleotide 
changes upstream of SLa5045. The cDNA based reverse genetics was carried out by 
transfecting the WT and m53 backbone of suppressor mutant cDNA into BSR-T7 cells as 
described in Section 2.13.1. WT MNV-1 and m53 full length infectious cDNA clones were 
used as controls. The m53RevA cDNA was constructed previously. The recovered viruses 
were harvested at 48h post transfection and subjected to TCID50. The cell lysates from 
transfected cells were prepared in RIPA buffer and subjected to western blot analysis 
against NS7. The top panel figure is the graph that illustrates the titre of the recovered 
viruses represented as log10 TCID50/ml. The ticked line across the graph represents the 
TCID50 detection limit and error bars represent the standard deviation. Statistically 
significant differences compared to the WT recovery titre (calculated by one way ANOVA 
with Tukey’s post test) are represented by the P-value of P < 0.05 (*) whilst non-
significant differences are represented by ns. The lower panel figure represents western 
blot analysis of the corresponding protein samples.  
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less virus compared to WT virus at 24 and 48h post infection (Figure 7.10a). This 
observation indicates that single nucleotide changes at specific position in viral 
genome were able to suppress the lethal phenotype of m53 SLa5045, producing a 
slower replication rate virus compared to WT virus. This observation was expected 
as previous characterisation for m53RevA virus showed that this m53 mutation 
suppressor virus produced a slower growth kinetics, protein production and viral RNA 
replication. Furthermore, all mutant viruses in m53 backbone also produced a lower 
virus yield compare to their respective mutant in WT backbone at both time points in 
the virus yield assay.  
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(a)                                                  
                           
 
(b) 
 
    
 
Figure 7.10 Virus yield assay of suppressor mutation viruses in the WT and the m53 
backbone. (a) Upper panel: Titre of viruses at 24h post infection. Bottom panel: Western 
blot analysis of corresponding protein samples from the infected cells. (b) Upper panel: 
Titre of viruses at 48h post infection. Bottom panel: Western blot analysis of 
corresponding protein samples from the infected cell. RAW264.7 cells were infected with 
suppressor mutant viruses (in WT and m53 backbone), which were recovered previously 
from the cDNA based reverse genetics system at m.o.i of 0.01 TCID50 per cell. WT virus 
was used as a positive control. The viruses were harvested at the given time points and 
subjected to the TCID50 as described in Section 2.15. The titre of virus is represented by 
log 10 TCID50 and the error bars on the graphs represent standard deviation. Statistical 
differences compared to the WT virus titre (calculated by one way ANOVA with Tukey’s 
post test) are represented by the P-values of P < 0.001 (***) and P < 0.05 (*) whilst the 
non significant differences (P > 0.05) are represent by ns. The cell lysates from 
corresponding infected cells were prepared in RIPA buffer and subjected to western blot 
analysis against NS7 and GAPDH. 
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From the virus yield assay above, it can be concluded that these specific 
single nucleotide changes in the WT backbone do not appear to affect viral 
replication. The suppressor mutations are not dominant in a WT background as they 
function in the presence of a WT or mutant SLa5045. The same changes in the 
context of m53 backbone however, were necessary and sufficient to suppress the 
m53 lethal phenotype.  
7.2.5 Characterisation of the sequence determinants at position 4922 
 and 4914 required for suppression of m53 mutation  
 The identification of the m53 mutation suppressor viruses with either coding 
or non-coding nucleotide changes in the NS7 region raised several questions: 1) Is 
the amino acid change in NS7 or the nucleotide change responsible for the 
suppressor phenotype; 2) Are other sequence changes at positions around 
nucleotides 4922 and 4914 able to suppress the m53 mutations. In order to address 
this question, the phenotypic m53 mutation suppressor viruses (m53RevA and 
m53RevG) were used as a guide in order to generate a panel of synonymous and 
non-synonymous mutations within the respective region, to gain a better insight into 
the mechanism of action of these suppressor mutations. The work in this section was 
carried out in conjunction with an MSc student under my direct supervision, Mr. Guo 
Zhang.  
7.2.5.1 Reverse genetics recovery of m53 suppressor mutant viruses with 
 synonymous  nucleotide changes at position 4922  
 The discovery of the m53 mutation suppressor, m53RevA, which carries a 
single non-coding nucleotide change in the NS7 region demonstrates that the MNV 
replication machinery possesses the ability to restore replication caused by mutations 
introduced in SLa5045. This phenotypic suppression caused by non-coding 
nucleotide substitutions upstream of the predicted promoter region is suggestive of 
long-range RNA-RNA interactions. Two additional mutants were generated at 
position 4922 by changing the original U nucleotide without affecting the alanine 
coded at position 461 in NS7. Mutants m53 U4922A and m53 U4922G (Table 2.2) 
were generated by site directed mutagenesis in order to examine the specificity of 
the silent mutation that suppresses the defect in m53 mutated SLa5045. Equivalent 
mutants in the WT backbone were also generated to examine if they had any 
dominant negative effect on viral replication ie. Viral replication is inhibited in the 
absence of the m53 mutations in SLa5045. Western blot analysis against virally 
encoded NS7 and NS5 suggested that equal transfection efficiencies were achieved 
from all the respective transfected cDNA plasmids (Figure 7.11 bottom panel). As 
high as 1.52 X 104 TCID50/ml viruses were rescued from WT (positive control), but 
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not from a cDNA clone carrying a frame-shift in the viral NS7 region (FS) or from the 
cDNA carrying the m53 mutations (Figure 7.11, top panel). Typical titres of WT virus 
from DNA based reverse genetics were also obtained from WT backbone mutant 
recoveries with ~104 TCID50/ml for both mutants (WT U4922C and WT U4922G). 
However ~1 log10 less virus (~103) was rescued from WT U4922A compared to WT. 
In contrast, only two m53 backbone mutants (m53 U4922C and m53 U4922A) were 
able to produce infectious virus in the recoveries and their titres were 9.57 X 102 and 
7.03 X 101 respectively. No infectious virus was recovered from m53 U4922G. Thus, 
these results indicated that the defect in replication caused by the m53 mutations in  
SLa5045 stem loop could be suppressed by the U4922C and U4922A mutations, but 
not the U4922G mutation.  
 
From this data it can be concluded that the nucleotide at position 4922 must 
be either a C or A (and not U or G) in order to suppress the defect in the m53 
mutated SLa5045 stem loop and therein restore virus replication. On the negative 
strand, a G (non-functional) can base pair with a C whereas a C or A (functional) 
cannot. If these were working on the negative strand then a U or G would be an A or 
                                                
                                                                
 
Figure 7.11 Recovery of synonymous 4922 mutants in the WT and m53 backbone 
using the cDNA based reverse genetics system. cDNA based reverse genetics was 
carried out as described in Section 2.13.1. Plasmids were transfected into BSR-T7 cells 
and viruses were harvested at 48 hours post transfection. The titres were determined by 
TCID50 (upper panel). The ticked line across the graph represents the TCID50 detection 
limit and error bars represent standard derivations. Corresponding cell lysates from 
transfected cells were prepared in RIPA buffer and equal amounts loaded onto SDS 
PAGE gels for western blot analysis using antisera against NS7 and NS5 (bottom panel) 
to examine transfection efficiency. WT full length MNV-1 infectious cDNA clone and 
POLFS were used as positive and negative controls respectively. m53, WT U4922C and 
m53 U4922C were the other controls.  
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C (non-functional) and a C or A would be a G or U (functional). Therefore in the 
positive strand RNA the non-functional suppressor mutations are able to base pair 
with C whereas in the negative strand, the functional suppressor mutations are able 
to base pair with a C. This observation indirectly implicates that the SLa5045 likely 
functions as a promoter on the negative strand RNA.  
7.2.5.2 Reverse genetics recovery of m53 suppressor mutant viruses with 
 nucleotide changes at position 4914 and 4915  
 The mutant suppressor virus m53RevG (A4914G) as identified in Section 
7.2.3 has a mutation at nucleotide position 4914 changing A (adenine) to G 
(guanine). This nucleotide change affected the NS7 amino acid sequence, changing 
threonine (ACT) to alanine (GCT) at amino acid position 459 in the mature protein. 
This change was of particular interest as the amino acid sequence change in the 
NS7 may potentially influence its interaction with viral RNA during replication, 
resulting in phenotypic suppression of the m53 mutation. Therefore, five additional 
mutants were generated by site directed mutagenesis within the m53 backbone to 
change the threonine to other amino acid apart from alanine (Table 2.2). These 5 
mutants were engineered to examine whether the amino acid change in NS7 or only 
the nucleotide change suppresses the m53 mutation in SLa5045. These mutants 
were designed to encode different amino acids for NS7 at position 459 by altering the 
nucleotides at positions 4914 and 4915 in ORF1 of the MNV genome (Table 2.2). As 
a control, five WT backbone mutants that contain the same mutations were 
generated to determine if these mutations (coding changes in NS7 at 459) had any 
effect on replication of the WT virus. All cDNA plasmids were confirmed to contain 
the correct engineered mutations by sequencing analysis and restriction enzyme 
digestion (data not shown). Subsequently, all these plasmids were used in the DNA 
based reverse genetics system in order to recover the mutant viruses, as described 
in Section 2.13.1. 
 The efficiency of transfection was first examined by western blot analysis of 
the transfected cell lysates for NS7. Figure 7.12 shows that the NS7 was expressed 
from all transfections except POLFS (negative control) and m53Mut 5. The inability to 
detect the NS7 expression from the m53Mut 5 transfected cell lysate sample was 
unexpected. Therefore a second western blot analysis was carried out to detect the 
presence of VPg protein in order to ensure that the NS7 protein was in fact not 
expressed from BSR-T7 transfected cells. The western blot analysis showed that 
VPg for m53Mut 5 was undetectable also (Figure 7.12). The same observation was 
obtained in repeat experiments for this plasmid. This observation was presumably 
due to the mutations that may have occurred outside of the cloned section which 
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affect the expression of viral proteins. Therefore, this mutant was excluded from the 
subsequent analysis. 
 WT Mut 1-4 and m53Mut 1-4 viruses were harvested at 48h post transfection 
of respective plasmids into BSR-T7 cells and subjected to TCID50. The virus yields 
for mutant viruses in WT backbone and m53 backbone were compared (Figure 7.13). 
As expected, transfection of POLFS and m53 cDNAs resulted in no infectious viral 
recovery whereas WT cDNA produced a typical virus titre of ~104 TCID50/ml. 
Recovery of all mutant viruses in WT backbone, namely WT A4914G, WT Mut1, WT 
Mut2, WT Mut3 and WT Mut4 yielded titres of 3.96 X 103, 8.23 X 103, 1.93 X 103, 
2.58 X 103 and 2.69 X 103 TCID50/ml respectively (Figure 7.13 bottom panel). The 
titres for WT A4914G and WT Mut 1-4 were similar to those of the WT virus, 
suggesting that the introduced mutations did not dramatically affect viral replication in 
the absence of the m53 mutations, at least in tissue culture. In contrast, only three 
mutant viruses in m53 backbone were rescued. They were m53RevG, the naturally 
occurring suppressor mutant virus identified previously, m53Mut1 (A4914G, C4915T) 
and m53Mut2 (A4914G, C4915A) with titres of 2.69 X 102, 7.95 X 101 and 7.95 X 101 
                     
                       
                                                                                             
 
Figure 7.12 Western blot analysis of protein samples obtained from cells transfected 
with the m53 suppressor mutant cDNAs with various nucleotide changes at position 
4914 and 4915. Upper panel: Western blot analysis of protein samples from the DNA 
based reverse genetics system. Cell lysates from plasmid transfected BSR-T7 cells were 
prepared in RIPA buffer at 48h post transfection as described in Section 2.20. The virally 
encoded NS7 and NS5 were targeted by using respective antisera during the detection. 
Bottom panel: The name and the description of each mutant plasmid used in the recovery 
system. The nucleotide T in the cDNA is equivalent to U in the context of RNA. The bold 
and underlined fonts highlight nucleotide changes.  
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TCID50/ml respectively (Figure 7.13 bottom panel). The titre of these mutant viruses 
in the m53 backbone was ~100 fold less compared to the titre of WT virus.  
 
 By comparing the titre of recovered mutant viruses in WT backbone and m53 
backbone to the titre of WT virus, several conclusions can be drawn on the affect of 
specific mutations. Firstly, all the introduced mutations at position 4914 and 4915 that 
altered the coding capacity of amino acid at position 459 of the NS7 in WT backbone, 
did not affect the replication of these viruses in tissue culture. This observation 
indicates that an amino acid change at position 459 in NS7 presumably does not 
critically affect the function of NS7 or that changing threonine 459 to alanine, valine 
or asparagine is well tolerated. As for the mutations in the m53 backbone, in addition 
to m53RevG, only m53Mut 1 and m53Mut 2 were able to produce detectable 
infectious virions in recoveries from reverse genetics (Figure 7.13). Recoveries from 
m53Mut3 and m53Mut4 did not produce any detectable virus as shown by the 
TCID50 data (Figure 7.13).  
                   
 
Figure 7.13 The cDNA based reverse genetics recovery of mutant viruses with 
nucleotide changes at position 4914 and 4915. Plasmids were transfected into BSR-T7 
cells as detailed in Section 2.13.1. Recovered viruses were harvested at 48h post 
transfection and subjected to TCID50 assay to determine the yield, as described in Section 
2.15. The ticked line across the graph represents the TCID50 detection limit and the error 
bars represent standard derivation. The name, description and titre of each mutant virus is 
presented in the table. The nucleotide T in the cDNA is equivalent to U in the context of 
RNA. The bold and underlined fonts highlight nucleotide changes.  
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 According to their biochemical amino acid properties (being small and 
hydrophobic), alanine (GCT) and valine (GTT) are closely related. Therefore, it was 
predicted that the amino acid change from alanine (in m53RevG) to valine in m53Mut 
1 produced a similar suppression effect on the m53 defect. In contrast, the amino 
acids alanine and aspartic acid are very different in their characteristics. Aspartic acid 
is acidic, charged and polar while alanine is neutral. Despite these differences, the 
substitution of this amino acid at position 459 (as in m53Mut 2) was still able to 
suppress the m53 mutated SLa5045. From these observations, it can be suggested 
that the phenotypic suppression of the m53 mutation in SLa5045 (as obtained for the 
m53RevG mutant virus) is not greatly influenced by the coding specificity of the 
amino acid at position 459 in NS7. The suppression effect in this case is more likely 
due to the nucleotide changes at position 4914. This fact is also supported by the 
observation that the m53Mut 3 and m53Mut 4 recoveries did not yield any detectable 
infectious virions. Although the newly encoded amino acids i.e.; glycine and serine in 
m53Mut 3 and m53Mut 4 respectively share similar characteristics with alanine, their 
substitution at position 459 in NS7 did not have any suppressive effect on the 
accompanying m53 mutation. Table 7.1 summarises the effect of nucleotides 
substitutions at position 4914 and 4915 (which also alter the amino acid coding) on 
the recovery of m53 backbone mutant viruses. To summarise, in order for these 
mutants to suppress the defect in the m53 mutated SLa5045 stem loop, the 
nucleotide at position 4914 must be a G, while at the same time the nucleotide at 
position 4915 must be A, U or C. 
 
 From these observations, it can be concluded that the nucleotide changes in 
m53RevG were responsible for the m53 mutation suppressor effect, not the resulting 
Mutant Nucleotides at 
position 4914-4916 
Amino acid Virus 
rescued 
WT ACU Threonine Yes 
m53RevG GCU Alanine Yes 
m53Mut 1 GUU Valine Yes 
m53Mut 2 GAU Aspartic acid Yes 
m53Mut 3 GGU Glycine No 
m53Mut 4 UCU  Serine No 
 
Table 7.1 Summary of the effect of nucleotide substitutions at position 4914 and 4915 
in the m53 backbone on the recovery of mutant viruses using DNA based reverse 
genetics system. Each of the generated mutant plasmids were transfected into BSR-T7 
cells in the DNA based reverse genetics system. The ability to rescue virus was 
determined by TCID50 assay. Highlighted in bold are the mutant viruses with m53 
suppression characteristics.  
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amino acid change within the NS7 region. However, the mechanism by which these 
nucleotide changes upstream of the SLa5045 region to suppress the lethal 
phenotype of m53 still remain to be investigated. It is possible that these nucleotide 
changes alleviate or restore a long range RNA-RNA interaction within the MNV 
genome, with which the SLa5045 plays an important role in promoting the synthesis 
of SG RNA. Possible mechanisms by which these may function are discussed later. 
7.2.6 Characterisation of the role of SLa5045 in MNV replication using 
 the MNV replicon 
To further investigate the role of SLa5045 and to determine if the defect in 
viral replication observed caused by the m53 mutations affected subgenomic RNA 
synthesis, the reporter replicon system (described in Chapter 6) was employed. The 
expression of Renilla luciferase gene (as VP2 fusion protein) in the reporter replicon 
system was used as a quantitative measure of SG RNA synthesis as translation of 
the Renilla-2A-VP2 fusion is dependent on the generation of the viral subgenomic 
RNA. In order to generate the reporter tagged constructs for m53, m53r and 
m53RevA, the respective mutations were cloned into the RL2A-VP2WT plasmid 
backbone and then used in both DNA and RNA based replicon assays as described 
below. 
For the DNA based replicon assay, the RL2A-VP2 reporter gene in WT, 
POLFS, POL-, m53, m53r and m53RevA backbone plasmids were transfected into the 
BSR-T7 cells as described in Section 2.13.1. The cell lysates were harvested at 
various time post transfection and subjected to Renilla luciferase assay as described 
in Section 2.21. Comparable levels of NS7 in all transfections, as detected by 
western blot, indicated that the plasmids were transfected at approximately the same 
efficiency (Figure 7.14b). The replication rate of each construct is represented by the 
Renilla luciferase signals at a given time point in Figure 7.14a. As observed 
previously in Chapter 6, the transfection of WT reporter tagged cDNA resulted in time 
dependent increase in the expression of Renilla luciferase due to viral replication. 
POLFS and POL- constructs were used as replication incompetent controls and as 
expected produced lower luciferase signals compared to WT construct. The 
difference in luciferase signals observed between POLFS and POL- was presumably 
due to an internal reinitiation of translation in POL- as discussed in Chapter 6. As 
discussed in Chapter 6, the production of luciferase from replication incompetent 
MNV replicons is suggestive of low level translation re-initiation at the NS7 stop – 
VP1 start junction. This has previously been described for bovine norovirus only 
(McCormick et al., 2008). 
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For the m53 reporter construct, the luciferase signal obtained was similar to 
that obtained for POLFS (Figure 7.14a). Since the majority of the luciferase protein 
produced from the MNV reporter constructs is translated from the SG RNA, the low 
luciferase signal produced from m53 suggests that the defect in SLa5045 RNA 
structure had abrogated the synthesis of the SG RNA and further blocked the 
efficient genome replication. Interestingly, the luciferase signal for m53 was less than 
the levels seen for the POL- in this assay. This observation alone might suggest that 
the stem loop somehow contributes to the reinitiation of translation at the NS7-VP1 
junction. This could have been tested by looking at these mutations in the context of 
a POL- background. This function of the stem loop would occur on the positive strand 
only and it might therefore suggest that the stem loop plays a dual role i.e. On the 
positive strand it contributes to translation termination-reinitiation at the NS7-VP1 
junction whilst on the negative strand RNA it functions as part of the SG RNA 
promoter. From the assay in Figure 7.14, in the case of m53r and m53RevA reporter 
constructs, their Renilla luciferase signals are substantially higher than m53 and 
closer to the WT signal with the m53RevA luciferase signal was ~2 fold lower than 
the WT. This observation correlates to the viral yield obtained from the reverse 
(a)   
             
(b)  
              
 
Figure 7.14 Analysis of replication kinetics for m53, m53r and m53RevA in Renilla 
luciferase (RL2A-VP2) constructs using cDNA based reverse genetics system. (a) 
Time course analysis of Renilla luciferase activity of MNV reporter tagged constructs in 
transfected cells. Plasmids were transfected into BSR-T7 as detailed in Section 2.13.1. At 
the given time points, the transfected cells were harvested and lysed in RLB and subjected 
to luciferase assay as described in Section 2.21. The error bars represent standard 
deviation and the luciferase activity was measured as relative luminescene unit (RLU). (b) 
Western blot analysis of the transfected reporter tagged cDNA plasmids by targeting the 
virally encoded NS7 protein. The cell lysates were prepared in RIPA buffer at 24h post 
transfection and analysis was carried out as described in Section 2.20.  
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genetics system for both m53r and WT construct as reported previously where the 
recovery of m53r was only found to be ~1 log lower to that of WT from the reverse 
genetics system (Simmonds et al., 2008). Furthermore, the characterisation of 
m53RevA virus in the earlier section (Section 7.2.2) of this chapter demonstrated that 
this mutant virus has a slower growth rate and lower protein production compared to 
the WT virus. These characteristics are also in agreement with the luciferase signals 
obtained from the m53RevA reporter construct where it was ~2 fold less compared to 
the WT sample (Figure 7.14a). 
 To further examine the role of Sla5045 in the replicon system, we used he 
RNA based transfections as described in Section 2.13.2. Transfection of the m53, 
m53r and m53RevA in vitro transcribed and enzymatically capped reporter tagged 
RNA produced the same Renilla luciferase signal pattern throughout the time course 
as observed in the cDNA based reverse genetics system above (Figure 7.15a). In 
this RNA based system, the transfected cell lysates were prepared at early (6h), log 
(24h) and late (48h) phase post transfection and subjected to luciferase assay as 
described in Section 2.21. Western blot analysis showed that there were comparable 
NS7 levels in all the transfected cells indicating that the transfection efficiencies were 
almost the same (Figure 7.15c). Transfection of in vitro transcribed and enzymatically 
capped reporter tagged RNA produced a peak luciferase activity at 24h post 
transfection. In the cDNA system, the peak luciferase activity was typically observed 
at 48h post transfection during the time course. A more clear representation of the 
luciferase signal pattern is demonstrated in Figure 7.15b. These luciferase signals 
were obtained from the RNA transfected cell lysates prepared at 24h post 
transfection. Whilst the low level of luciferase from the m53 sample was similar to 
that obtained from replication defective controls (POLFS and POL-), the luciferase 
signal from m53r sample confirmed that the intact SLa5045 structure is presumably 
required in order to achieve an efficient viral SG RNA synthesis (Figure 7.15b). Using 
this RNA based replicon system however, we did not observed the same difference 
between the POL- and POLFS as observed in the DNA based system above. This 
was probably due to the difference between transfection of DNA and capped RNA 
used as discussed in Chapter 6. In DNA transfection, the transfected construct is 
being transcribed, producing the RNA then followed by translation of proteins which 
explains the delayed luciferase production. The presence of transfected DNA plasmid 
which is more stable (compared to the RNA) in cells may also result in more RNA 
transcripts being produced and translated, and thus explains the difference between 
luciferase levels for POL- in the DNA and RNA based replicon systems.  
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(a)  
                        
(b)  
                        
(c) 
                            
Figure 7.15 Analysis of replication kinetics for m53, m53r and m53RevA in Renilla 
luciferase (RL2A-VP2) constructs using RNA based reverse genetics system. (a) Time 
course analysis of Renilla luciferase activity from in vitro transcribed reporter tagged 
RNA transfected cells. The in vitro transcribed and enzymatically capped RNA prepared 
from WT, POLFS, POL-, m53, m53r and m53RevA cDNA templates were transfected into 
BSR-T7 cells as detailed in Section 2.13.2. At the given time points, the transfected cells 
were harvested and lysed in RLB and subjected to luciferase activity measurement as 
described in Section 2.21. The error bars represent standard deviation the luciferase 
activity was measured as relative luminescene unit (RLU). (b) Renilla luciferase assay 
from RNA transfected cell lysates prepared at 24h post transfection. Statistical differences 
of luciferase activities compare to the WT activity (calculated by one way ANOVA with 
Tukey’s post test) are represented by the P-values of P < 0.001 (***) and P < 0.05 (*). (c) 
Western blot analysis of the transfected reporter tagged RNAs by targeting the virally 
encoded NS7 protein. The cell lysates were prepared in RIPA buffer at 24h post 
transfection as described in Section 2.20. 
 Amir Yunus PhD Thesis 2012 
199 
 From the data obtained in both DNA and RNA based replicon systems above 
using the relevant reporter tagged constructs, it can be concluded that the lethal 
phenotype observed for m53 recoveries in the previous study (Simmonds et al., 
2008) was in fact due to the impaired SG RNA synthesis.  
7.2.7 Characterisation of double SLa5045 mutant viruses  
 Due to its position in the coding region of the MNV genome, it is difficult to 
mutate the SLa5045 without affecting the NS7 coding sequence. This therefore 
makes full mutational analysis of the structure impossible. Only three nucleotide 
changes at the lower 7-nucleotide stem, which destabilised the RNA structure in the 
m53 mutant, were permitted in order to maintain the amino acid sequence 
conservation of NS7 (Figure 7.4). Even though the ability to recover infectious virus 
from the compensation mutation (m53r) implied that the RNA structure itself is 
essential rather than the primary sequence for the functionality, the role of other 
features within SLa5045 was still elusive. For instance, the conservation of a 6 
nucleotide spacer region between the SLa5045 and the SG RNA initiation site, the 
importance of the loop sequence, the terminal stem base pair and the polarity of the 
functional structure, could not be dissected by mutagenesis study due to the need to 
preserve the amino acid sequence of NS7.  
7.2.7.1 Generation of double SLa5045 mutant constructs 
 To overcome the limitations mentioned above, a second identical SLa5045 
sequence namely SLa5045*2 was introduced downstream of the NS7 coding region 
in the MNV genome (Figure 7.16b). This SLa5045*2 sequence, which includes the 
introduced 6 unpaired nucleotides, the SG RNA initiation site and the NS7 stop 
codon, was designed to be inserted exactly after the authentic NS7 stop codon by 
introducing a unique Cla I restriction site (Figure 7.16a). Details on the cloning 
strategies to generate this mutant construct are described in Section 2.1. In total, 4 
double SLa5045 cDNA constructs were successfully generated (Figure 7.16c). The 
WT-WT construct was designed to examine whether the insertion of extra SLa5045 
would affect the viral replication. Other constructs (WT-m53, m53-WT and m53-m53) 
were made to test whether the second introduced stem loop sequence could function 
as promoter for SG RNA synthesis. 
 Amir Yunus PhD Thesis 2012 
200 
 
 
(a) 
 
(b) 
 
(c) 
                                      
Figure 7.16 Generation of double SLa5045 mutant cDNA clones. (a) Schematic 
representation of the double SLa5045 mutant cDNA construct. The authentic stem loop 
sequence (SLa5045) is depicted as black box (position 5018 – 5045) while the introduced 
stem loop sequence (SLa5045*2) is represents by the blue box (position 5081 – 5108). 
Note that the sense strand is shown in the 5’ to 3’ orientation. The blue colour font 
represents the introduced DNA sequence into the infectious MNV cDNA clone facilitated 
by the introduced Cla I site (underlined sequence). (b) Schematic representation to 
illustrate the RNA secondary structure from the double SLa5045 mutant cDNA clone on 
the negative sense RNA strand. The number next to the nucleotide of the stem loop 
represents the nucleotide position in MNV genome on the antisense polarity (3’ to 5’). 
The grey highlighted font represent the conserved 6 nucleotide distance of stem loop 
structure from the SG RNA initiation site. The green and orange colour font for ATG 
represents the authentic and the introduced start codon for VP1. Both stem loop structures 
in this figure representing the WT sequence. The m53 mutant stem loop (Figure 7.4) 
contains nucleotide substitution at position 5018, 5021 and 5024 (for SLa5045) or at 
position 5081, 5084 and 5087 (for SLa5045*2). (c) The name and description of the 
double SLa5045 mutant constructs generated. Two cDNA constructs with WT and m53 
SLa5045 were used to generate 4 double SLa5045 mutant construct with either WT or 
m53 SLa5045*2 as an introduced stem loop.  
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7.2.7.2 WT SLa5045*2 is required for SG RNA synthesis and viral 
 replication 
 The RNA based reverse genetics system was employed in order to examine 
the ability of each double SLa5045 mutant clone to produce infectious virus. The 
same amount of in vitro transcribed and enzymatically capped RNA generated from 
the respective cDNA clones were transfected into the BSR-T7 cells as described in 
Section 2.13.2. Cell lysates were prepared at 24h post transfection for western blot 
analysis. Supernatants containing recoveries from the transfected cells were 
harvested and subjected to TCID50 assay as described in Section 2.15. Comparable 
levels of NS7 expression were observed by western blot analysis indicating that all 
the RNAs were successfully transfected into the BSR-T7 cells with approximately the 
same efficiency (Figure 7.17b, bottom panel). Interestingly however, there was 
slightly difference in the NS7 signal from Ψ1, where 2 different size NS7 protein 
bands were detected. This presumably an artefact of introducing a stable stem loop 
structure downstream of the stop codon which affected translation termination 
efficiency. This would also implicate a role of the stem loop (in positive strand RNA) 
in translation-reinitiation. From the TCID50 data obtained, the transfection of WT 
RNA as a positive control, produced a typical yield of infectious virus of ~105 
TCID50/ml. As expected, transfection of POLFS and m53 RNA did not produce any 
detectable virus by TCID50 (Figure 7.17b, top panel). In the case of double SLa5045 
however, only the transfection of Ψ1 (WT-WT) and Ψ3 (m53-WT) RNA transcripts 
produced detectable infectious virus. The titre of each recovery was lower than that 
of the WT clone at ~5 X 102 and ~3 X 102 TCID50/ml respectively (Figure 7.17b, top 
panel).  
 The fact that the m53SLa5045*2 in Ψ2 and Ψ4 did not produce any infectious 
virions in the recoveries from the RNA based reverse genetics system implies that 
the WT version of SLa5045*2 is required for viral replication. The WTSLa5045*2 
presumably compensates for the defect in the authentic SLa5045 (m53 SLa5045 in 
Ψ3) and potentially acts as a substitute promoter for SG RNA synthesis in the 
duplicate background viral genome. However, the lower titre observed from the 
recoveries of Ψ1 and Ψ3 suggests that the introduction of the extra sequences into 
the viral genome presumably affects the authentic viral replication. Importantly 
however, the second copy of SLa5045 was functional when placed in the non-coding 
region therefore allowing further mutational analysis of the structure. 
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 All the supernatants containing recoveries from the RNA based reverse 
genetics assay above were amplified in RAW 264.7 cells. Figure 7.17c represents 
the titre obtained from passage 1 viruses. There was an ~0.5 log10 increase 
observed in the titre for the Ψ1(WT-WT) and Ψ3(m53-WT) viruses. The Ψ2(WT-m53) 
(a)     
                                     
(b) 
                         
(c) 
                                 
Figure 7.17 Recovery of infectious double SLa5045 mutant viruses using RNA based 
reverse genetics system. (a) In vitro transcribed and enzymatically capped RNA 
generated from the respective double SLa5045 cDNAs used in RNA based reverse 
genetics system. (b) Recovery of mutant viruses using the RNA based reverse genetics 
system. Top panel: TCID50 of recovered viruses. Equal amount of in vitro transcribed 
RNA generated from the respective mutant cDNA were transfected into the BSR-T7 cells 
as described in Section 2.13.2. Viruses were harvested at 24h post transfection and 
subjected to TCID50 assay. Bottom panel: Western blot analysis of the respective cell 
lysate samples targeted against NS7. The cell lysates were prepared in RIPA buffer at 24h 
post transfection as described in Section 2.20 (c) TCID50 analysis of passage 1 viruses in 
RAW264.7 cells. The rescued viruses obtained from the RNA based reverse genetics 
system were subjected to amplification by infecting RAW264.7 cells. Once the cytophatic 
effect (c.p.e) were observed, the viruses were harvested by one freeze thaw cycle and were 
precleared by filtration before subjected to TCID50 assay.  
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and Ψ2(m53-m53) however, did not produce any detectable infectious virions by 
TCID50 even after 2 blind passages in tissue culture (data not shown). Sequence 
analysis of passage 2 viruses (Ψ1 and Ψ3) found that the introduced SLa5045*2 was 
stable and tolerated. This observation partially implies that the mutant viruses could 
tolerate the introduced extra sequence into the viral genome for up to two passages 
in tissue culture.  
7.2.7.3 Further characterisation of the SLa5045*2 by mutagenesis 
 Even though the introduced WTSLa5045*2 was found to reduce the authentic 
viral replication (in Ψ1), this introduced mutation was stable in the viral genome (for 
up to 2 passages) and was able to functionally compensate the defect in the 
authentic SLa5045 (m53SLa5045 in Ψ3) (Figure 7.17b). Since it is located outside 
the NS7 coding region, more mutations could be introduced within this SLa5045*2 
and used to represent the SG RNA promoter. To further examine various aspects of 
the SLa5045 structure required for its function as part of the promoter for SG RNA 
synthesis, a panel of mutant cDNA clones were generated using the Ψ4(m53-m53) 
cDNA as a template. By taking advantage of the introduced unique Cla I restriction 
site that was introduced into the Ψ4 plasmid previously, the standard cloning strategy 
was carried out by using various forward mutagenesis primers and reverse primer 
6034R (Table 2.1) to introduced the respective mutations by PCR amplification 
(Figure 7.18a). These PCR products were cloned into the Ψ4 background plasmid by 
employing the unique Cla I and Sac II sites. This panel of mutant constructs (Figure 
7.18a) were designed to probe various aspects of SLa5045 structure required for 
viral replication in tissue culture as listed below : 
(1) The Ψ4 – m53r mutant construct was designed to examine whether the 
compensatory mutations, which restore the formation of destabilised SLa5045*2 
(m53SLa5045*2), could restore the viral replication in the duplicate construct. Note 
that in the previous published study, the compensation of m53 mutation in the 
authentic SLa5045 (m53r) resulted in the restoration of the viral replication in tissue 
culture (Simmonds et al., 2008). Furthermore, these compensatory mutations also 
confirmed that the functional stem loop is structurally dependent rather than the 
primary sequence (Simmonds et al., 2008). Therefore, this construct was generated 
to recreate the m53r sequence in the duplicate SLa5045.  
(2) Since the SLa5045 is invariably situated 6 nucleotides upstream of the SG RNA 
initiation site among caliciviruses (Figure 7.3), the importance of this distance 
conservation was examined using a duplicate background construct by insertion of 
another 2 extra U (in RNA) nucleotides immediately after the WTSLa5045*2 (at 
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position 5108). This nucleotide insertion resulted in an increase to 8 nucleotides 
distance of the SG RNA initiation site from WTSLa5045*2 and designated as Ψ4 – 
WT+8 (Figure 7.18b).  
(3) The Ψ4 – TL-dis construct was designed to examine any contribution of the 
terminal loop sequence in the function of SLa5045*2, and was assessed by changing 
the nucleotides C5092U and A5095G (on positive strand) or G5092A and U5095C 
(on negative strand RNA) (Figure 7.18b).  
(4) The polarity (positive or negative strand RNA) in which SLa5045*2 may function 
was examined by changing the 7 nucleotides stretch of the SLa5045*2 stem. This 
change only permits the formation of such RNA structure in the positive or negative 
strand RNA. The G•U base pair stretch was introduced in the positive or negative 
strand RNA by replacing all the 7 nucleotides of the WT base paired sequences at 
the lower stem of SLa5045*2 as described for the Ψ4 – SL+ and Ψ4 – SL- constructs 
(Figure 7.18a) and as illustrated in the RNA structure (Figure 7.18b). This approach 
also may determine the mechanism (internal initiation or premature termination) 
employed by MNV to produce the SG RNA. If the G•U base pair functions on the 
positive strand, this would indicate that the premature termination mechanism is 
employed. However, if the mentioned base pairs function on the negative strand, it 
would suggest that an internal initiation mechanism is likely employed. 
(5) Finally, the role of the terminal stem which consists of 3 nucleotide base pairs 
(one G•U and two G-C) was also examined by disruption of such stem base pairing 
in the Ψ4 – S2+ construct (Figure 7.18a). The introduced nucleotide substitutions of 
G5096U, G5097U and A5098U (on positive strand) or C5096A, C5097A and U5098A 
(on negative strand) disrupted the formation of the stem on both positive and 
negative polarity RNA since the C and U (on positive sense) or G and A (on negative 
sense) cannot form a base pair (Figure 7.18b).  
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 (a) 
                     
 
(b)  
      
      
Figure 7.18 Generation of various mutant SLa5045*2 constructs in duplicate 
background Ψ4 cDNA. (a) The name and description of the SLa5045*2 mutant 
constructs generated. Various type of mutations were introduced into the SLa5045*2 by 
mutagenesis PCR using the mutagenesis forward primers and reverse primer 6034R 
(Table 2.1) and Ψ4 plasmid as template. The resulted PCR insert was cloned into the Ψ4 
plasmid by using the unique Cla I and Sac II sites. (b) Schematic representation to 
illustrate RNA secondary structures from the SLa5045*2 mutant cDNA clones. The 
number next to the nucleotide of the stem loop represents the nucleotide position in MNV 
genome on the antisense polarity (3’ to 5’). The blue font represents SLa5045*2 and the 
red font represents the introduced mutations. The grey shaded sequence is the unpaired 
nucleotides which determined the distance between the stem loop structure with the SG 
RNA initiation site. 
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 All the correct constructs (in Figure 7.18a) were confirmed by sequence 
analysis and the ability of each clone to produce infectious virus was tested by 
employing the RNA based reverse genetics system. In vitro transcribed and 
enzymatically capped RNA from each of the plasmids were generated as described 
in Section 2.11 and subjected to the RNA based revere genetics system by 
transfection into the BSR-T7 cells. Protein samples and viruses were harvested at 
24h post transfection as described previously. From the western blot analysis of NS7 
as a target, all the transfected RNA expressed the virally encoded NS7 except the 
Ψ4 – WT+10. Therefore, this clone was excluded from subsequent analysis. The 
comparable expression levels of NS7 from all the RNAs transfected indicated that all 
the RNAs were transfected at approximately the same efficiency (Figure 7.19a, 
bottom panel). However, the TCID50 data revealed that only the Ψ4–m53r and Ψ4–
TL-dis were able to produce infectious virus with a very low titre, just above the 
detection limit of ~63 TCID50/ml (Figure 7.19a, top panel). To further confirm this 
observation, each recovery samples were subjected to subsequent amplification by 
infecting the RAW264.7 cells until the c.p.e was observed. From a rough preliminary 
observation, only RAW264.7 cells infected with the Ψ4–m53r and Ψ4–TL-dis 
recoveries produced the c.p.e at ~3 days post infection (data not shown). 
Subsequent TCID50 analysis confirmed the observed c.p.e as mentioned above, with 
only the Ψ4–m53r and Ψ4–TL-dis amplifications in RAW264.7 cells producing 
infectious viruses with titres of 9.6 X 103 and 4.5 X 103 TCID50/ml respectively 
(Figure 7.19b). This data indicated that the compensatory mutations of m53r in the 
SLa5045*2, which presumably restored the formation of the duplicate stem loop, 
restored replication as expected. In addition, the ability of Ψ4–TL-dis clone to 
produce virus from the reverse genetics system suggests that the sequences in the 
terminal loop are not essential for the function of the SLa5045 stem loop.  
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 Based on the data presented above, we can draw a number of conclusions 
on the relative requirements for the function of SLa5045 in the context of the stem-
loop duplicated virus; firstly, the spacing of the stem loop and the SG RNA start site 
suggests that the conserved 6 nucleotides distance is required for efficient SG RNA 
synthesis. Secondly, the stem of the terminal loop was found to be vital for the 
function of this SLa5045*2. Complete disruption of this stem in the clone Ψ4–S2+, 
(a) 
                 
 
(b) 
                                
Figure 7.19 Effect of various SLa5045*2 mutants in duplicate background (Ψ4) on 
viral recovery as examined by RNA based reverse genetics system. (a) Top panel: 
Titre of recovered infectious viruses from RNA based reverse genetics system by TCID50 
assay.  Equal amount of in vitro transcribed RNA generated from the respective mutant 
cDNA were transfected into the BSR-T7 cells as described in Section 2.13.2. Viruses were 
harvested at 24h post transfection and subjected to TCID50 assay. Bottom panel: Western 
blot analysis of the respective cell lysate samples targeted against NS7. The cell lysates 
were prepared in RIPA buffer at 24h post transfection as described in Section 2.20 (b) 
TCID50 analysis of amplified (passage 1) SLa5045*2 mutant in Ψ4 background viruses. 
The recovered viruses from assay in (a) were subjected to amplification by infecting 
RAW264.7 cells. Once the cytophatics effect (c.p.e) was observed, the viruses were 
harvested by one freeze thaw cycle and were precleared by filtration before being 
subjected to TCID50 assay. 
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which disrupts the structure in both the positive and negative strand polarity RNA, 
prevented viral replication. Finally, the inability to recover infectious viruses from the 
Ψ4–SL+ and Ψ4 – SL- clones (Figure 7.19) however, prevented a conclusion to be 
drawn regarding the polarity in which the SLa5045 functions. It is possible that the 
introduced G•U base pairing to try to determine which strand the SLa5045 functions 
on was not strong enough to form a stable RNA structure. The number of hydrogen 
bonds in this introduced G•U stem loop was less than the number of hydrogen bonds 
in the WT and the m53r stem loop. Therefore, it was likely that the introduced G•U 
base pair did not form the stable stem loop structure in the Ψ4–SL+ and Ψ4 – SL- 
clones, thus affecting the virus SG RNA synthesis and replication.  
7.2.7.4 Replication competent SLa5045*2 viruses produce an authentic 
 5’end SG RNA messenger in infected cells 
 5’ rapid amplification of cDNA ends (RACE) was performed to determine the 
sequence of the 5’ end of the viral SG RNA produced by SLa5045*2 mutant viruses. 
Viral RNAs were extracted from RAW264.7 cells infected with passage 1 Ψ1 (WT-
WT), Ψ3 (WT-m53) or Ψ3-m53r viruses and subjected to 5’ RACE as described in 
Section 2.22. The same reaction was also performed for WT MNV viral RNA 
extracted from WT virus infected RAW264.7 cells as a positive control. Briefly, all the 
purified cDNAs were first subjected to the 3’end poly(C) tailing reaction catalysed by 
terminal transferase. The resulting 3’end tailed cDNA was then employed as a 
template for PCR reaction using an anchor primer (which binds to the poly(C) 3’end 
of cDNA) and the 5414R reverse primer. All the purified PCR products were then 
subjected to TA cloning and several clones were selected for DNA plasmid extraction 
and subsequent DNA sequence analysis. All the PCR products obtained from the 
amplification reactions were of the expected size of about 400 bp (Figure 7.20a). The 
specificity of RACE PCR amplification was confirmed since there were no 
amplification products obtained from the control reactions which did not contain any 
cDNA template (- lane in Figure 7.20a).  
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 As a positive control, sequence analysis of the 5’ end sequence for WT SG 
RNA revealed that the MNV SG RNA starts at position 5052 (Figure 7.20b). This 
observation confirms that the SG RNA initiation site for MNV is at position 5052 
relative to the full-length G RNA as predicted by Simmonds et al. Furthermore, 
sequence analysis of various clones obtained from the cloning of the respective 
RACE PCR products into the TA cloning vector revealed that all the mutant 
SLa5045*2 viruses produced the authentic 5’ end SG RNA sequence (at position 
5115) (Figure 7.20a). This sequence analysis data also further confirms that the 
(a)  
                                
 
(b)  
 
 
Figure 7.20 Determination of the sequence of the 5’ end of SG RNA produced by 
SLa5045*2 mutant viruses during the replication in infected cells. (a) The 5’end rapid 
amplification of cDNA ends (RACE) assay to determine the 5’ end sequence of SG RNA 
for  positive control WT virus and SLa5045*2 mutant viruses Ψ1, Ψ3 and Ψ4-m53r. The 
RACE PCR amplification was carried out by employing the cDNAs generated from the 
viral RNAs that were extracted from RAW264.7 cells infected with the passage 1 mutant 
viruses. The PCR reactions were carried out using 5414R reverse primer, anchored primer 
(included in the 5’ end RACE kit, Invitrogen) and the 3’ end poly(C) cDNA template. As 
negative control, the reactions without cDNA template were also carried out. All PCR 
amplification products were resolved in 0.8% agarose gel electrophoresis and visualise by 
UV after EtBr staining. (b) Sequence analysis of the 5’ end SG RNA produced by WT 
virus and SLa5045*2 mutant viruses. The obtained RACE PCR products in (a) were 
subjected to TA cloning and several clones for each RACE PCR were subjected to DNA 
plasmid extraction and purification prior to DNA sequencing reaction. The obtained DNA 
sequences were analysed using the Vector NTI software from Invitrogen. The asterisk 
symbols represent the nucleotide alignment of DNA sequences for SG RNA region of 
MNV as represented by full length cDNA MNV infectious clone.  
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second stem-loop (SLa5045*2) is sufficient to promote the initiation of the SG RNA 
synthesis at the second introduced SG RNA initiation site at position 5115, rather 
than the original position at 5052.  
 
7.3 Discussion 
 The genome of positive strand RNA viruses contain secondary or more 
complex higher order RNA structures which play important functional roles in their life 
cycle. Such important functional RNA structures are known as cis-acting RNA 
elements (cre). Generally, the cre at 5’ and 3’ UTRs of viral genome accommodates 
several functional domains which are involved in translation and replication. In the 
case of PV, an RNA element at the 5’ UTR called the clover leaf structure (CL), is 
required for both replication and translation through RNA-protein interactions 
(Gamarnik and Andino, 1998; Parsley et al., 1997; Xiang et al., 1995). This structure 
is followed by an IRES element that facilitates viral polyprotein translation (Pelletier 
and Sonenberg, 1988). A small stem loop structure at the 5’ end of the HCV genomic 
5’ UTR, called domain I, is also required for viral replication (Luo et al., 2003). This is 
followed by the other three domains (II-IV) in the IRES element which are required for 
translation and also aid the replication process (Jang, 2006; Kim et al., 2002). Other 
functional RNA elements are also located at the 3’UTR of the PV and HCV genomes, 
which possess essential signals for viral replication through the synthesis of minus 
strand RNA by RNA-RNA and RNA-protein interactions (Liu et al., 2009b).  
 One of the distinguishing characteristics of calicivirus genomes is that they 
contain very short 5’ UTRs of 5 and 4 nucleotides preceeding the coding region in the 
G and SG RNA, respectively. Therefore, any functional RNA elements are likely to 
also be located within the coding region. The presence of RNA structures has been 
predicted in the first 150 nucleotides of the calicivirus genome (Simmonds et al., 
2008). Mutagenesis studies that disrupted the two stem loop structures immediately 
adjacent to the MNV 5’ UTR resulted in a significant reduction in viral titre but no 
inhibition of translation (Simmonds et al., 2008). This data implies that these RNA 
structures near the 5’ UTR of MNV are not crucial for viral replication and translation. 
This was not surprising as calicivirus translation initiation is not dependent on cap or 
IRES elements as is the case for PV or HCV. Instead, the translation initiation is 
mediated by interaction between the initiation factor eIF4E with viral VPg which is 
linked to the 5’ end of the G and SG RNA (Goodfellow et al., 2005). In addition, the 
3’UTR of MNV contains three stem loop structures which have been biochemically 
mapped and shown to interact with the polypyrimidine tract-binding (PTB) and 
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poly(C)-binding proteins (PCBPs) with the 3’ proximal stem loop being functionally 
important for replication in tissue culture (Bailey et al., 2010b; Simmonds et al., 
2008).  
 As observed for other positive strand RNA viruses, functional RNA elements 
are also frequently found deep within viral coding regions. This includes the 
identification of RNA structures in the NS5B region of HCV which are important for 
replication and also the well-established role of the 2C-cre of PV that is required for 
VPg uridylation (Goodfellow et al., 2000; Goodfellow et al., 2003; You et al., 2004). In 
the case of MNV, a small stem loop structure at the ORF1-ORF2 junction was 
identified which potentially contains a functional RNA element (Simmonds et al., 
2008). This small stem loop (SLa5045) was suggested to play a role as a promoter in 
SG RNA synthesis. The internal initiation mechanism has been established for RHDV 
(an animal calicivirus) SG RNA synthesis by in vitro mapping using a nested set of 
different length minus strand SG RNAs as templates during in vitro RdRp driven SG 
RNA synthesis assays (Morales et al., 2004). Furthermore, mutagenesis studies of 
SLa5045 (which is slightly more stable on the negative strand) showed that this stem 
loop structure (not the primary sequence) is important for viral replication (Simmonds 
et al., 2008). In addition, the emergence of revertant viruses naturally selected with 
repairs to the m53 mutation in SLa5045 signifies the importance of this SLa5045 
structure in MNV replication (Figure 7.5). This reliance on only secondary structure is 
in contrast to the hepatitis E virus (HEV) and barley yellow dwarf virus (BYDV), which 
also produce a SG RNA via the same mechanism but which require both primary 
RNA sequence and secondary structure of the promoter to be intact (Cao et al., 
2010; Koev et al., 1999). Further examination of SLa5045 using the VP2 fusion 
Renilla luciferase reporter tagged replicon in this chapter confirmed that this RNA 
element upstream of the SG RNA start site of MNV likely functions as a promoter for 
the transcription of SG RNA synthesis, as indicated by the levels of expression of 
Renilla luciferase in the reporter replicons (Figure 7.14a, 7.15a and 7.15b). In 
addition, this stem loop may also function on positive strand RNA by contributing to 
the translation reinitiation. This hypothesis is drawn since the data from DNA based 
reporter replicon assays showed that there was a significant increase in luciferase 
level for the replication incompetent replicon construct (POL-) compared to the m53 
and FS constructs (Figure 7.14) This observation however requires further 
investigation.  
 Mutational analysis of m53RevA and m53revG in this chapter showed that 
these nucleotide changes were responsible for the suppression phenotype rather 
than any amino acid change, indicating the potential involvement of long range RNA-
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RNA interactions between SLa5045 and a region ~100 nucleotides upstream of this 
stem loop structure. Such long range RNA-RNA interactions between promoter 
regions are well established with some sequences being up to ~1500 nucleotides 
apart e.g. the nodavirus Flock House virus (FHV) and tombusvirus tomato bushy 
stunt virus (TBSV) have been documented to contain such interactions even though 
these viruses employ a premature termination mechanism for their SG RNA 
synthesis (Choi et al., 2001; Lindenbach et al., 2002). In the MNV however, it is worth 
to note that this long range RNA-RNA interaction presumably occurs on the negative 
strand RNA to produce a suppression effect on the m53 mutation as characterised 
for m53RevA and m53RevG viruses. Our detailed mutational analysis of SLa5045 
was expanded by introducing an identical copy of SLa5045 into the non-coding 
region of MNV. A similar approach was used to characterise the SG RNA promoter 
elements of Rubella virus BYDV (Koev et al., 1999; Tzeng and Frey, 2002). Even 
though the duplicate WT stem loop structure allowed SG RNA synthesis (as shown 
by the recovery of the Ψ1 and Ψ3 viruses) this extra sequence insertion, which is 
adjacent to the authentic WT SLa5045 caused a reduction in viral replication (Figure 
7.17). The two adjacent and identical stem loop structures may possibly have altered 
the interactions with the viral RdRp and other replication factors within the promoter 
region thereby affecting SG RNA synthesis.  
 It should also be noted that there is another putative mechanism for SG RNA 
synthesis of positive strand RNA viruses called discontinuous template synthesis 
involving the generation of non-contiguous minus strands from the genomic template 
(Sztuba-Solinska et al., 2011; White, 2002). In this model, the viral RdRp produces a 
nested series of fragments of the minus strand RNA (3’ co-terminal and 5’ co-
terminal- called leader sequences) through a ‘hopping-step’ mechanism during the 
elongation stage (templated by genomic plus strand RNA). This leader sequence and 
other 3’ co-terminal sequences are joined together during the replication of Equine 
arteritis virus (EAV), a member of the Arteriviridae family (Sawicki and Sawicki, 2005; 
Sztuba-Solinska et al., 2011). However, this mechanism is less likely to be employed 
in this case since the SG RNA of MNV does not contain leader sequences of this 
nature. 
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7.4 Conclusion 
 In this chapter, the role of SLa5045 in MNV replication has been further 
characterised. The identification of SLa5045 by bioinformatics analysis (Simmonds 
et. al. 2008) led to its putative role as the promoter element for MNV SG RNA 
synthesis. By manipulating the replicon system that was developed in Chapter 6, the 
role of this small stem loop in MNV SG RNA synthesis was further analysed. 
Destabilisation of SLa5045 (via the m53 mutation) in the reporter tagged replicon 
was shown to abolish SG RNA transcription (Figure 7.14 and 7.15). This observation 
also demonstrated on a wider scale that SG RNA synthesis in MNV is an indicator of 
efficient viral replication. In addition, this small stem loop may also function on the 
positive strand RNA by aiding the translation reinitiation at the NS7-VP1 junction. 
Therefore, this stem loop may play a dual role in viral viral life cycle. This observation 
however requires further investigations. Furthermore, data from the duplicate 
SLa5045 cDNA constructs proved that the presence of stable and intact stem loop 
structure upstream (downstream on negative strand RNA) of the start site of the MNV 
SG RNA are required for efficient viral replication and specifically for SG RNA 
synthesis through internal initiation mechanism. 
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 All viruses are obligate intracellular parasites. Therefore, their life cycle 
depends solely on the host cell to provide the appropriate environment and 
accessory machinery to support protein translation, genome replication and 
infectious progeny production. Positive strand RNA virus genome replication occurs 
in close association with cellular structures, in particular intracellular membranous 
organelles including the endoplasmic reticulum, endosomes and mitochondria. The 
positive strand RNA genomes act as an mRNA and are translated directly following 
their release from the virion into the cytoplasm. The expression of viral non-structural 
proteins induces the rearrangement of intracellular membranes and leads to the 
formation of membrane vesicles which provide a scaffold for viral replication (Miller 
and Krijnse-Locker, 2008). Studies on PV and HCV provide the best example of how 
host and viral proteins interact to mediate the formation of replication complexes. PV 
subverts the intracellular ER-Golgi trafficking pathway to establish its replication 
complexes where its non-structural proteins 3A and 3CD recruit the host cells factors, 
namely ADP-ribosylation factor (ARF)–guanine nucleotide-exchange factor (GEF) 
known as GBF1 and BIG1/2 respectively, which, in turn recruit ARF1, 3 and 5. These 
ARFs subsequently employ the coatomer protein complex (COPI/II) to form virus-
induced membrane structures (Belov et al., 2007; Belov et al., 2005; Rust et al., 
2001). The HCV proteins NS5A and NS5B have been shown to interact with vesicle-
associated-membrane protein (VAP), which is a cellular multifunctional protein that is 
involved in intracellular transport, including the regulation of COPI-mediated transport 
(ER-Golgi) (Hamamoto et al., 2005). VAP was found to be crucial for the formation of 
HCV replication complexes and RNA replication (Gao et al., 2004). In MNV-1 
infected cells, the establishment of replication complexes has been demonstrated to 
be derived from the endoplasmic reticulum, trans-Golgi apparatus, and endosomes 
(Hyde et al., 2009). MNV genome replication is believed to take place in or on the 
surface of these replication complexes which are adjacent to the nucleus where all 
the non-structural proteins from ORF1 have been shown to associate with dsRNA 
within the replication complexes (Hyde and Mackenzie, 2010; Hyde et al., 2009). 
These data imply that all the viral non-structural proteins are potentially involved in 
viral RNA replication within the replication complex. Among all of these non-structural 
proteins, the NS7, which carries the RdRp enzymatic capabilities, plays a key role in 
viral RNA replication, as has been demonstrated in vitro (Chaudhry et al., 2007; Han 
et al., 2010; Lee et al., 2011; Yunus et al., 2010). To date however, there is no 
published report on any interaction between norovirus RdRps and host cell derived 
proteins or viral proteins during viral infection. This is partly due to the unavailability 
of tissue culture systems to propagate HuNv. Due to this reason, characterisation of 
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the MNV RdRp especially involving the interaction with host cell proteins and viral 
RNA to facilitate the viral genome replication was carried out in this project.  
 The first half of this project aimed to identify MNV NS7 binding partners and 
to identify any potential small peptides that are able to bind to this enzyme with high 
specificity and act as inhibitors. The tandem affinity purification approach was 
employed to screen any potential host cell or viral derived binding partners for NS7. 
In the first attempt, the TAP purification of MNV NS7 was carried out by employing 
RAW264.7 cell lines which stably express the NS7 as an N-terminal fusion to the 
TAP protein. This approach aimed to identify any host cell factors as well as viral 
proteins which may interact with NS7. The RAW264.7 cell was chosen to express the 
NS7 because this cell is permissive to MNV infection. Therefore, infection of 
RAW264.7 stable cell line expressing TAP-NS7 with MNV was predicted to result in 
identification of viral proteins as well as host cell proteins in the final elution product 
from the TAP purification. This hypothesis was drawn since other MNV non-structural 
proteins have been demonstrated to be localised within the viral replication 
complexes, besides the NS7 during infection in RAW264.7 cells (Hyde and 
Mackenzie, 2010). However, no viral or host cells factors were identified as silver 
staining analysis of PAGE gels of the final elution products from infected and 
uninfected NS7-TAP did not identify any other distinct protein bands except the 
overexpressed NS7 (Figure 3.4). This observation is presumably due to the issue 
regarding the level of expression of exogenous fusion NS7 protein in RAW264.7 
cells. Furthermore, potential misfolding of exogenous NS7 because of the N-terminal 
fusion of the TAP tag may have contributed to the mentioned observation also. 
Further attempts using different cell lines system, namely HEK 293T cells, resulted in 
the identification of several host cell proteins which may potentially associate with 
MNV NS7. The identification of guanosine monophosphate reductase (GMPR) and 
N(2)-dimethylguanosine tRNA methyltransferase from TAP purification indicates that 
these proteins could potentially interact with NS7 in infected cells. A GMPR protein 
plays a role in the conversion of nucleoside and nucleotide derivatives of guanine (G) 
to adenine (A) nucleotides, and in the maintenance of the intracellular balance 
between G and A nucleotides. A GMPR enzyme catalyzes the irreversible reductive 
deamination of GMP to IMP (GMP+NADPH+H+→IMP+NH3+NADP+) and participates 
in the re-utilization of free intracellular bases and purine nucleosides. This protein 
has been shown to have high amino acid conservation throughout the eukaryote 
species (Li et al., 2006). In rats, GMPR has been shown to play a role in non-
shivering thermogenesis as evidenced by significant increases in expression in 
brown adipose tissue (BAT) during cold exposure. BAT functions by uncoupling 
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oxidative phosphorylation in the heat production response and GMPR is 
hypothesized to enhance the uncoupling protein-1 (UCP-1) function by reducing 
inhibition of endogenous guanine nucleotides (Salvatore et al., 1998). In humans, a 
GMPR isozyme, namely hGMPR2, has been shown to promote monocytic 
differentiation of HL-60 leukemia cells (Zhang et al., 2003). Any functional 
involvement of this protein in the context of viral infection is unknown. It could be 
hypothesised that during the MNV infection, once the replication complexes have 
been established, the GMPR protein might be concentrated in the replication 
complexes. The interaction between NS7 and this host cell protein may allow 
regulation of the GMP levels in infected cells. Nucleotide level regulation is important 
to provide sufficient adenine or guanine nucleotides as substrates for NS7 to catalyse 
viral RNA synthesis. The N(2)-dimethylguanosine tRNA methyltransferase is involved 
in tRNA processing as it dimethylates a single guanine residue at position 26 of most 
tRNAs using S-adenosyl-L-methionine as the donor of the methyl group (Edqvist et 
al., 1992). This type of methylation is achieved in order to help stabilise the tRNA 
structure. Any functional involvement of this host cell protein during viral infection is 
also unknown. It could be speculated that the interaction of this protein with NS7 is 
achieved in order to stabilise the structure of newly synthesised viral RNA during the 
viral infection. However, these interactions have yet to be further confirmed. If any of 
the identified interactions could be confirmed, they would represent attractive targets 
for antiviral therapeutic intervention.   
 Another study in this project that involved MNV NS7, was the attempted 
identification of small peptides with NS7 binding capacity. Several different 
approaches using a phage display technique were carried out to identify such 
peptides which could potentially inhibit MNV NS7 activity. Even though several 
peptides with binding activity towards purified NS7 were successfully identified 
(Figure 4.5 and 4.6), subsequent specificity assays found that they were not 
specifically bound to NS7. Specificity assays (Figure 4.7 and 4.15) clearly 
demonstrated that the isolated peptide phage against NS7 also bound to other 
recombinant proteins purified within the lab but not to the non-recombinant proteins. 
This observation implies that instead of binding specifically to the NS7, the isolated 
peptide phage presumably binds to the unidentified factor which is only present in the 
recombinant proteins. This unidentified factor could be a small co-purified product 
isolated during the purification of the respective recombinant proteins used in the 
specificity assays. During this study recombinant NS7 and VPg were successfully 
purified. An ELISA assay (Figure 4.13) showed that the purified NS7 and VPg could 
interact directly, which is consistent with reported observations (Belliot et al., 2008; 
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Han et al., 2010). This observation also implies that the recombinant NS7 and VPg 
purified during this study are enzymatically active. Furthermore, the expression of 
recombinant calicivirus NS7 in bacteria often results in the production of active forms 
of recombinant RdRp (Han et al., 2010; Lee et al., 2011; Vazquez et al., 1998). 
However, a more specific RNA synthesis assay could be used to confirm the 
enzymatic activity of these recombinant proteins. The availability of active 
recombinant MNV NS7 and VPg would facilitate future in vitro studies regarding RNA 
replication of MNV. 
 During this project, two methods which contributed to the study of MNV 
replication have been successfully developed. The first one is the development of an 
improved, robust and efficient RNA-based reverse genetics system for MNV (Chapter 
5). The previous reverse genetics system which employs transfection of the MNV 
infectious clone under the T7 driven promoter into BSR-T7 cells produces typically 
103-4 TCID50/ml of recovery yield (Chaudhry et al., 2007). The development of 
another reverse genetics system which uses the transfection of in vitro transcribed 
and enzymatically capped MNV RNA into permissive cells resulted in up to 105-6 
TCID50/ml (Figure 5.2 and 5.4). This improved virus yield is roughly 10 to 100 fold 
more efficient than the previous cDNA-based reverse genetics system. The ability to 
recover virus by transfection of in vitro transcribed and enzymatically capped RNA 
into permissive cells demonstrated the otherwise absolute requirement for covalent 
linkage of VPg to the 5’end of the viral RNA genome could be “avoided” by 
generation of capped MNV transcripts that are presumably recognised by the cellular 
ribosomes. Transfection of capped viral RNA transcripts can therefore mimic the 
authentic viral infection event. Following translation, viral RNA replication can take 
place in a normal manner since all the non-structural proteins are available. 
However, the recovery yield of this recently developed RNA-based reverse genetics 
system is still lower when compared to the yield from the transfection of purified VPg-
linked viral RNA (isolated from infected cells). This technique for generating virus 
typically yields 10-1000 fold more virus at 24h post transfection (Figure 5.5) although 
there are obvious limitations from a reverse genetics perspective. This observation is 
also consistent with the level of recovery from a PV reverse genetics system in which 
the in vitro transcribed RNA shows 10-100 lower infectivity than RNA extracted from 
viral populations (Van der Werf et al., 1986). Therefore, the ability to synthesise such 
VPg-linked MNV RNA transcripts in vitro would presumably provide further 
improvement to the recovery yields of our MNV reverse genetics system. These VPg-
linked RNA transcripts could hypothetically be generated by adding certain ligase 
catalysts or purified MNV RdRp to the in vitro transcription reaction.  
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 The second system developed during this study was the reporter-tagged 
MNV replicon system (Chapter 6) which also had a significant contribution to the 
MNV sub-genomic synthesis investigations. This reporter-tagged MNV replicon 
system provides a tool to study MNV RNA replication in vitro when combined with the 
RNA based reverse genetics system described above. The insertion and expression 
of a reporter gene as a VP2 fusion protein (which is co-translationally separated by 
FMDV 2A protease) has been successfully developed and tested. Even though 
transfection of this reporter-tagged construct did not yield any detectable infectious 
particles, it was used as a bio-marker to quantify active viral RNA genome replication 
in permissive cells. Perhaps the combination of these two techniques could facilitate 
the study of MNV genomic cis-acting RNA elements (RNA-RNA/ RNA-protein 
interactions) or the screening of inhibitors of MNV genome replication in the future. 
 The last part of this project focused on the production of MNV SG RNA 
(Chapter 7). The synthesis of calicivirus SG RNA has often been used as an indicator 
for the existence of genome replication since the production of this smaller RNA (that 
is 3’ co-terminal with the full-length viral genome) is dependent on efficient genome 
replication in infected cells. Furthermore, the transcription of SG RNA at the middle 
and latter stages of infection is also thought to regulate the production of infectious 
virions. Since the capsid proteins of caliciviruses are translated from the SG RNA 
messenger, the encapsidation process is initiated once the viral RNA replication 
begins. Investigating the involvement of functional RNA elements in regulating the 
synthesis of the MNV SG RNA was the specific aim of the final part of this thesis. 
Initially, a small RNA secondary structure at the ORF1/ORF2 junction in the MNV 
genome (referred to as SLa5045) was identified by computational and mutational 
analysis (Simmonds et al., 2008). This small RNA structure was hypothesised to play 
a role in regulating the synthesis of viral SG RNA during genome replication by 
promoting the binding of viral RdRp to the negative strand RNA and internally 
initiating the transcription of SG RNA. Throughout this particular study, the role of the 
SLa5045 stem loop in MNV SG RNA transcription was characterised and confirmed 
by employing the reporter-tagged replicon and reverse genetics systems. 
Furthermore, the generation of mutant viruses by inserting identical SLa5045 outside 
of the NS7 coding region namely SLa5045*2 allowed further characterisation on the 
role of this specific stem loop in regulating the SG RNA synthesis. The ability to 
recover lower yields of infectious virus from reverse genetics system for Ψ1, Ψ3, Ψ4-
m53r and Ψ4-TL-dis (Figure 7.17 and 7.19), indicates that the intact structural 
SLa5045*2 and the 6 nucleotides before the SG RNA start site are required to allow 
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SG RNA synthesis in these mutant viruses. This observation was confirmed by 
employing 5’ end RACE where these mutant viruses produced the authentic 5’end 
SG RNA sequence starting at position 5115 (Figure 7.20). Production of low yield 
infectious mutant virions from reverse genetics implies that insertion of extra 
sequences into the viral genome might affect the authentic viral replication. However, 
in this particular case the generation of SLa5045*2 mutant viruses permitted 
extensive mutagenesis studies to be carried out since any nucleotides changes to 
the SLa5045*2 would not affect the amino acid sequence of the NS7 protein.  
 The exact mechanism of how MNV produces the SG RNA still remains 
unclear, although we are definitely closer to this elusive goal. As mentioned in 
Chapter 7, there are two proposed models either of which could theoretically be 
employed by MNV to synthesise its SG RNA. These are the internal initiation and 
premature termination models. The detection of the minus strand SG RNA length in 
infected cells has been argued to support the premature termination model (Miller 
and Koev, 2000) However, in the case of brome mosaic virus, minus strand SG 
RNA4 has constantly been extracted from infected cells (Ishikawa et al., 1997), even 
though this virus clearly employs an internal initiation mechanism for its SG RNA4 
synthesis. It is possible that the internal initiation (+) SG RNA product could undergo 
independent replication through the synthesis of (-) strand intermediates which in turn 
serve as templates for (+) strand SG RNA. In addition, the requirement for RNA 
secondary structures has also been suggested to support premature termination. 
However, probably all SG RNA promoters require RNA secondary structures 
including those that are known to be synthesised by internal initiation on the (-) 
strand (Haasnoot et al., 2000). Therefore, it is important to determine on which RNA 
strand that this secondary structure functions in order to prove the exact mechanism 
employed by viruses to produce their SG RNA. In this study, attempts to determine 
the exact mechanism for the synthesis of MNV SG RNA was carried out by 
introducing G•U base pairs on the stem of SLa5045*2 to examine whether this stem 
loop functions on the negative or positive strand RNA genome. However, the 
introduced G•U base pairs on both the negative and positive strand mutant virus 
genome did not yield any detectable infectious virus from the reverse genetics 
system. Presumably the substitution of G•U base pairs on the 7 nucleotide stretch of 
the stem structure was not sufficient to stabilise the stem loop structure since this 
nucleotide base pair is thermodynamically less stable than the WT G-C base pair. 
This outcome therefore warrants further study in order to accurately determine which 
mechanism is employed by MNV for the synthesis of its SG RNA. It is unlikely 
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however, the SLa5045 functions on the positive strand RNA as a termination signal 
for RdRp during production of a full-length genome intermediate RNA during 
replication as proposed in the premature termination model. Generally, this 
termination signal would involve long range RNA-RNA interaction as observed for 
TBSV where the stem loop structure upstream of the SG RNA initiation site on the 
positive strand RNA interacts with RNA sequences up to ~1000 nucleotides away at 
the 5’ region in order to form the higher order structure which stalls the RdRp on the 
template during the synthesis of the negative strand intermediate (Wang et al., 2008). 
Therefore, the mechanism for MNV SG RNA synthesis is still thought to be achieved 
by internal initiation where the stem loop functions as a promoter element on the 
negative strand RNA, SLa5045 (Figure 8.1). Further work such as in vitro promoter 
mapping study of this putative promoter element on the negative strand RNA 
template, as been demonstrated for RHDV (Morales et al., 2004) could be carried out 
to examine the mentioned hypothesis. In addition, the enzyme mobility shift assay 
(EMSA) could also be employed to further investigate the interaction between this 
RNA element and the viral RdRp. By using both positive and negative strand RNA as 
substrates it may be possible to determine on which strand this RNA element is 
functioning. This approach has been demonstrated for HCV where a small stem loop 
structure (within the NS5B coding region, termed 5BSL3.2) on the negative strand 
RNA was found to bind viral NS5B protein, presumably to stabilise the replication 
complex for more efficient positive-strand viral RNA synthesis (Kanamori et al., 
2010). 
 
 Identification of m53 mutation suppressor viruses during the study of the SG 
RNA synthesis of MNV indirectly indicates that SLa5045 is functioning on the 
negative strand RNA. A single nucleotide change at the upstream region of the 
mutated functional RNA structure was sufficient to suppress the lethal phenotype of 
the m53 mutation suggesting that the MNV genome could mutate to retain the higher 
             
Figure 8.1 The potential function of SLa5045 on the negative strand RNA. The 
SLa5045 (which as predicted by M-fold has a slightly higher probability to form on the 
negative strand) is proposed to function as a promoter element where the viral RdRp 
interacts directly internally initiating the transcription of SG RNA.  
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order RNA structure of SLa5045. Extensive mutagenesis studies that have been 
performed on the m53 suppressor viruses (m53RevA and m53RevG) indicate that 
the nucleotide changes play the key role in determining the m53 suppression 
phenotype, not amino acid changes in NS7. These single nucleotide changes 
presumably interact with the ‘introduced’ nucleotides (in m53) or with nucleotides 
around the m53 mutation (the negative strand RNA only) and relieve the destabilised 
RNA structure (m53). As a result, this repaired stem-loop could then be recognised 
by RdRp to initiate SG RNA synthesis albeit with a lower efficiency compared to the 
wild type structure (Figure 8.2). This hypothesis warrants further studies.  
 
 In conclusion, genome replication of MNV in infected cells involves complex 
protein-protein, RNA-protein and RNA-RNA interactions. As a key catalyst for MNV 
RNA replication, the viral RdRp interacts with other host cells and viral proteins as 
well as specific RNA elements in the genome in order to regulate this pivotal stage of 
the viral life cycle. Interruption of any of these interactions by inhibitor molecules or 
artificial drugs could lead to the development of an antiviral therapeutic agent. 
Construction of attenuated viruses, which are defective in their pivotal cis-acting RNA 
elements could also possibly lead to the production of new vaccines. 
  
             
Figure 8.2 Proposed mechanism for m53 suppressor viruses. A single nucleotide 
change at the upstream region of the introduced m53 mutation which destabilised the 
SLa5045 is able to interact with the nucleotides within the destabilised stem loop structure 
and forms a higher order RNA structure to minimally retain the function of SLa5045.  
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